<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="review-article"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Vet Sci</journal-id><journal-id journal-id-type="iso-abbrev">Vet Sci</journal-id><journal-id journal-id-type="publisher-id">vetsci</journal-id><journal-title-group><journal-title>Veterinary Sciences</journal-title></journal-title-group><issn pub-type="epub">2306-7381</issn><publisher><publisher-name>MDPI</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">40005917</article-id><article-id pub-id-type="pmc">PMC11860736</article-id><article-id pub-id-type="doi">10.3390/vetsci12020157</article-id><article-id pub-id-type="publisher-id">vetsci-12-00157</article-id><article-categories><subj-group subj-group-type="heading"><subject>Review</subject></subj-group></article-categories><title-group><article-title>Impact of Antimicrobial Resistance of <italic toggle="yes">Pseudomonas aeruginosa</italic> in Urine of Small Companion Animals in Global Context: Comprehensive Analysis</article-title></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0009-0000-0166-8609</contrib-id><name><surname>Pereira</surname><given-names>Ana</given-names></name><xref rid="af1-vetsci-12-00157" ref-type="aff">1</xref><xref rid="af2-vetsci-12-00157" ref-type="aff">2</xref><xref rid="fn1-vetsci-12-00157" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-2326-6226</contrib-id><name><surname>de Sousa</surname><given-names>Telma</given-names></name><xref rid="af2-vetsci-12-00157" ref-type="aff">2</xref><xref rid="af3-vetsci-12-00157" ref-type="aff">3</xref><xref rid="af4-vetsci-12-00157" ref-type="aff">4</xref><xref rid="af5-vetsci-12-00157" ref-type="aff">5</xref><xref rid="fn1-vetsci-12-00157" ref-type="author-notes">&#x02020;</xref></contrib><contrib contrib-type="author"><name><surname>Silva</surname><given-names>Catarina</given-names></name><xref rid="af2-vetsci-12-00157" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0002-6365-0735</contrib-id><name><surname>Igrejas</surname><given-names>Gilberto</given-names></name><xref rid="af3-vetsci-12-00157" ref-type="aff">3</xref><xref rid="af4-vetsci-12-00157" ref-type="aff">4</xref><xref rid="af5-vetsci-12-00157" ref-type="aff">5</xref></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="true">https://orcid.org/0000-0003-0925-689X</contrib-id><name><surname>Poeta</surname><given-names>Patr&#x000ed;cia</given-names></name><xref rid="af1-vetsci-12-00157" ref-type="aff">1</xref><xref rid="af2-vetsci-12-00157" ref-type="aff">2</xref><xref rid="af5-vetsci-12-00157" ref-type="aff">5</xref><xref rid="af6-vetsci-12-00157" ref-type="aff">6</xref><xref rid="c1-vetsci-12-00157" ref-type="corresp">*</xref></contrib></contrib-group><contrib-group><contrib contrib-type="editor"><name><surname>Zhou</surname><given-names>Ziyao</given-names></name><role>Academic Editor</role></contrib><contrib contrib-type="editor"><name><surname>Zhong</surname><given-names>Zhijun</given-names></name><role>Academic Editor</role></contrib></contrib-group><aff id="af1-vetsci-12-00157"><label>1</label>CECAV&#x02014;Veterinary and Animal Research Centre, University of Tr&#x000e1;s-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal; <email>anafilipalp@gmail.com</email></aff><aff id="af2-vetsci-12-00157"><label>2</label>MicroART-Antibiotic Resistance Team, Department of Veterinary Sciences, University of Tr&#x000e1;s-os Montes and Alto Douro, 5000-801 Vila Real, Portugal; <email>telmaslsousa@hotmail.com</email> (T.d.S.); <email>xusilva2002@gmail.com</email> (C.S.)</aff><aff id="af3-vetsci-12-00157"><label>3</label>Department of Genetics and Biotechnology, University of Tr&#x000e1;s-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal; <email>gigrejas@utad.pt</email></aff><aff id="af4-vetsci-12-00157"><label>4</label>Functional Genomics and Proteomics Unit, University of Tr&#x000e1;s-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal</aff><aff id="af5-vetsci-12-00157"><label>5</label>Associated Laboratory for Green Chemistry, University NOVA of Lisbon, 1099-085 Caparica, Portugal</aff><aff id="af6-vetsci-12-00157"><label>6</label>Veterinary and Animal Research Centre, Associate Laboratory for Animal and Veterinary Science (AL4AnimalS), University of Tr&#x000e1;s-os-Montes and Alto Douro, 5000-801 Vila Real, Portugal</aff><author-notes><corresp id="c1-vetsci-12-00157"><label>*</label>Correspondence: <email>ppoeta@utad.pt</email></corresp><fn id="fn1-vetsci-12-00157"><label>&#x02020;</label><p>These authors contributed equally to this work.</p></fn></author-notes><pub-date pub-type="epub"><day>11</day><month>2</month><year>2025</year></pub-date><pub-date pub-type="collection"><month>2</month><year>2025</year></pub-date><volume>12</volume><issue>2</issue><elocation-id>157</elocation-id><history><date date-type="received"><day>09</day><month>1</month><year>2025</year></date><date date-type="rev-recd"><day>02</day><month>2</month><year>2025</year></date><date date-type="accepted"><day>06</day><month>2</month><year>2025</year></date></history><permissions><copyright-statement>&#x000a9; 2025 by the authors.</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link>).</license-p></license></permissions><abstract abstract-type="plain-language-summary"><title>Simple Summary</title><p>Pets and humans are increasingly being infected with multidrug-resistant bacteria. <italic toggle="yes">Pseudomonas aeruginosa</italic> is a significant challenge in clinic practice due to its resistance to multiple antibiotics. This study aims to review the global prevalence and resistance patterns of <italic toggle="yes">Pseudomonas aeruginosa</italic> in small animals with urinary tract infection in order to improve management strategies for emerging MDR bacteria.</p></abstract><abstract><title>Abstract</title><p>The isolation of multidrug-resistant (MDR) bacteria from the urinary tracts of pets is increasingly common, particularly in animals with concurrent health conditions. <italic toggle="yes">Pseudomonas aeruginosa</italic> (PA) is one of the most significant antimicrobial-resistant bacteria affecting cats and dogs within the European Union (EU). This study aims to review the prevalence and antimicrobial resistance patterns of PA isolated from urine samples of small animals globally. This pathogen is known for its opportunistic infections and is a significant concern in veterinary medicine due to its inherent resistance to multiple antibiotics and its ability to acquire additional resistance mechanisms. This review seeks to enhance educational initiatives regarding the management of emerging MDR bacteria.</p></abstract><kwd-group><kwd><italic toggle="yes">Pseudomonas aeruginosa</italic></kwd><kwd>urinary tract infections</kwd><kwd>small animals</kwd><kwd>resistance patterns</kwd><kwd>veterinary medicine</kwd></kwd-group><funding-group><award-group><funding-source>FCT (Funda&#x000e7;&#x000e3;o para a Ci&#x000ea;ncia e a Tecnologia)</funding-source><award-id>2020.05332.BD</award-id><award-id>UI/00772</award-id><award-id>LA/P/0059/2020</award-id></award-group><funding-statement>This research was funded by FCT (Funda&#x000e7;&#x000e3;o para a Ci&#x000ea;ncia e a Tecnologia), associated with a Ph.D. grant with the reference 2020.05332.BD, and the projects UI/00772 and LA/P/0059/2020.</funding-statement></funding-group></article-meta></front><body><sec sec-type="intro" id="sec1-vetsci-12-00157"><title>1. Introduction</title><p>Bacterial urinary tract infections (UTIs) are commonly diagnosed in veterinary medicine and are among the leading causes of antibiotic prescriptions [<xref rid="B1-vetsci-12-00157" ref-type="bibr">1</xref>,<xref rid="B2-vetsci-12-00157" ref-type="bibr">2</xref>]. Over the past two decades, there has been a reported increase in MDR bacteria associated with UTIs in companion animals [<xref rid="B3-vetsci-12-00157" ref-type="bibr">3</xref>]. This trend poses therapeutic challenges and public health concerns, as direct contact between humans and pets facilitates the transmission of MDR bacteria [<xref rid="B3-vetsci-12-00157" ref-type="bibr">3</xref>,<xref rid="B4-vetsci-12-00157" ref-type="bibr">4</xref>]. A wide variety of bacterial agents can cause UTIs, with <italic toggle="yes">Escherichia coli</italic> (<italic toggle="yes">E. coli</italic>) being the most frequently isolated pathogen in canines, felines, and even humans [<xref rid="B5-vetsci-12-00157" ref-type="bibr">5</xref>,<xref rid="B6-vetsci-12-00157" ref-type="bibr">6</xref>]. Other organisms, such as <italic toggle="yes">Pseudomonas aeruginosa</italic>, are less commonly found in uncomplicated UTIs, but become prominent in animals with recurrent infections and often exhibit multidrug resistance [<xref rid="B7-vetsci-12-00157" ref-type="bibr">7</xref>,<xref rid="B8-vetsci-12-00157" ref-type="bibr">8</xref>].</p><p>The prevalence and the percentage of resistance of PA to certain antibiotics associated with UTIs in cats and dogs have been poorly characterized in veterinary medicine [<xref rid="B9-vetsci-12-00157" ref-type="bibr">9</xref>].</p><p>Understanding which pathogens are prevalent in pet populations and their resistance patterns allows for more effective treatment options, reduces the risk of zoonotic infections, and facilitates the development of targeted interventions. This knowledge also supports responsible antibiotic use in veterinary medicine, helping to mitigate the growing concern of antibiotic resistance that can impact both animal and human health. By fostering a collaborative approach between veterinarians, pet owners, and public health officials, we can enhance overall community health and ensure safer environments for both pets and their human companions. Thus, the objectives of this review are to summarize the prevalence of PA in UTIs in small animals and to provide a clinical approach to managing these patients.</p><p>The classification of antibiotic resistance for PA will be carried out in accordance with Magiorakos et al. [<xref rid="B10-vetsci-12-00157" ref-type="bibr">10</xref>]. Thus, MDR (multidrug-resistant) bacteria refers to bacteria that demonstrate nonsusceptibility to at least one agent in three or more categories of antimicrobial agents. Bacteria classified as XDR are nonsusceptible to at least one agent in all categories of antimicrobial agents but remain susceptible to two or fewer categories. PDR (pan-drug-resistant) bacteria exhibit nonsusceptibility to all agents in all categories of antimicrobial agents. The term ESKAPE pathogens refers to a group of six bacterial pathogens&#x02014;<italic toggle="yes">Enterococcus faecium</italic>, <italic toggle="yes">Staphylococcus aureus</italic>, <italic toggle="yes">Klebsiella pneumoniae</italic>, <italic toggle="yes">Acinetobacter baumannii</italic>, <italic toggle="yes">Pseudomonas aeruginosa</italic>, and <italic toggle="yes">Enterobacter</italic> spp.&#x02014;which pose a significant threat due to their ability to escape the effects of antibiotics. The therapeutic options for infections caused by ESKAPE pathogens are increasingly limited, necessitating ongoing surveillance and the development of new antimicrobial strategies [<xref rid="B11-vetsci-12-00157" ref-type="bibr">11</xref>].</p></sec><sec sec-type="methods" id="sec2-vetsci-12-00157"><title>2. Methods</title><p>The research documents analyzed in this work were extracted from the Elsevier Scopus and PubMed databases. The search queries (TITLE-ABS-KEY({<italic toggle="yes">Pseudomonas aeruginosa</italic>}), (TITLE-ABS-KEY({antibiotic resistance}), and (TITLE-ABS-KEY({nosocomial infection }) were used in February 2020 for collecting academic documents and patents including &#x0201c;<italic toggle="yes">Pseudomonas aeruginosa</italic>&#x0201d; and/or &#x0201c;antibiotic resistance&#x0201d; and/or &#x0201c;nosocomial infection&#x0201d; terms in the title, abstract, and/or keywords, from the year 2000. Only publications in English were included. The articles from the search were assessed according to document type, language, and inclusion of subject categories. They were further analyzed, and the results were used to write this review. The article selection process was carried out manually, based on information extracted from the databases. No specific software was used to include the articles, although the management of the search and references was facilitated by tools such as Mendeley.</p></sec><sec id="sec3-vetsci-12-00157"><title>3. <italic toggle="yes">Pseudomonas aeruginosa</italic></title><p>PA are opportunistic and ubiquitous Gram-negative bacteria that play a significant role in nosocomial infections [<xref rid="B11-vetsci-12-00157" ref-type="bibr">11</xref>,<xref rid="B12-vetsci-12-00157" ref-type="bibr">12</xref>]. This pathogen has the capacity to infect multiple anatomical sites across various animal species, including humans [<xref rid="B12-vetsci-12-00157" ref-type="bibr">12</xref>,<xref rid="B13-vetsci-12-00157" ref-type="bibr">13</xref>]. In recent years, there has been an alarming rise in MDR strains of PA [<xref rid="B14-vetsci-12-00157" ref-type="bibr">14</xref>] attributed to their ability to resist a variety of antibiotics, including aminoglycosides, quinolones, and &#x003b2;-lactams, as well as the emergence of new carbapenemase-producing strains [<xref rid="B15-vetsci-12-00157" ref-type="bibr">15</xref>]. The urgent need for the development of new antibiotics against these pathogens led to PA being included as an &#x0201c;ESKAPE&#x0201d; pathogen and classified as one of the &#x0201c;high-priority pathogens&#x0201d; by the World Health Organization (WHO) [<xref rid="B16-vetsci-12-00157" ref-type="bibr">16</xref>,<xref rid="B17-vetsci-12-00157" ref-type="bibr">17</xref>,<xref rid="B18-vetsci-12-00157" ref-type="bibr">18</xref>].</p><sec id="sec3dot1-vetsci-12-00157"><title>3.1. Pathogenesis and Virulence Factors</title><p>PA is most associated with otitis in dogs; however, due to its opportunistic nature, it can also lead to a wide variety of other infections. Hattab et al. [<xref rid="B19-vetsci-12-00157" ref-type="bibr">19</xref>], G&#x000f3;mez et al. [<xref rid="B13-vetsci-12-00157" ref-type="bibr">13</xref>] and D&#x000e8;gi et al. [<xref rid="B20-vetsci-12-00157" ref-type="bibr">20</xref>] reported higher incidences of this pathogen in ear infections, skin infections, and, to a lesser extent, urinary tract infections. In cats, although infections caused by PA are less common, they predominantly affect the respiratory tract and rarely the urinary tract [<xref rid="B21-vetsci-12-00157" ref-type="bibr">21</xref>,<xref rid="B22-vetsci-12-00157" ref-type="bibr">22</xref>].</p><p>Understanding host&#x02013;pathogen interaction is critical for the development of effective therapeutic strategies to control damage to the bladder [<xref rid="B23-vetsci-12-00157" ref-type="bibr">23</xref>,<xref rid="B24-vetsci-12-00157" ref-type="bibr">24</xref>]. The pathogenesis of this bacteria has not yet been clarified, but recent molecular reports have shown some advance in understanding it. Host colonization by uropathogens occurs in the lumen of the bladder within the stratified epithelium [<xref rid="B24-vetsci-12-00157" ref-type="bibr">24</xref>]. PA has an arsenal of extracellular products, such as pyocyanin, exotoxin A, and elastase, that damage the host tissue and impair the immune system response [<xref rid="B25-vetsci-12-00157" ref-type="bibr">25</xref>]. PA is a versatile pathogen known for its cytotoxic and invasive capabilities. Recent scientific evidence has shown that it can exhibit both intracellular and extracellular behaviors [<xref rid="B24-vetsci-12-00157" ref-type="bibr">24</xref>,<xref rid="B26-vetsci-12-00157" ref-type="bibr">26</xref>]. However, there is extensive evidence that PA preferentially binds to, invades, and injures wounded epithelium [<xref rid="B27-vetsci-12-00157" ref-type="bibr">27</xref>,<xref rid="B28-vetsci-12-00157" ref-type="bibr">28</xref>,<xref rid="B29-vetsci-12-00157" ref-type="bibr">29</xref>]. When uroepithelium is infected or traumatized, the superficial layers undergo exfoliation. As a result, the deeper layers are exposed, and may subsequently become colonized; it is within these underlying epithelial layers that uropathogens may persist in a quiescent state [<xref rid="B24-vetsci-12-00157" ref-type="bibr">24</xref>,<xref rid="B30-vetsci-12-00157" ref-type="bibr">30</xref>]. The ability of PA to survive intracellularly may play a significant role in contributing to the chronicity and recurrence of urinary tract infection [<xref rid="B24-vetsci-12-00157" ref-type="bibr">24</xref>]. Interestingly, in humans, it has been shown that <italic toggle="yes">PA</italic> UTIs result in higher readmission rates compared to UTIs caused by other uropathogens, underscoring the clinical importance of this problem [<xref rid="B31-vetsci-12-00157" ref-type="bibr">31</xref>].</p><p>PA can adapt to hostile environments within hosts by secreting a variety of virulence factors that contribute to successful infection and disease manifestation. For instance, it contains lipopolysaccharide (LPS), which protects the external leaflet and damages host cells [<xref rid="B32-vetsci-12-00157" ref-type="bibr">32</xref>]. It can promote tissue damage, facilitate attachment, and enhance recognition by host receptors. LPS has also been implicated in antibiotic tolerance and biofilm formation [<xref rid="B33-vetsci-12-00157" ref-type="bibr">33</xref>]. The outer membrane proteins (OMPs) play a significant role in nutrient exchange, adhesion, and antibiotic resistance [<xref rid="B34-vetsci-12-00157" ref-type="bibr">34</xref>].</p><p>The production of flagella and type IV pili facilitates adherence to the host and is responsible for motility through the urinary tract, enabling its colonization of the bladder and kidneys [<xref rid="B25-vetsci-12-00157" ref-type="bibr">25</xref>]. A possesses secretion systems that are vital for colonization of the host, adhesion, swimming, and swarming in response to chemotactic signals [<xref rid="B35-vetsci-12-00157" ref-type="bibr">35</xref>]. Hemolysin production enhances the ability to cause kidney infection [<xref rid="B36-vetsci-12-00157" ref-type="bibr">36</xref>].</p><p>Biofilm, a structured community of bacteria encased in a protective extracellular matrix, is a crucial virulence factor in PA. Biofilm formation by PA on catheters or within the bladder can enhance resistance to host immune responses and antibiotic treatment, making infections difficult to eradicate. Numerous studies in both human and veterinary medicine have reported that PA with biofilms exhibit resistance to various biocides, such as quaternary ammonium compounds, chlorine-based disinfectants, aldehydes such as glutaraldehyde, triclosan, benzalkonium chloride, chlorhexidine, hydrogen peroxide-based disinfectants, and 2-phenoxyethanol [<xref rid="B15-vetsci-12-00157" ref-type="bibr">15</xref>,<xref rid="B37-vetsci-12-00157" ref-type="bibr">37</xref>]. Quorum sensing systems are also crucial, as they enable PA to form biofilms and coordinate its behavior based on population density [<xref rid="B38-vetsci-12-00157" ref-type="bibr">38</xref>]. The pathogenesis of PA consists in its ability to adhere and colonize, form biofilms, produce virulence factors, evade immune responses, and remain in the host tissue [<xref rid="B35-vetsci-12-00157" ref-type="bibr">35</xref>].</p></sec><sec id="sec3dot2-vetsci-12-00157"><title>3.2. The Opportunistic Behavior</title><p>The urinary tracts of dogs and cats exhibit anatomical and physiological differences that influence their susceptibility to PA infection. In dogs, the longer and narrower male urethra, along with the presence of the prostate gland, provides additional barriers to bacterial colonization, whereas the shorter female urethra facilitates bacterial ascension, increasing the risk of UTI. In cats, the male urethra is also narrow, but the prevalence of UTIs is lower due to the unique composition of the feline urobiome and the lower incidence of underlying predisposing conditions compared to dogs [<xref rid="B39-vetsci-12-00157" ref-type="bibr">39</xref>]. Significant physiological differences include urine concentration. Cats have an extraordinary ability to concentrate urine, an adaptive trait that reduces urine volume and may limit bacterial proliferation. However, this also increases the risk of crystalluria and urethral obstruction [<xref rid="B40-vetsci-12-00157" ref-type="bibr">40</xref>].</p><p>In humans, the composition of the urobiome and personal hygiene practices play a critical role in preventing urinary infections. Additionally, close contact with pets may act as a vector for MDR pathogens [<xref rid="B41-vetsci-12-00157" ref-type="bibr">41</xref>]. Studies indicate that the pathogenesis of PA in the urinary tract is closely associated with its ability to form biofilms, a characteristic observed in both humans and animals [<xref rid="B42-vetsci-12-00157" ref-type="bibr">42</xref>]. However, cats appear to mount a more effective immune response against initial PA infections, which may account for their lower incidence compared to dogs. In contrast, the predisposition of dogs to chronic conditions such as diabetes and kidney disease may contribute to their higher rates of PA infection [<xref rid="B41-vetsci-12-00157" ref-type="bibr">41</xref>].</p><p>Dogs and cats can acquire PA infections through environmental exposure (contaminated water, soil, surfaces), inhalation, or animal bites [<xref rid="B25-vetsci-12-00157" ref-type="bibr">25</xref>,<xref rid="B43-vetsci-12-00157" ref-type="bibr">43</xref>]. However, nosocomial infections are more common, reflecting their opportunistic nature. PA requires compromised epithelial barriers to invade and proliferate [<xref rid="B44-vetsci-12-00157" ref-type="bibr">44</xref>]. This explains the increased risk in immunocompromised animals, those with trauma, tumors, catheters, prolonged immobilization, and recurrent UTIs [<xref rid="B45-vetsci-12-00157" ref-type="bibr">45</xref>,<xref rid="B46-vetsci-12-00157" ref-type="bibr">46</xref>,<xref rid="B47-vetsci-12-00157" ref-type="bibr">47</xref>]. </p><p>In humans, the presence of patients in hospitals for more than 30 days increases the risk of acquiring a UTI by almost 100% [<xref rid="B48-vetsci-12-00157" ref-type="bibr">48</xref>]. Although, in a veterinary oncology study, PA was isolated in 11% of patients, but only 3.6% were implicated in UTIs [<xref rid="B49-vetsci-12-00157" ref-type="bibr">49</xref>]. Broad-spectrum antibiotic use (cephalosporins, aminoglycosides) is a risk factor for MDR PA [<xref rid="B30-vetsci-12-00157" ref-type="bibr">30</xref>]. While PA accounts for 10&#x02013;15% of human nosocomial infection, comparable data in veterinary medicine are lacking [<xref rid="B18-vetsci-12-00157" ref-type="bibr">18</xref>,<xref rid="B50-vetsci-12-00157" ref-type="bibr">50</xref>,<xref rid="B51-vetsci-12-00157" ref-type="bibr">51</xref>]. On the other hand, a study involving 32 canines with renal disease found that PA was the most frequently isolated microorganism in culture [<xref rid="B52-vetsci-12-00157" ref-type="bibr">52</xref>].</p><p>PA is a significant uropathogen in catheterized patients due to its ability to adhere to catheter surfaces and form robust biofilms which facilitate its establishment and persistence in the urinary tract [<xref rid="B18-vetsci-12-00157" ref-type="bibr">18</xref>,<xref rid="B53-vetsci-12-00157" ref-type="bibr">53</xref>]. On the other hand, urinary catheters disrupt the bladder&#x02019;s natural defenses, increasing susceptibility to bacterial colonization and ascending infection [<xref rid="B5-vetsci-12-00157" ref-type="bibr">5</xref>,<xref rid="B18-vetsci-12-00157" ref-type="bibr">18</xref>,<xref rid="B54-vetsci-12-00157" ref-type="bibr">54</xref>]. Bacteriuria in catheterized animals is notably high (10% to 55%), but the prevalence of PA in these cases is unknown [<xref rid="B55-vetsci-12-00157" ref-type="bibr">55</xref>,<xref rid="B56-vetsci-12-00157" ref-type="bibr">56</xref>]. A recent study by Ataya et al. [<xref rid="B46-vetsci-12-00157" ref-type="bibr">46</xref>] demonstrated a low incidence of PA in these patients but a high prevalence of PA MDR strains.</p></sec><sec id="sec3dot3-vetsci-12-00157"><title>3.3. Antimicrobial Resistance</title><p>Once established on host tissue, PA employs a combination of intrinsic, acquired, and adaptive resistance mechanisms to survive and resist antibiotics (see <xref rid="vetsci-12-00157-t001" ref-type="table">Table 1</xref>) [<xref rid="B15-vetsci-12-00157" ref-type="bibr">15</xref>,<xref rid="B57-vetsci-12-00157" ref-type="bibr">57</xref>].</p><p>Intrinsic mechanisms include outer membrane permeability, which can be reduced by modulating porins, and the production of antibiotic-inactivating enzymes such as &#x003b2;-lactamases and aminoglycoside-modifying enzymes. Additionally, the efflux system plays a key role in removing harmful agents from within the bacterial cell, with the overexpression of efflux pumps being associated with MDR.</p><p>Acquired mechanisms involve genetic mutations or the acquisition of new genetic material through processes such as transduction, conjugation, and transformation, often influenced by exposure to antibiotics.</p><p>Finally, adaptive mechanisms allow PA to increase its resistance to antibiotics, contributing to persistent infections. Among these mechanisms, persistent cells, which are metabolically inactive and have a reversible phenotype, and the formation of biofilms, which facilitate the exchange of genetic material and protect bacteria from antibiotic treatment and disinfectants, stand out. Drug resistance associated with biofilm formation is linked to structures such as flagella, pili, and other adhesins [<xref rid="B58-vetsci-12-00157" ref-type="bibr">58</xref>]. Furthermore, the quorum sensing system enables PA to coordinate behaviors and form biofilms efficiently, especially in chronic and biofilm-associated infections. These mechanisms contribute to the high resistance of PA to a wide range of antibiotics, including &#x003b2;-lactams, aminoglycosides, fluoroquinolones, and colistin.</p><p>Recent studies have shown that prior use of antimicrobials promotes the emergence of resistant pathogens. This happens because the antimicrobial used causes selective pressure in all susceptible bacteria that are killed or inhibited, while resistant ones survive. As a result, the composition of the host&#x02019;s microbiome is altered, and the proportion of resistant bacteria may increase and become the majority in the host. This explains why the emergence of multidrug-resistant strains is more common in hospital environments or communities with uncontrolled use of these drugs [<xref rid="B59-vetsci-12-00157" ref-type="bibr">59</xref>]. Thus, Lin et al. [<xref rid="B60-vetsci-12-00157" ref-type="bibr">60</xref>] found resistance levels of PA in otitis and pyoderma in dogs to be lower than in other studies, attributing this to the fact that the animals studied had no history of prior antimicrobial use. On the other hand, Vingopoulou et al. [<xref rid="B61-vetsci-12-00157" ref-type="bibr">61</xref>] observed that resistance to fluoroquinolones was significantly higher in dogs that had been treated systemically with antimicrobials up to 6 months before the study. <table-wrap position="anchor" id="vetsci-12-00157-t001"><object-id pub-id-type="pii">vetsci-12-00157-t001_Table 1</object-id><label>Table 1</label><caption><p>Resistance mechanisms of PA.</p></caption><table frame="hsides" rules="groups"><thead><tr><th colspan="4" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">PA Resistance Mechanisms</th></tr><tr><th colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">Mechanisms</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Associated Antibiotic</th><th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Intrinsic <break/> Natural mechanisms to eliminate antimicrobials</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Outer membrane (OM) permeability: decreases OM permeability by managing the number of non-specific porins present in the membrane.</p></list-item><list-item><p>Antibiotic-inactivating enzymes: produce enzymes capable of selectively inactivating or modifying antibiotics (ex:&#x003b2;-lactamases and aminoglycoside-modifying enzymes).</p></list-item><list-item><p>Efflux system: Remove harmful agents from the interior of the bacterial cell. The overexpression of multiple efflux pumps by this species has been associated with multidrug resistance.</p></list-item></list></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-lactams, <break/> Aminoglycosides, Fluoroquinolones</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B15-vetsci-12-00157" ref-type="bibr">15</xref>,<xref rid="B17-vetsci-12-00157" ref-type="bibr">17</xref>,<xref rid="B62-vetsci-12-00157" ref-type="bibr">62</xref>,<xref rid="B63-vetsci-12-00157" ref-type="bibr">63</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Acquired <break/> Implies a change in the microorganism&#x02019;s genetic material.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Gene mutation</p></list-item><list-item><p>Acquisition of new DNA (transduction (by bacteriophage); conjugation (cell&#x02013;cell contact); transformation (transfer of naked DNA).</p></list-item></list>(It is influenced by external stressors, such as exposure to antibiotics.)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x003b2;-lactams, <break/> Aminoglycosides, <break/> Fluoroquinolones, <break/> Colistin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B15-vetsci-12-00157" ref-type="bibr">15</xref>,<xref rid="B62-vetsci-12-00157" ref-type="bibr">62</xref>,<xref rid="B64-vetsci-12-00157" ref-type="bibr">64</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Adaptative <break/> Increases their ability to resist the effects of antibiotics and contributes to persistent infections.</td><td align="left" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1"><list list-type="bullet"><list-item><p>Persistent cells: metabolically inactive cells that exhibit tolerance to antibiotics and possess a transient, reversible phenotype. They arise under stressful conditions and are implicated in chronic bacterial infections as well as the recurrence of biofilm-associated infections</p></list-item><list-item><p>Biofilm: A structured community of bacteria embedded within a self-produced extracellular polymeric substance matrix. It can colonize natural tissues or inert materials. Facilitates the exchange of genetic material among bacteria.</p></list-item><list-item><p>Quorum sensing: Enables PA to form biofilms and coordinate behavior based on population density.</p></list-item></list></td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Increased <break/> tolerance to antibiotic and disinfectant treatments(&#x0003e;1000-fold).</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B15-vetsci-12-00157" ref-type="bibr">15</xref>,<xref rid="B54-vetsci-12-00157" ref-type="bibr">54</xref>,<xref rid="B65-vetsci-12-00157" ref-type="bibr">65</xref>,<xref rid="B66-vetsci-12-00157" ref-type="bibr">66</xref>,<xref rid="B67-vetsci-12-00157" ref-type="bibr">67</xref>,<xref rid="B68-vetsci-12-00157" ref-type="bibr">68</xref>]</td></tr></tbody></table></table-wrap></p></sec></sec><sec id="sec4-vetsci-12-00157"><title>4. Transmission</title><p>The transmission of antimicrobial-resistant bacteria has become a One Health issue as MDR bacteria can be transmitted between humans, animals, and the environment [<xref rid="B59-vetsci-12-00157" ref-type="bibr">59</xref>,<xref rid="B69-vetsci-12-00157" ref-type="bibr">69</xref>].</p><p>It is a fact that the use of antimicrobials in animals and humans promotes the development of MDR bacteria in both commensal and pathogenic bacteria [<xref rid="B70-vetsci-12-00157" ref-type="bibr">70</xref>]. In the environment, soil itself acts as a natural reservoir for antimicrobial-resistant bacteria; additionally, manure-treated soil and animal and human fecal waste contribute to the maintenance and the spread of MDR bacteria [<xref rid="B71-vetsci-12-00157" ref-type="bibr">71</xref>]. Furthermore, soils and irrigation water are sources of contamination for vegetables and fruits, where resistant bacteria have been identified [<xref rid="B70-vetsci-12-00157" ref-type="bibr">70</xref>]. Transmission by food consumption or wildlife vectors can also occur [<xref rid="B59-vetsci-12-00157" ref-type="bibr">59</xref>]. Thus, the impact of MDR bacteria (including MDR PA) is a problem that should be addressed with a One Health approach (<xref rid="vetsci-12-00157-f001" ref-type="fig">Figure 1</xref>). In hospital environments, where antimicrobial pressure is higher, there is an increased likelihood of encountering MDR bacteria. In this context, the transmission of these pathogens can easily occur between hospital settings and the community [<xref rid="B59-vetsci-12-00157" ref-type="bibr">59</xref>]. The impact of this transmission is becoming increasingly relevant in clinical practice, especially as more people bring their pets closer to them.</p><p>Because of this approximation, MDR bacteria can be transmitted directly through close interactions between pets and humans; or indirectly through environmental transmission, where bacteria can spread when humans and pets coexist in the same household [<xref rid="B21-vetsci-12-00157" ref-type="bibr">21</xref>,<xref rid="B52-vetsci-12-00157" ref-type="bibr">52</xref>,<xref rid="B72-vetsci-12-00157" ref-type="bibr">72</xref>,<xref rid="B73-vetsci-12-00157" ref-type="bibr">73</xref>]. A study conducted by Jin et al. [<xref rid="B69-vetsci-12-00157" ref-type="bibr">69</xref>] demonstrated that AMR can be transmitted from animals to humans and vice versa, with evidence indicating that this transmission has risen over the past two decades. However, the authors note that most studies offer a low level of evidence regarding this transmission, highlighting the need for more robust studies.</p><p>Regarding PA, the information is lacking, but some studies and case reports deserve some consideration. Evidence indicates that some species, such as sheep, chinchillas, rabbits, and snakes, can be naturally infected by this microorganism [<xref rid="B74-vetsci-12-00157" ref-type="bibr">74</xref>,<xref rid="B75-vetsci-12-00157" ref-type="bibr">75</xref>,<xref rid="B76-vetsci-12-00157" ref-type="bibr">76</xref>,<xref rid="B77-vetsci-12-00157" ref-type="bibr">77</xref>]. Additionally, wildlife species also exhibit some sensitivity to PA [<xref rid="B78-vetsci-12-00157" ref-type="bibr">78</xref>,<xref rid="B79-vetsci-12-00157" ref-type="bibr">79</xref>,<xref rid="B80-vetsci-12-00157" ref-type="bibr">80</xref>]. The capacity of these species to act as reservoirs for PA increases the potential for the transmission of this pathogen [<xref rid="B81-vetsci-12-00157" ref-type="bibr">81</xref>,<xref rid="B82-vetsci-12-00157" ref-type="bibr">82</xref>]. According to P&#x00142;&#x000f3;karz D. and Rypu&#x00142;a K. [<xref rid="B41-vetsci-12-00157" ref-type="bibr">41</xref>] dogs and cats are significant reservoirs for PA and can transmit it to humans through saliva, aerosols, urine, feces, and close contact. On the other hand, molecular studies have shown that clones associated with human infections have also been identified in animal infections; however, this does not serve as definitive evidence of transmission between species. Consequently, information regarding this transmission is still limited, but reports indicate the need for careful practices when PA is present [<xref rid="B83-vetsci-12-00157" ref-type="bibr">83</xref>,<xref rid="B84-vetsci-12-00157" ref-type="bibr">84</xref>].</p><p>Although there is no evidence of animal-to-animal transmission, the transmission between susceptible individuals (with cystic fibrosis) has been documented in humans [<xref rid="B12-vetsci-12-00157" ref-type="bibr">12</xref>,<xref rid="B85-vetsci-12-00157" ref-type="bibr">85</xref>]. Mohan et al. [<xref rid="B21-vetsci-12-00157" ref-type="bibr">21</xref>] described a case of PA respiratory infection transmitted from a human to a cat. Close contact between the individuals likely facilitated transmission, potentially via droplet spread, aerosolization, or indirect contact with contaminated surfaces [<xref rid="B12-vetsci-12-00157" ref-type="bibr">12</xref>]. The transmission of PA from animals to humans is not yet clearly understood [<xref rid="B86-vetsci-12-00157" ref-type="bibr">86</xref>], but a possible case of transmission from a dog to a young child with CF has been reported by Michl et al. [<xref rid="B87-vetsci-12-00157" ref-type="bibr">87</xref>]. Morris et al. also [<xref rid="B88-vetsci-12-00157" ref-type="bibr">88</xref>] described cross-contamination between the environment and owners and dogs with PA otitis. These studies were case reports or case series studies, suggesting that more rigorous primary studies, such as longitudinal, cohort, or case&#x02013;control studies are needed to provide higher levels of evidence [<xref rid="B69-vetsci-12-00157" ref-type="bibr">69</xref>]. However, it is important to emphasize that the veterinary niche represents a potential reservoir of resistance genes for pathogenic bacteria in both animals and humans [<xref rid="B84-vetsci-12-00157" ref-type="bibr">84</xref>].</p><p>Most PA infections are primarily acquired from environmental sources rather than through direct transmission from infected individuals [<xref rid="B12-vetsci-12-00157" ref-type="bibr">12</xref>]. A study in human medicine demonstrated that environmental contamination, rather than cross-transmission, was the predominant source of infection in most cases [<xref rid="B89-vetsci-12-00157" ref-type="bibr">89</xref>]. The ability of PA to thrive in various potential niches and adapt to different hosts is concerning. This adaptability may enhance their capacity to acquire new traits related to both virulence and resistance [<xref rid="B90-vetsci-12-00157" ref-type="bibr">90</xref>]. These findings highlight the impact of this pathogen on human, animal, and environmental health. Because of this, a One Health approach could be used to address this pathogen.
<fig position="anchor" id="vetsci-12-00157-f001"><label>Figure 1</label><caption><p>The importance of the One Health approach [<xref rid="B91-vetsci-12-00157" ref-type="bibr">91</xref>].</p></caption><graphic xlink:href="vetsci-12-00157-g001" position="float"/></fig></p><p>The spread of MDR bacteria can occur not only within but also between hospitals [<xref rid="B47-vetsci-12-00157" ref-type="bibr">47</xref>,<xref rid="B92-vetsci-12-00157" ref-type="bibr">92</xref>,<xref rid="B93-vetsci-12-00157" ref-type="bibr">93</xref>]. Because of this, when a PA infection occurs, it is crucial to consider all potential environments, including veterinary hospitals and homes [<xref rid="B43-vetsci-12-00157" ref-type="bibr">43</xref>,<xref rid="B47-vetsci-12-00157" ref-type="bibr">47</xref>,<xref rid="B93-vetsci-12-00157" ref-type="bibr">93</xref>]. In a Swiss study, the percentage of MDR bacteria found in clinics for companion animals was detected at 8.2% of the sampling sites [<xref rid="B93-vetsci-12-00157" ref-type="bibr">93</xref>].</p><p>To prevent the transmission of these bacteria, efforts should focus not only on reducing the use of antimicrobials, but also on establishing barriers to effectively prevent environmental contamination [<xref rid="B90-vetsci-12-00157" ref-type="bibr">90</xref>]. This can be achieved through the implementation of improved sanitation measures to contain resistant strains within healthcare settings and animal production facilities [<xref rid="B90-vetsci-12-00157" ref-type="bibr">90</xref>]. For instance, veterinary clinics with poor infection and prevention control standards showed an extensive environmental contamination [<xref rid="B69-vetsci-12-00157" ref-type="bibr">69</xref>]. The WHO has published guidelines for the &#x0201c;Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, <italic toggle="yes">Acinetobacter baumannii</italic>, and PA in Health Care Facilities&#x0201d;, which can be easily consulted, and which provide valuable guidance for clinical implementation [<xref rid="B94-vetsci-12-00157" ref-type="bibr">94</xref>].</p></sec><sec id="sec5-vetsci-12-00157"><title>5. Prevalence/Epidemiological Data</title><sec id="sec5dot1-vetsci-12-00157"><title>5.1. Europe</title><p>In the EU, antibiotic resistance among PA is a pressing concern, with significant implications for public health. According to The European Antimicrobial Resistance Surveillance Network (EARS-Net), the incidence of MDR PA is lower compared to other Gram-negative bacteria; however, it remains a leading cause of healthcare-associated infections across Europe [<xref rid="B95-vetsci-12-00157" ref-type="bibr">95</xref>] (<xref rid="vetsci-12-00157-f002" ref-type="fig">Figure 2</xref>). This issue can be partly attributed to shared risk factors, including high consumption rates of broad-spectrum antimicrobials and varied infection prevention and control (IPC) practices in healthcare settings.</p><p>A notable resistance gradient is observed across the EU, with a clear north-to-south and west-to-east pattern. The northern and western regions generally report lower resistance rates, while the eastern and southern regions show higher rates of antimicrobial resistance (<xref rid="vetsci-12-00157-f001" ref-type="fig">Figure 1</xref>). In particular, carbapenem resistance in PA is notably more prevalent in these regions [<xref rid="B95-vetsci-12-00157" ref-type="bibr">95</xref>].</p><p>Between 2019 and 2023, the estimated incidence of PA infections resistant to piperacillin-tazobactam, ceftazidime, and carbapenems has shown significant increases, reflecting a troubling upward trend in resistance. By 2023, the highest estimated incidence of PA infections in the EU was attributed to carbapenem resistance, followed by resistance to piperacillin-tazobactam, fluoroquinolones, ceftazidime, and aminoglycosides [<xref rid="B95-vetsci-12-00157" ref-type="bibr">95</xref>].</p><p>The WHO classified carbapenem-resistant PA as a high-priority pathogen, as these agents are often utilized as last-line therapies in humans [<xref rid="B96-vetsci-12-00157" ref-type="bibr">96</xref>]. In the EU, the distribution of carbapenem resistance in PA is variable; some countries report resistance rates exceeding 50%, while others have rates below 5% [<xref rid="B96-vetsci-12-00157" ref-type="bibr">96</xref>].</p><p>In 2022, data from the European Surveillance of Antimicrobial Consumption Network (ESAC-Net) showed that 17 out of 28 countries met or exceeded the WHO&#x02019;s target of 60% for total antibiotic use. However, only 4 out of 15 countries that reported reached this target [<xref rid="B97-vetsci-12-00157" ref-type="bibr">97</xref>].</p><p>The slow progress towards EU targets on antimicrobial consumption, coupled with the continued rise in the use of &#x02019;Reserve&#x02019; and broad-spectrum antibiotics, underscores the urgent need to strengthen efforts aimed at curbing unnecessary and inappropriate antimicrobial use across all sectors of healthcare.</p></sec><sec id="sec5dot2-vetsci-12-00157"><title>5.2. Portugal</title><p>Portugal has reported resistance rates to the main classes of antimicrobials exceeding 10%, although there has been a declining trend over the years (<xref rid="vetsci-12-00157-f003" ref-type="fig">Figure 3</xref>). However, this decline has not been observed in the group of multidrug-resistant bacteria.</p><p>Resistance to PA in Portugal gradually increased until around 2014&#x02013;2016, after which there has been a steady decrease in resistance levels (<xref rid="vetsci-12-00157-f003" ref-type="fig">Figure 3</xref>). Interestingly, data from the European Medicines Agency (EMA) indicated that antibiotic sales in Portugal fluctuated during this period, peaking in 2016 [<xref rid="B98-vetsci-12-00157" ref-type="bibr">98</xref>]. The veterinary sales percentage ranged from 70% in 2011 to 55% in 2021. Among the antibiotics, fluoroquinolones and piperacillin-tazobactam showed the highest levels of resistance by PA in Portugal. Since 2011, the EMA has reported a significant overall decrease of 51.5% in annual antibiotics sales, including a 25% reduction in third- and fourth-generation cephalosporins, a 36.9% decline in fluoroquinolone sales, and a remarkable 76.5% reduction in polymyxin sales [<xref rid="B98-vetsci-12-00157" ref-type="bibr">98</xref>].</p><p>The EMA attributes these declines in antibiotic sales to various factors, including changes in legislation, the implementation of electronic prescriptions in January 2022, and workshops and training sessions for veterinarians and producers. It is possible that the reduction in resistance rates of PA may be connected to these decreases in antibiotic sales [<xref rid="B98-vetsci-12-00157" ref-type="bibr">98</xref>].</p></sec><sec id="sec5dot3-vetsci-12-00157"><title>5.3. Animals with UTI</title><p>The prevalence of PA in UTIs in cats and dogs is unclear as of yet, and varies with geographic location, the presence of underlying conditions, and prior antibiotic use [<xref rid="B46-vetsci-12-00157" ref-type="bibr">46</xref>]. In contrast, in humans, it is well documented and is responsible for 2.4&#x02013;9% of UTIs [<xref rid="B38-vetsci-12-00157" ref-type="bibr">38</xref>]. <xref rid="vetsci-12-00157-t002" ref-type="table">Table 2</xref> shows the various published studies on PA in dogs with UTIs around the world.</p><p>In the United States, studies conducted across various states have reported prevalence rates ranging from 1.3% in Louisiana (2012&#x02013;2014) to 3.6% in California (1969&#x02013;1995), with a higher prevalence observed in female dogs and the Rottweiler breed [<xref rid="B45-vetsci-12-00157" ref-type="bibr">45</xref>,<xref rid="B99-vetsci-12-00157" ref-type="bibr">99</xref>]. However, in Illinois (2019&#x02013;2020), the prevalence was 2.99%, with low resistance rates to gentamicin, piperacillin-tazobactam, amikacin, and imipenem [<xref rid="B100-vetsci-12-00157" ref-type="bibr">100</xref>].</p><p>In Europe, the prevalence of PA also varies significantly. In Italy (2013&#x02013;2015), the rate was 13.4%, with gentamicin identified as the most effective antimicrobial [<xref rid="B101-vetsci-12-00157" ref-type="bibr">101</xref>]. In Portugal (1999&#x02013;2016), the prevalence was only 2% [<xref rid="B102-vetsci-12-00157" ref-type="bibr">102</xref>] while in Germany (2019&#x02013;2020), it was 2.1%, with 33% of isolates classified as MDR. Larger European studies conducted between 2013 and 2018 reported prevalences ranging from 3% to 4%, with high resistance levels to fluoroquinolones such as enrofloxacin and marbofloxacin [<xref rid="B103-vetsci-12-00157" ref-type="bibr">103</xref>].</p><p>In Asia, a study conducted in Chiang Mai, Thailand (2012&#x02013;2016), reported a prevalence of 13.1% [<xref rid="B4-vetsci-12-00157" ref-type="bibr">4</xref>]. In Hong Kong (2018&#x02013;2020), the prevalence was 4.9%, with high resistance levels to antimicrobials such as amoxicillin, ampicillin, and trimethoprim-sulfamethoxazole, while susceptibility to ciprofloxacin and ofloxacin was below 25% [<xref rid="B9-vetsci-12-00157" ref-type="bibr">9</xref>].</p><p>In Brazil (2021&#x02013;2022), the prevalence was 2%, with high resistance rates to penicillin, ceftriaxone, and trimethoprim-sulfamethoxazole [<xref rid="B104-vetsci-12-00157" ref-type="bibr">104</xref>]. Conversely, in Egypt (2024), prevalence reached 12.5%, with all feline isolates classified as MDR, showing susceptibility only to fluoroquinolones and nitrofurantoin [<xref rid="B105-vetsci-12-00157" ref-type="bibr">105</xref>].</p><p>These variations can be attributed to factors such as the geographic differences, study periods, data collection methodologies, and canine populations evaluated. Furthermore, the antimicrobial resistance of PA is a growing concern in veterinary medicine. Studies indicate that this bacterium is often resistant to multiple antibiotics, including fluoroquinolones and aminoglycosides, complicating the treatment of infections in dogs [<xref rid="B106-vetsci-12-00157" ref-type="bibr">106</xref>].</p><p>In cats, the data also reveal significant variations between countries. <xref rid="vetsci-12-00157-t003" ref-type="table">Table 3</xref> shows the various published studies on PA from catswith UTIs around the world.</p><p>In Australia, among the 107 samples analyzed, the prevalence was 1.6%, with resistance documented in 5 of the 14 antimicrobials tested. Susceptibility was observed for marbofloxacin and ciprofloxacin, while enrofloxacin showed intermediate results [<xref rid="B107-vetsci-12-00157" ref-type="bibr">107</xref>].</p><p>In Italy (2013&#x02013;2015), the prevalence was 5.5%, with gentamicin being the most effective antimicrobial, and a documented increase in resistance over time [<xref rid="B101-vetsci-12-00157" ref-type="bibr">101</xref>]. In Spain (2016&#x02013;2018), 5.2% of cats tested were positive for PA, with 4.6% being multidrug-resistant, and 0.2% XDR. Furthermore, one isolate was classified as pan-drug-resistant (PDR), with high levels of resistance (&#x02265;50%) to antimicrobials such as amoxicillin-clavulanate, ampicillin, and first- to third-generation cephalosporins [<xref rid="B1-vetsci-12-00157" ref-type="bibr">1</xref>].</p><p>In Southeast Asia, in Chiang Mai, Thailand (2012&#x02013;2016), the prevalence was significantly higher (25%), with all isolates classified as MDR [<xref rid="B4-vetsci-12-00157" ref-type="bibr">4</xref>]. These data are alarming, as they demonstrate a growing global trend of resistance in regions where the control of antimicrobial use and hygiene practices may be less rigorous, exacerbating the problem of bacterial resistance. In Portugal, data indicate a prevalence of 4% (1999&#x02013;2016) and 1.6% (2017&#x02013;2021), reinforcing the importance of local surveillance [<xref rid="B108-vetsci-12-00157" ref-type="bibr">108</xref>]. In Hong Kong (2018&#x02013;2020), the prevalence was 4.8%, with 90% of isolates showing resistance to cefovecin and reduced susceptibility to fluoroquinolones and nitrofurantoin [<xref rid="B9-vetsci-12-00157" ref-type="bibr">9</xref>].</p><p>In Germany (2019&#x02013;2020), 4.1% of the analyzed cats presented PA, with 41.7% MDR and four strains classified as XDR [<xref rid="B3-vetsci-12-00157" ref-type="bibr">3</xref>]. In Brazil (2021&#x02013;2022), the prevalence was 2%, with high rates of resistance to trimethoprim-sulfamethoxazole, penicillin, and ceftriaxone [<xref rid="B104-vetsci-12-00157" ref-type="bibr">104</xref>]. Finally, European studies from 2013 to 2018 indicated prevalences ranging from 0% to 4.2%, with high rates of resistance to enrofloxacin and marbofloxacin [<xref rid="B103-vetsci-12-00157" ref-type="bibr">103</xref>]. Resistance to these classes of antibiotics is of particular concern because these drugs are frequently used to treat bacterial infections in animals and humans. <table-wrap position="anchor" id="vetsci-12-00157-t002"><object-id pub-id-type="pii">vetsci-12-00157-t002_Table 2</object-id><label>Table 2</label><caption><p>Published studies on PA in dogs with UTIs around the world.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country and Year</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">No. of Dogs and %PA Isolates</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Resistance</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Notes</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">California (EUA) <break/> 1969&#x02013;1995</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 2165</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 3.6%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x0003e;Frequency of PA in dog females and Rottweiler breed</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B45-vetsci-12-00157" ref-type="bibr">45</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy <break/> 2013&#x02013;2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 253</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 13.4%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GEN is the most effective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">An increase in antimicrobial resistance over time</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-vetsci-12-00157" ref-type="bibr">101</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Louisiana (EUA) <break/> 2012&#x02013;2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 208</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 1.3%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B99-vetsci-12-00157" ref-type="bibr">99</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Spain <break/> 2016&#x02013;2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 52</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 3.8%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">&#x02265;50%&#x02014;AMC, AMP, LEX, CEF, CXM, CTX, CVN, ENR, PRA DOX, FOF, NIT, SXT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In total, 4% of isolates were MDR </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B1-vetsci-12-00157" ref-type="bibr">1</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chiang Mai (Thailand) <break/> 2012&#x02013;2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 203</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 13.1%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B4-vetsci-12-00157" ref-type="bibr">4</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Portugal <break/> 1999&#x02013;2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 700</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 2%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B102-vetsci-12-00157" ref-type="bibr">102</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Ilinois (EUA) <break/> 2019&#x02013;2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 803</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 2.99%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Low resistance to GENT, TZP, AMK, IPM</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B100-vetsci-12-00157" ref-type="bibr">100</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Central Italy <break/> 2020</td><td align="center" valign="middle" rowspan="1" colspan="1">N = 450</td><td align="center" valign="middle" rowspan="1" colspan="1">%PA = 3.55%</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">AMP, NIT, TET, SXT, CPP, FQs</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Susceptibility: AMK, DOX; GENT, IMI</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B109-vetsci-12-00157" ref-type="bibr">109</xref>]</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">93.7% MDR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Germany <break/> 2019&#x02013;2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 697</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 2.1%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ENR <break/> PRA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">33% MDR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B3-vetsci-12-00157" ref-type="bibr">3</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hong Kong <break/> 2018&#x02013;2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 2011 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 4.9%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AMX, AMC, AMP, CFE, CVN, CPD, CRO, CET, DOX, NIT, SXT <break/> &#x0003c;25%: CIP, ENR, MAR, OFX</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B9-vetsci-12-00157" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brazil <break/> 2021&#x02013;2022</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 90 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 2%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SXT, PEN, CRO, CTX</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-vetsci-12-00157" ref-type="bibr">104</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Romania <break/> 2022&#x02013;2023</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 83</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 4%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">CXM <break/> NIT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-vetsci-12-00157" ref-type="bibr">110</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Europe <break/> 2013&#x02013;2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 606 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 3%</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1GC, TET, CVN, SXT.</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Extremely high resistance levels against ENR and MAR</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B103-vetsci-12-00157" ref-type="bibr">103</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Europe <break/> 2017&#x02013;2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 773</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 4%</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Cairo (Egypt) <break/> 2024</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 146</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 12.5%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AMX, 3GC, 4GC, DOX, SXT</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Susceptibility: FQS and NIT <break/> 100% PA isolated from feline were MDR strains</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B105-vetsci-12-00157" ref-type="bibr">105</xref>]</td></tr></tbody></table><table-wrap-foot><fn><p>1GC: first-generation cephalosporins; 3GC: third-generation cephalosporins; 4GC: fourth-generation cephalosporins; AMC: amoxicillin clavulanic acid; AMP: ampicillin; AMK: amikacin; AMX: amoxicillin; CEF: ceftiofur; CPP: cephalosporins; CET: cefalotin; CIP: ciprofloxacin; CPD: cefpodoxime; CRO: ceftriaxone; CTX: cefotaxime; CVN: cefovecin; CXM: cefuroxime (axetil or sodium); DOX: doxycycline; ENR: enrofloxacin; FOF: fosfomycin; FQS: fluoroquinolones; GEN: gentamicin;IMI: imipenem; LEX: cephalexin; MAR: marbofloxacin; NIT: nitrofurantoin; OFX: ofloxacin; PEN: penicillin; PRA: pradofloxacin; SXT: trimethoprim&#x02013;sulfamethoxazole; TET: tetracycline; TZP: piperacillin&#x02013;tazobactam.</p></fn></table-wrap-foot></table-wrap>
<table-wrap position="anchor" id="vetsci-12-00157-t003"><object-id pub-id-type="pii">vetsci-12-00157-t003_Table 3</object-id><label>Table 3</label><caption><p>Published studies on PA in cats with UTIs around the world.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Country and Year</th><th colspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">No. of Cats and %PA Isolates</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Resistance</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Notes</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Austr&#x000e1;lia</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 107</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 1.6%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In total, 5/14 antimicrobials tested</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Susceptible: MAR and CIP Intermediate: ENR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B107-vetsci-12-00157" ref-type="bibr">107</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Italy <break/> 2013&#x02013;2015</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 81</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 5.5%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">GEN is the most effective</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">An increase in antimicrobial resistance over time</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B101-vetsci-12-00157" ref-type="bibr">101</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Spain <break/> 2016&#x02013;2018</td><td align="center" valign="middle" rowspan="1" colspan="1">N = 24 </td><td align="center" valign="middle" rowspan="1" colspan="1">%PA = 5.2%</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">&#x02265;50%&#x02014;AMC, AMP, LEX, CEF, CXM, CTX, CVN, ENR, PRA DOX, FOF, NIT, SXT</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">In total, 4% of isolates were MDR and one <break/> isolate from a cat was PDR</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B1-vetsci-12-00157" ref-type="bibr">1</xref>]</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">4.6% MDR <break/> 0.2% XDR</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Chiang Mai (Thailand) <break/> 2012&#x02013;2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 49</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 25%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">All isolates were MDR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B4-vetsci-12-00157" ref-type="bibr">4</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Portugal <break/> 1999&#x02013;2016</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 240 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 4%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B102-vetsci-12-00157" ref-type="bibr">102</xref>]</td></tr><tr><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Central Italy <break/> 2020</td><td align="center" valign="middle" rowspan="1" colspan="1">N = 185 </td><td align="center" valign="middle" rowspan="1" colspan="1">%PA = 6.48%</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">AMP, NIT, TET, SXT, CPP, FQs</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Susceptibility: AMK, DOX; GENT, IMI</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B109-vetsci-12-00157" ref-type="bibr">109</xref>]</td></tr><tr><td colspan="2" align="center" valign="middle" style="border-bottom:solid thin" rowspan="1">100%MD</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Germany <break/> 2019&#x02013;2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 313 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 4.1%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">ENR <break/> PRA</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">41.7% MDR <break/> 4 XDR e 1PDR</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B3-vetsci-12-00157" ref-type="bibr">3</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Hong Kong <break/> 2018&#x02013;2020</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 3708</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 4.8%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">AMX, AMC, AMP, CFE, CVN, CPD, CRO, CET, DOX, NIT, SXT <break/> &#x0003c;25%: CIP, ENR, MAR, OFX</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In cats, 90% were resistant to CVN</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B9-vetsci-12-00157" ref-type="bibr">9</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Portugal <break/> 2017&#x02013;2021</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 5306</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 1.6%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B108-vetsci-12-00157" ref-type="bibr">108</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Brazil <break/> 2021&#x02013;2022</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 90 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 2%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">SXT, PEN, CRO, CTX</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B104-vetsci-12-00157" ref-type="bibr">104</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Romania <break/> 2022&#x02013;2023</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 83 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 0%</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">
</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-vetsci-12-00157" ref-type="bibr">110</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">European <break/> 2013&#x02013;2014</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 263 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 0%</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">1GC, TET, CVN, SXT</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">Extremely high resistance levels against ENR and MAR</td><td rowspan="2" align="center" valign="middle" style="border-bottom:solid thin" colspan="1">[<xref rid="B103-vetsci-12-00157" ref-type="bibr">103</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">European <break/> 2017&#x02013;2018</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">N = 379 </td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">%PA = 4.2%</td></tr></tbody></table><table-wrap-foot><fn><p>1GC: first-generation cephalosporins;; AMC: amoxicillin clavulanic acid; AMP: ampicillin; AMK: amikacin; AMX: amoxicillin; CFE: ceftiofur; CPP: cephalosporins; CET: cefalotin; CIP: ciprofloxacin; CPD: cefpodoxime; CRO: ceftriaxone; CTX: cefotaxime; CVN: cefovecin; CXM: cefuroxime (axetil or sodium); DOX: doxycycline; ENR: enrofloxacin; FOF: fosfomycin; FQS: fluoroquinolones; GEN: gentamicin;IMI: imipenem; LEX: cephalexin; MAR: marbofloxacin; NIT: nitrofurantoin; OFX: ofloxacin; PEN: penicillin; PRA: pradofloxacin; SXT: trimethoprim&#x02013;sulfamethoxazole; TET: tetracycline.</p></fn></table-wrap-foot></table-wrap></p></sec></sec><sec id="sec6-vetsci-12-00157"><title>6. Diagnosis</title><p>Diagnosis is based on a combination of clinical signs and standard bacterial culture (gold standard) to identify the pathogen [<xref rid="B111-vetsci-12-00157" ref-type="bibr">111</xref>]. Furthermore, while traditional culture takes 24&#x02013;72 h, rapid methods like matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF MS) and genomic analysis provide results within minutes to an hour, enabling timely treatment [<xref rid="B112-vetsci-12-00157" ref-type="bibr">112</xref>,<xref rid="B113-vetsci-12-00157" ref-type="bibr">113</xref>]. Antimicrobial susceptibility testing (AST), including MIC and disk diffusion methods, is crucial for choosing the best treatment [<xref rid="B114-vetsci-12-00157" ref-type="bibr">114</xref>]. Biofilm-associated infections, particularly those caused by PA, can yield negative culture results due to bacterial aggregation within the biofilm matrix [<xref rid="B115-vetsci-12-00157" ref-type="bibr">115</xref>,<xref rid="B116-vetsci-12-00157" ref-type="bibr">116</xref>]. Newer molecular techniques like 16S rRNA PCR, LAMP, FISH, and CLSM offer promising alternatives for detecting biofilm-associated pathogens [<xref rid="B116-vetsci-12-00157" ref-type="bibr">116</xref>,<xref rid="B117-vetsci-12-00157" ref-type="bibr">117</xref>]. </p><p>During cystotomy for urolithiasis, bladder mucosal biopsies should be cultured alongside urolith analysis to identify potential uropathogens missed by standard urine cultures [<xref rid="B118-vetsci-12-00157" ref-type="bibr">118</xref>]. PCR testing can characterize bacteria and detect resistance genes, aiding antimicrobial selection [<xref rid="B119-vetsci-12-00157" ref-type="bibr">119</xref>,<xref rid="B120-vetsci-12-00157" ref-type="bibr">120</xref>]. However, this approach is not routinely used for PA.</p></sec><sec id="sec7-vetsci-12-00157"><title>7. Treatment</title><p>The treatment should always be guided by culture and susceptibility testing; however, initial empirical treatment may be necessary. For uncomplicated UTIs, the International Society for Companion Animal Infectious Diseases (ISCAID) guidelines recommend amoxicillin/amoxicillin-clavulanic acid or trimethoprim-sulfamethoxazole as first-line options [<xref rid="B5-vetsci-12-00157" ref-type="bibr">5</xref>]. In PA infections, due to its intrinsic resistance mechanisms, only third-generation cephalosporins, fluoroquinolones, or aminoglycosides are considered suitable for UTI treatment [<xref rid="B3-vetsci-12-00157" ref-type="bibr">3</xref>]. While carbapenems are effective against severe nosocomial PA infections, their use should be reserved for human medicine [<xref rid="B121-vetsci-12-00157" ref-type="bibr">121</xref>]. Aminoglycoside use in UTIs is limited by nephrotoxicity, parenteral administration requirements, reduced effectiveness in acidic urine, and inactivation by purulent debris [<xref rid="B122-vetsci-12-00157" ref-type="bibr">122</xref>]. For complicated UTIs, nitrofurantoin, fluoroquinolones, and third-generation cephalosporins may be reasonable first-line choices. In pyelonephritis, veterinary fluoroquinolones or cefpodoxime are considered appropriate [<xref rid="B5-vetsci-12-00157" ref-type="bibr">5</xref>]. In catheterized animals, systemic antibiotics are recommended, and catheter removal or replacement should be considered prior to initiating therapy. Inadequate management of UTIs, especially in catheterized animals, increases the risk of bacteremia [<xref rid="B50-vetsci-12-00157" ref-type="bibr">50</xref>].</p><p>Some studies have investigated antimicrobial combinations or novel agents to address the challenges in treating PA, particularly those involving biofilms. Saini et al. [<xref rid="B66-vetsci-12-00157" ref-type="bibr">66</xref>] demonstrated the potential efficacy of azithromycin combined with ciprofloxacin in treating biofilm-associated urinary tract infections. Novel antibiotics such as doripenem (a carbapenem) and plazomicin (a next-generation aminoglycoside) may offer future therapeutic options [<xref rid="B123-vetsci-12-00157" ref-type="bibr">123</xref>].</p><p>Treatment success can be challenging, and recurrent infections following treatment cessation have been reported [<xref rid="B124-vetsci-12-00157" ref-type="bibr">124</xref>]. However, data on the specific rate of treatment failure in dogs and cats is limited [<xref rid="B12-vetsci-12-00157" ref-type="bibr">12</xref>].</p><sec><title>Alternative Therapeutic Strategies</title><p>Excessive antibiotic use contributes to the emergence and dissemination of MDR organisms, including PA [<xref rid="B123-vetsci-12-00157" ref-type="bibr">123</xref>]. This necessitates the exploration and development of alternative therapeutic strategies. Several promising approaches are summarized in <xref rid="vetsci-12-00157-t004" ref-type="table">Table 4</xref>. However, the translation of many of these innovative strategies into clinical practice remains limited due to concerns regarding cost, potential side effects, and overall safety [<xref rid="B123-vetsci-12-00157" ref-type="bibr">123</xref>].</p><p>The analysis of alternative therapeutic approaches for the treatment of PA reveals a diverse array of strategies, each with varying levels of efficacy according to the reviewed studies. The AMP2041 peptide has shown promising results against MDR strains in both humans and animals, with inhibition rates exceeding 80% in some studies [<xref rid="B125-vetsci-12-00157" ref-type="bibr">125</xref>]. Fruit extracts, such as those from <italic toggle="yes">Cornus mas</italic> L. and <italic toggle="yes">Sorbus aucuparia</italic>, have demonstrated a significant reduction in bacterial growth, with an efficacy of approximately 60&#x02013;70% in UTIs in companion animals. Nanoparticles have excelled in reducing biofilm formation, achieving success rates above 70% [<xref rid="B110-vetsci-12-00157" ref-type="bibr">110</xref>,<xref rid="B126-vetsci-12-00157" ref-type="bibr">126</xref>].</p><p>Phillyrin, a quorum sensing inhibitor, has exhibited up to an 80% reduction in pathogen virulence in experimental models [<xref rid="B127-vetsci-12-00157" ref-type="bibr">127</xref>]. Phage therapy has shown exceptionally high efficacy, with up to 90% success in eradicating skin infections in dogs models [<xref rid="B60-vetsci-12-00157" ref-type="bibr">60</xref>,<xref rid="B128-vetsci-12-00157" ref-type="bibr">128</xref>]. Protein Epitope Mimics, while promising, still require further evaluation, showing an efficacy of around 60&#x02013;70% in inhibiting resistant strains. Although vaccines against PA are not yet widely available, experimental vaccines have demonstrated up to 70% efficacy in preventing infections [<xref rid="B129-vetsci-12-00157" ref-type="bibr">129</xref>,<xref rid="B130-vetsci-12-00157" ref-type="bibr">130</xref>]. Additionally, the use of electrochemical structures to combat biofilms and enhance antibiotic penetration has proven effective, achieving success rates of 75&#x02013;80% [<xref rid="B131-vetsci-12-00157" ref-type="bibr">131</xref>].</p><p>Alternative strategies for the treatment of PA reveal promising advances in combating infections caused by this MDR pathogen. Despite differences in reported efficacy rates, which range between 60% and 90% depending on the approach and experimental context, these results highlight the importance of exploring alternatives to traditional antibiotic-based therapies. However, there is still a need for additional studies to validate the clinical applicability of these strategies on a large scale and in different epidemiological scenarios.</p></sec></sec><sec sec-type="discussion" id="sec8-vetsci-12-00157"><title>8. Discussion</title><p>UTIs are among the most prevalent medical conditions affecting domestic cats and dogs. These infections not only pose significant health risks, but also contribute to the emergence and proliferation of antibiotic resistance [<xref rid="B46-vetsci-12-00157" ref-type="bibr">46</xref>].</p><p>While there is extensive literature on the antimicrobial resistance patterns of PA in human medicine, data for this in veterinary medicine have been poorly characterized, particularly in UTIs [<xref rid="B9-vetsci-12-00157" ref-type="bibr">9</xref>]. These findings may be explained by the greater impact of PA on human health compared to that on small animals. For instance, this pathogen has been associated with high morbidity and a substantial mortality rate in human medicine, accounting for 3.57 million deaths in 2019 [<xref rid="B16-vetsci-12-00157" ref-type="bibr">16</xref>].</p><p>PA is frequently isolated from ear and wound swabs in dogs and from the nasal cavity in cats [<xref rid="B22-vetsci-12-00157" ref-type="bibr">22</xref>]; this may explain the limited number of studies focusing on the prevalence of PA in the urinary tract in these species.</p><p>With this review, we aim to provide insights into the prevalence of urinary tract infections in dogs and cats, as well as how this has changed over the years. However, due to the aforementioned reasons, the data available for clarification are still limited. Nonetheless, we believe that, given its impact on public health, further investigation into this topic should not be overlooked. <xref rid="vetsci-12-00157-t002" ref-type="table">Table 2</xref> and <xref rid="vetsci-12-00157-t003" ref-type="table">Table 3</xref> present a compilation of studies from around the world that document the isolation of PA in UTIs in dogs and cats, respectively. The prevalence of PA varies over the years and across different countries in these studies. However, when compared to other pathogen isolates, the prevalence of PA remains low in both species (varies between 1.3% and 13.4% in dogs and 0 and 25% in cats). These findings may be attributed to the opportunistic nature of PA, which only affects a small group of patients (immunocompromised animals). Furthermore, the bacterium&#x02019;s ability to form biofilms may lead to an underestimation of its presence in culture results, potentially resulting in false negatives [<xref rid="B116-vetsci-12-00157" ref-type="bibr">116</xref>]. This underscores the need for further research to enhance our understanding of the epidemiology of PA in UTIs among small animals. We believe that understanding the prevalence of PA among pets is crucial from both veterinary and human medicine perspectives [<xref rid="B83-vetsci-12-00157" ref-type="bibr">83</xref>].</p><p>European studies from 2013 to 2018 indicated prevalences ranging from 0% to 4.2% in cats and 3&#x02013;4% in dogs (<xref rid="vetsci-12-00157-t002" ref-type="table">Table 2</xref> and <xref rid="vetsci-12-00157-t003" ref-type="table">Table 3</xref>). According to <xref rid="vetsci-12-00157-f002" ref-type="fig">Figure 2</xref>, in 2023 the percentage of MDR PA varies greatly from country to country, ranging from 1% to 50%.</p><p><italic toggle="yes">E. coli</italic> is the most isolated pathogen in UTIs [<xref rid="B5-vetsci-12-00157" ref-type="bibr">5</xref>,<xref rid="B6-vetsci-12-00157" ref-type="bibr">6</xref>,<xref rid="B132-vetsci-12-00157" ref-type="bibr">132</xref>] in contrast, a study conducted in Chiang Mai reported PA as the predominant isolate in feline UTIs (25% of the isolates) [<xref rid="B4-vetsci-12-00157" ref-type="bibr">4</xref>]. This discrepancy between the microbial profiles observed in Thailand and those in other countries may be attributable to variations in empirical antimicrobial prescription practices, which can create selective pressure on bacterial populations, or can be justified by natural geographical differences [<xref rid="B7-vetsci-12-00157" ref-type="bibr">7</xref>].</p><p>The number of dogs with suspected UTIs was higher than that of cats (<xref rid="vetsci-12-00157-t002" ref-type="table">Table 2</xref> and <xref rid="vetsci-12-00157-t003" ref-type="table">Table 3</xref>). This observation may be attributed to a greater number of dogs visiting veterinary clinics or the ease of obtaining samples from canines [<xref rid="B108-vetsci-12-00157" ref-type="bibr">108</xref>]. These findings are also consistent with numerous studies that report a higher incidence of non-infection urinary tract diseases (idiopathic and inflammatory) in cats [<xref rid="B133-vetsci-12-00157" ref-type="bibr">133</xref>,<xref rid="B134-vetsci-12-00157" ref-type="bibr">134</xref>]. In fact, according to Rodriguez [<xref rid="B135-vetsci-12-00157" ref-type="bibr">135</xref>] and Heseltine [<xref rid="B134-vetsci-12-00157" ref-type="bibr">134</xref>], less than 10% of cats with urinary clinical signs have a positive urine culture. In a study by to P&#x00142;&#x000f3;karz D. and Rypu&#x00142;a K. [<xref rid="B41-vetsci-12-00157" ref-type="bibr">41</xref>] dogs presented higher frequencies of PA (92%) than cats (72%), but these data considered samples from the nasal cavity, ear, and wounds. Perhaps cats are more resistant to PA than dogs, which could explain the differences observed between the two species regarding this bacterium in these reports. But more studies are needed to determine this.</p><p>In the context of UTI, sufficient data are not yet available. The data regarding UTIS in dogs and cats cannot be compared based on the information provided in <xref rid="vetsci-12-00157-t002" ref-type="table">Table 2</xref> and <xref rid="vetsci-12-00157-t003" ref-type="table">Table 3</xref>. This is primarily due to the significant differences in the population sizes of cats and dogs included in the respective studies, which may influence the observed prevalence rates. Therefore, without more balanced data or additional studies specifically targeting PA prevalence in UTIs among both species, it remains unclear whether the trend observed in other samples would hold true for UTIs [<xref rid="B30-vetsci-12-00157" ref-type="bibr">30</xref>]. On the other hand, different methods were employed to assess antibiotic susceptibility, and the years of the studies also varied. These factors are crucial for the interpretation of results, as the guidelines for interpretation PA sensitivity have undergone changes. In humans, the elderly and women appear to be more susceptible to PA UTI. In companion animals, bacterial UTIs are also more common in females, and age is a significant risk factor as well. In a previous study, Norris et al. [<xref rid="B45-vetsci-12-00157" ref-type="bibr">45</xref>] found a higher frequency of PA in female dogs and in the Rottweiler breed (<xref rid="vetsci-12-00157-t002" ref-type="table">Table 2</xref>) [<xref rid="B136-vetsci-12-00157" ref-type="bibr">136</xref>].</p><p>Some studies [<xref rid="B103-vetsci-12-00157" ref-type="bibr">103</xref>,<xref rid="B137-vetsci-12-00157" ref-type="bibr">137</xref>] in <xref rid="vetsci-12-00157-t002" ref-type="table">Table 2</xref> and <xref rid="vetsci-12-00157-t003" ref-type="table">Table 3</xref> indicated a gradual increase in the prevalence of MDR pathogens over the years [<xref rid="B3-vetsci-12-00157" ref-type="bibr">3</xref>,<xref rid="B14-vetsci-12-00157" ref-type="bibr">14</xref>]. If we compare with EARS-NET data, we can observe a similar trend. A significant isolation of MDR PA strains was observed across all the studies. Included in this, G&#x000f3;mez et al. [<xref rid="B13-vetsci-12-00157" ref-type="bibr">13</xref>] and Darwich et al. [<xref rid="B1-vetsci-12-00157" ref-type="bibr">1</xref>] identified PA as one of the bacterial species with the highest levels of MDR strains. These findings underscore the versatility of PA, attributed to its diverse resistance mechanisms, the presence of numerous virulence factors, and its capacity to form biofilms [<xref rid="B14-vetsci-12-00157" ref-type="bibr">14</xref>]. At same time, these findings have enhanced the overuse and misuse of antibiotics over the years and the need to improve antimicrobial prescription procedures [<xref rid="B138-vetsci-12-00157" ref-type="bibr">138</xref>,<xref rid="B139-vetsci-12-00157" ref-type="bibr">139</xref>]. Likewise, the EMA and ESAC-Net report a high consumption of antibiotics in recent years in Europe.</p><p>The prevalence of AMR strains was found to be higher in cats compared to dogs [<xref rid="B13-vetsci-12-00157" ref-type="bibr">13</xref>]. Similar results were also obtained by G&#x000f3;mez-Beltr&#x000e1;nthe authors of [<xref rid="B13-vetsci-12-00157" ref-type="bibr">13</xref>]. Although there are currently no publications addressing this disparity, it is plausible that differences in the urobiome composition between these species may contribute to this observation. Additionally, the nature of urinary diseases in cats, which are often inflammatory, may facilitate the growth of MDR PA in the urinary tract. Further studies are necessary to elucidate these relationships and to better understand the underlying factors contributing to the observed resistance patterns in this bacterium. Likewise, PDR strains were isolated exclusively from feline species in Spain and in Germany. These results are frightening, as in these cases clinicians did not have any effective antimicrobials to eliminate this pathogen [<xref rid="B3-vetsci-12-00157" ref-type="bibr">3</xref>].</p><p>Damborg et al. [<xref rid="B43-vetsci-12-00157" ref-type="bibr">43</xref>] propose that pet-associated bacterial zoonoses represent a relatively neglected area of study compared with food borne zoonoses, and we support this assertion due to the lack of information available on the topic of PA in companion animals. While the precise transmission routes of PA are not fully understood, some studies suggest potential transmission between humans, animals, and the environment. Therefore, a One Health approach (<xref rid="vetsci-12-00157-f001" ref-type="fig">Figure 1</xref>) is crucial for effectively addressing these infections [<xref rid="B14-vetsci-12-00157" ref-type="bibr">14</xref>]. Robust biosecurity and infection control measures are essential for combating the spread of PA, particularly in hospital environments [<xref rid="B140-vetsci-12-00157" ref-type="bibr">140</xref>]. However, controlling PA presents significant challenges due to its inherent resistance to certain biocides and its ability to adapt and survive in challenging environments [<xref rid="B15-vetsci-12-00157" ref-type="bibr">15</xref>].</p><p>The innate resistance of PA contributes to its reduced susceptibility to beta-lactams, cephalosporins, trimethoprim, and sulfonamides [<xref rid="B1-vetsci-12-00157" ref-type="bibr">1</xref>,<xref rid="B103-vetsci-12-00157" ref-type="bibr">103</xref>]. As shown in <xref rid="vetsci-12-00157-t002" ref-type="table">Table 2</xref> and <xref rid="vetsci-12-00157-t003" ref-type="table">Table 3</xref>, the levels of resistance to these antimicrobials were consistently high across all studies. Additionally, elevated resistance levels were also observed for tetracyclines and cefovecin [<xref rid="B1-vetsci-12-00157" ref-type="bibr">1</xref>,<xref rid="B103-vetsci-12-00157" ref-type="bibr">103</xref>]. The resistance patterns to fluoroquinolones and aminoglycosides displayed significant variability among the studies. This variation may be attributed to factors such as geographical location, differences in prescription practices, or the specific populations studied [<xref rid="B105-vetsci-12-00157" ref-type="bibr">105</xref>].</p><p>According to ISCAID guidelines, nitrofurantoin, fluoroquinolones, and third-generation cephalosporins may be reasonable first-line choices for complicated or resistant UTIs [<xref rid="B5-vetsci-12-00157" ref-type="bibr">5</xref>]. However, these studies revealed a wide range of resistance patterns for these antibiotics. For instance, fluoroquinolones demonstrated efficacy in populations in Europe, Illinois, and Egypt, but were ineffective in a feline population in Germany. Gentamicin exhibited consistent efficacy across species and locations in most studies, likely due to careful dosing practices in veterinary settings to minimize toxicity [<xref rid="B109-vetsci-12-00157" ref-type="bibr">109</xref>]. These findings suggest geographical consistency in PA susceptibility patterns [<xref rid="B103-vetsci-12-00157" ref-type="bibr">103</xref>]. Notably, high resistance rates to marbofloxacin and enrofloxacin were observed in European studies, potentially attributed to the widespread use of fluoroquinolones in these species, particularly for UTIs [<xref rid="B141-vetsci-12-00157" ref-type="bibr">141</xref>,<xref rid="B142-vetsci-12-00157" ref-type="bibr">142</xref>,<xref rid="B143-vetsci-12-00157" ref-type="bibr">143</xref>]. Likewise, the data reported by EARS-Net show the highest incidence of PA infections in the EU which was attributed to carbapenem resistance, followed by piperacillin-tazobactam, and fluoroquinolones. Although PA resistance to carbapenems was generally low in companion animal studies, they were not evaluated in all studies. Because of this, the antimicrobial profiles of <italic toggle="yes">PA</italic> isolates are difficult to compare between different studies [<xref rid="B83-vetsci-12-00157" ref-type="bibr">83</xref>]. But in the Illinois study, some isolates were found to be resistant to imipenem [<xref rid="B83-vetsci-12-00157" ref-type="bibr">83</xref>,<xref rid="B100-vetsci-12-00157" ref-type="bibr">100</xref>]. In Europe, the eastern and southern regions show higher rates of carbapenem antimicrobial resistance. It may be interesting to introduce this drug in future studies in these countries.</p><p>It is important to note that the in vitro susceptibility results may not always accurately predict the clinical outcomes. Some antibiotics achieve significantly higher concentrations in urine compared to plasma, which can enhance their efficacy in treating UTIs despite in vitro resistance [<xref rid="B111-vetsci-12-00157" ref-type="bibr">111</xref>]. Understanding in vivo sensitivity could clarify treatment failure rates for this versatile pathogen. In human medicine, the relationship between multidrug resistance and clinical outcomes also remains unclear [<xref rid="B144-vetsci-12-00157" ref-type="bibr">144</xref>].</p><p>The optimal treatment approach should be guided by culture and AST results [<xref rid="B139-vetsci-12-00157" ref-type="bibr">139</xref>,<xref rid="B141-vetsci-12-00157" ref-type="bibr">141</xref>]. However, in clinical practice, constraints such as time, financial limitations, and physical resources can impede the implementation of this standard [<xref rid="B139-vetsci-12-00157" ref-type="bibr">139</xref>]. Consequently, clinicians may resort to empirical antimicrobial therapy. While necessary in some cases, this practice can contribute to the emergence and spread of antimicrobial resistance [<xref rid="B101-vetsci-12-00157" ref-type="bibr">101</xref>]. A study conducted in an Italian veterinary teaching hospital found that only 5% of antimicrobial prescriptions were based on microbiological culture and susceptibility testing [<xref rid="B138-vetsci-12-00157" ref-type="bibr">138</xref>]. Additionally, Robbins et al. [<xref rid="B141-vetsci-12-00157" ref-type="bibr">141</xref>] and Mouiche et al. [<xref rid="B142-vetsci-12-00157" ref-type="bibr">142</xref>] reported a substantial number of cases where antimicrobials were prescribed unnecessarily. Additionally, data from ESAC-NET reveal that antimicrobial consumption in most EU countries exceeds the target set by the WHO. These results highlight the need for an antimicrobial control system.</p><p>Inadequate regulatory oversight and ineffective surveillance of antibiotic prescriptions contribute to the emergence and spread of MDR in pets with UTIs [<xref rid="B145-vetsci-12-00157" ref-type="bibr">145</xref>]. For example, the implementation of an online antimicrobial stewardship program in Switzerland significantly reduced antibiotic prescriptions for UTIs in dogs and cats [<xref rid="B146-vetsci-12-00157" ref-type="bibr">146</xref>,<xref rid="B147-vetsci-12-00157" ref-type="bibr">147</xref>]. Urgent action is needed to improve the surveillance and monitoring of antimicrobial resistance in veterinary medicine [<xref rid="B145-vetsci-12-00157" ref-type="bibr">145</xref>,<xref rid="B148-vetsci-12-00157" ref-type="bibr">148</xref>]. We believe that effective antimicrobial stewardship strategies include educational initiatives, clinical guidelines, and computer-based decision support systems [<xref rid="B141-vetsci-12-00157" ref-type="bibr">141</xref>,<xref rid="B145-vetsci-12-00157" ref-type="bibr">145</xref>].</p><p>Due to this paradigm, future treatments may focus less on eradicating pathogens and more on maintaining the integrity of the urinary tract barrier [<xref rid="B30-vetsci-12-00157" ref-type="bibr">30</xref>]. Concurrently, research is actively exploring alternative strategies for eliminating pathogens, as summarized in <xref rid="vetsci-12-00157-t004" ref-type="table">Table 4</xref>. While these approaches offer promising potential, further research is necessary to validate their efficacy and safety. We hope that this review serves as a foundation for future studies aimed at investigating the prevalence of PA in UTIs, improving monitoring techniques, and developing effective strategies for its elimination.</p></sec><sec sec-type="conclusions" id="sec9-vetsci-12-00157"><title>9. Conclusions</title><p>Current understanding of PA prevalence and its resistance patterns in canine and feline UTIs is limited. Existing research suggests a low overall prevalence of PA in UTIs, but the incidence of MDR strains appears to be alarmingly high. Further investigation is crucial, particularly regarding feline UTIs. PA antimicrobial resistance patterns varied geographically and temporally. Therefore, the empirical antimicrobial agents suggested by the ISCAID guidelines are not always effective against isolated strains. This highlights the importance of bacterial culture. which should be performed whenever UTIs are suspected to minimize antimicrobial overuse. Future research can include the correlation of MDR strains with clinical outcomes in order to clarify their impact on treatment success. Future studies should also consider more epidemiological data on animals with PA infection. Genomics has proven to be a powerful tool for understanding PA and guiding targeted antibiotic therapy. The exploration of alternative therapies to antibiotics can also be a useful tool to minimize their impact. In any case, a collaborative effort (human, animal, and environment) is essential to eliminate this pathogen (a One Health approach).</p><p>Implementing antimicrobial stewardship programs is increasingly urgent, and research like this can contribute to enhanced monitoring efforts.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work received support and help from FCT/MCTES (LA/P/0008/2020 DOI 10.54499/LA/P/0008/2020, UIDP/50006/2020 DOI 10.54499/UIDP/50006/2020, and UIDB/50006/2020 DOI 10.54499/UIDB/50006/2020) through national funds.</p></ack><fn-group><fn><p><bold>Disclaimer/Publisher&#x02019;s Note:</bold> The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.</p></fn></fn-group><notes><title>Author Contributions</title><p>Conceptualization, A.P.; investigation, A.P.; formal analysis, A.P. and T.d.S.; data curation, A.P., T.d.S. and C.S.; writing&#x02014;original draft preparation, A.P., T.d.S. and C.S.; supervision, G.I. and P.P. All authors have read and agreed to the published version of the manuscript.</p></notes><notes><title>Institutional Review Board Statement</title><p>Not applicable.</p></notes><notes><title>Informed Consent Statement</title><p>Not applicable.</p></notes><notes notes-type="data-availability"><title>Data Availability Statement</title><p>Not applicable.</p></notes><notes notes-type="COI-statement"><title>Conflicts of Interest</title><p>The authors declare no conflicts of interest.</p></notes><ref-list><title>References</title><ref id="B1-vetsci-12-00157"><label>1.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Darwich</surname><given-names>L.</given-names></name>
<name><surname>Seminati</surname><given-names>C.</given-names></name>
<name><surname>Burballa</surname><given-names>A.</given-names></name>
<name><surname>Nieto</surname><given-names>A.</given-names></name>
<name><surname>Dur&#x000e1;n</surname><given-names>I.</given-names></name>
<name><surname>Tarradas</surname><given-names>N.</given-names></name>
<name><surname>Molina-L&#x000f3;pez</surname><given-names>R.A.</given-names></name>
</person-group><article-title>Antimicrobial Susceptibility of Bacterial Isolates from Urinary Tract Infections in Companion Animals in Spain</article-title><source>Vet. Rec.</source><year>2021</year><volume>188</volume><fpage>e60</fpage><pub-id pub-id-type="doi">10.1002/vetr.60</pub-id><pub-id pub-id-type="pmid">33960452</pub-id>
</element-citation></ref><ref id="B2-vetsci-12-00157"><label>2.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hernando</surname><given-names>E.</given-names></name>
<name><surname>Vila</surname><given-names>A.</given-names></name>
<name><surname>D&#x02019;Ippolito</surname><given-names>P.</given-names></name>
<name><surname>Rico</surname><given-names>A.J.</given-names></name>
<name><surname>Rodon</surname><given-names>J.</given-names></name>
<name><surname>Roura</surname><given-names>X.</given-names></name>
</person-group><article-title>Prevalence and Characterization of Urinary Tract Infection in Owned Dogs and Cats from Spain</article-title><source>Top. Companion Anim. Med.</source><year>2021</year><volume>43</volume><fpage>100512</fpage><pub-id pub-id-type="doi">10.1016/j.tcam.2021.100512</pub-id><pub-id pub-id-type="pmid">33484889</pub-id>
</element-citation></ref><ref id="B3-vetsci-12-00157"><label>3.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aurich</surname><given-names>S.</given-names></name>
<name><surname>Prenger-Berninghoff</surname><given-names>E.</given-names></name>
<name><surname>Ewers</surname><given-names>C.</given-names></name>
</person-group><article-title>Prevalence and Antimicrobial Resistance of Bacterial Uropathogens Isolated from Dogs and Cats</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>1730</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11121730</pub-id><pub-id pub-id-type="pmid">36551391</pub-id>
</element-citation></ref><ref id="B4-vetsci-12-00157"><label>4.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Amphaiphan</surname><given-names>C.</given-names></name>
<name><surname>Yano</surname><given-names>T.</given-names></name>
<name><surname>Som-in</surname><given-names>M.</given-names></name>
<name><surname>Kungwong</surname><given-names>P.</given-names></name>
<name><surname>Wongsawan</surname><given-names>K.</given-names></name>
<name><surname>Pusoonthornthum</surname><given-names>R.</given-names></name>
<name><surname>Salman</surname><given-names>M.D.</given-names></name>
<name><surname>Tangtrongsup</surname><given-names>S.</given-names></name>
</person-group><article-title>Antimicrobial Drug Resistance Profile of Isolated Bacteria in Dogs and Cats with Urologic Problems at Chiang Mai University Veterinary Teaching Hospital, Thailand (2012&#x02013;2016)</article-title><source>Zoonoses Public Health</source><year>2021</year><volume>68</volume><fpage>452</fpage><lpage>463</lpage><pub-id pub-id-type="doi">10.1111/zph.12832</pub-id><pub-id pub-id-type="pmid">33844465</pub-id>
</element-citation></ref><ref id="B5-vetsci-12-00157"><label>5.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Weese</surname><given-names>J.S.</given-names></name>
<name><surname>Blondeau</surname><given-names>J.</given-names></name>
<name><surname>Boothe</surname><given-names>D.</given-names></name>
<name><surname>Guardabassi</surname><given-names>L.G.</given-names></name>
<name><surname>Gumley</surname><given-names>N.</given-names></name>
<name><surname>Papich</surname><given-names>M.</given-names></name>
<name><surname>Jessen</surname><given-names>L.R.</given-names></name>
<name><surname>Lappin</surname><given-names>M.</given-names></name>
<name><surname>Rankin</surname><given-names>S.</given-names></name>
<name><surname>Westropp</surname><given-names>J.L.</given-names></name>
<etal/>
</person-group><article-title>International Society for Companion Animal Infectious Diseases (ISCAID) Guidelines for the Diagnosis and Management of Bacterial Urinary Tract Infections in Dogs and Cats</article-title><source>Vet. J.</source><year>2019</year><volume>247</volume><fpage>8</fpage><lpage>25</lpage><pub-id pub-id-type="doi">10.1016/j.tvjl.2019.02.008</pub-id><pub-id pub-id-type="pmid">30971357</pub-id>
</element-citation></ref><ref id="B6-vetsci-12-00157"><label>6.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Koc&#x000fa;rekov&#x000e1;</surname><given-names>T.</given-names></name>
<name><surname>Ko&#x00161;&#x0010d;ov&#x000e1;</surname><given-names>J.</given-names></name>
<name><surname>Hajdu&#x0010d;kov&#x000e1;</surname><given-names>V.</given-names></name>
</person-group><article-title>Infections of the Urinary Tract of Bacterial Origin in Dogs and Cats</article-title><source>Folia Vet.</source><year>2021</year><volume>65</volume><fpage>59</fpage><lpage>66</lpage><pub-id pub-id-type="doi">10.2478/fv-2021-0008</pub-id></element-citation></ref><ref id="B7-vetsci-12-00157"><label>7.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wong</surname><given-names>C.</given-names></name>
<name><surname>Epstein</surname><given-names>S.E.</given-names></name>
<name><surname>Westropp</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Antimicrobial Susceptibility Patterns in Urinary Tract Infections in Dogs (2010&#x02013;2013)</article-title><source>J. Vet. Intern. Med.</source><year>2015</year><volume>29</volume><fpage>1045</fpage><lpage>1052</lpage><pub-id pub-id-type="doi">10.1111/jvim.13571</pub-id><pub-id pub-id-type="pmid">26133165</pub-id>
</element-citation></ref><ref id="B8-vetsci-12-00157"><label>8.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Johnstone</surname><given-names>T.</given-names></name>
</person-group><article-title>A Clinical Approach to Multidrug-Resistant Urinary Tract Infection and Subclinical Bacteriuria in Dogs and Cats</article-title><source>N. Z. Vet. J.</source><year>2020</year><volume>68</volume><fpage>69</fpage><lpage>83</lpage><pub-id pub-id-type="doi">10.1080/00480169.2019.1689196</pub-id><pub-id pub-id-type="pmid">31707934</pub-id>
</element-citation></ref><ref id="B9-vetsci-12-00157"><label>9.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chan</surname><given-names>O.S.K.</given-names></name>
<name><surname>Baranger-Ete</surname><given-names>M.</given-names></name>
<name><surname>Lam</surname><given-names>W.W.T.</given-names></name>
<name><surname>Wu</surname><given-names>P.</given-names></name>
<name><surname>Yeung</surname><given-names>M.</given-names></name>
<name><surname>Lee</surname><given-names>E.</given-names></name>
<name><surname>Bond</surname><given-names>H.</given-names></name>
<name><surname>Swan</surname><given-names>O.</given-names></name>
<name><surname>Tun</surname><given-names>H.M.</given-names></name>
</person-group><article-title>A Retrospective Study of Antimicrobial Resistant Bacteria Associated with Feline and Canine Urinary Tract Infection in Hong Kong SAR, China&#x02014;A Case Study on Implication of First-Line Antibiotics Use</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>1140</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11091140</pub-id><pub-id pub-id-type="pmid">36139920</pub-id>
</element-citation></ref><ref id="B10-vetsci-12-00157"><label>10.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Magiorakos</surname><given-names>A.P.</given-names></name>
<name><surname>Srinivasan</surname><given-names>A.</given-names></name>
<name><surname>Carey</surname><given-names>R.B.</given-names></name>
<name><surname>Carmeli</surname><given-names>Y.</given-names></name>
<name><surname>Falagas</surname><given-names>M.E.</given-names></name>
<name><surname>Giske</surname><given-names>C.G.</given-names></name>
<name><surname>Harbarth</surname><given-names>S.</given-names></name>
<name><surname>Hindler</surname><given-names>J.F.</given-names></name>
<name><surname>Kahlmeter</surname><given-names>G.</given-names></name>
<name><surname>Olsson-Liljequist</surname><given-names>B.</given-names></name>
<etal/>
</person-group><article-title>Multidrug-Resistant, Extensively Drug-Resistant and Pandrug-Resistant Bacteria: An International Expert Proposal for Interim Standard Definitions for Acquired Resistance</article-title><source>Clin. Microbiol. Infect.</source><year>2012</year><volume>18</volume><fpage>268</fpage><lpage>281</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2011.03570.x</pub-id><pub-id pub-id-type="pmid">21793988</pub-id>
</element-citation></ref><ref id="B11-vetsci-12-00157"><label>11.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Bernal-Rosas</surname><given-names>Y.</given-names></name>
<name><surname>Osorio-Mu&#x000f1;oz</surname><given-names>K.</given-names></name>
<name><surname>Torres-Garc&#x000ed;a</surname><given-names>O.</given-names></name>
</person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic>: An Emerging Nosocomial Trouble in Veterinary</article-title><source>Rev. MVZ Cordoba</source><year>2015</year><volume>20</volume><fpage>4937</fpage><lpage>4946</lpage><pub-id pub-id-type="doi">10.21897/rmvz.9</pub-id></element-citation></ref><ref id="B12-vetsci-12-00157"><label>12.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Nielsen</surname><given-names>S.S.</given-names></name>
<name><surname>Bicout</surname><given-names>D.J.</given-names></name>
<name><surname>Calistri</surname><given-names>P.</given-names></name>
<name><surname>Canali</surname><given-names>E.</given-names></name>
<name><surname>Drewe</surname><given-names>J.A.</given-names></name>
<name><surname>Garin-Bastuji</surname><given-names>B.</given-names></name>
<name><surname>Gonzales Rojas</surname><given-names>J.L.</given-names></name>
<name><surname>Gort&#x000e1;zar</surname><given-names>C.</given-names></name>
<name><surname>Herskin</surname><given-names>M.</given-names></name>
<name><surname>Michel</surname><given-names>V.</given-names></name>
<etal/>
</person-group><article-title>Assessment of Listing and Categorisation of Animal Diseases within the Framework of the Animal Health Law (Regulation (EU) No 2016/429): Antimicrobial-Resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> in Dogs and Cats</article-title><source>EFSA J.</source><year>2022</year><volume>20</volume><fpage>e07310</fpage><pub-id pub-id-type="doi">10.2903/J.EFSA.2022.7310</pub-id><pub-id pub-id-type="pmid">35515338</pub-id>
</element-citation></ref><ref id="B13-vetsci-12-00157"><label>13.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>G&#x000f3;mez-Beltr&#x000e1;n</surname><given-names>D.A.</given-names></name>
<name><surname>Villar</surname><given-names>D.</given-names></name>
<name><surname>L&#x000f3;pez-Osorio</surname><given-names>S.</given-names></name>
<name><surname>Ferguson</surname><given-names>D.</given-names></name>
<name><surname>Monsalve</surname><given-names>L.K.</given-names></name>
<name><surname>Chaparro-Guti&#x000e9;rrez</surname><given-names>J.J.</given-names></name>
</person-group><article-title>Prevalence of Antimicrobial Resistance in Bacterial Isolates from Dogs and Cats in a Veterinary Diagnostic Laboratory in Colombia from 2016&#x02013;2019</article-title><source>Vet. Sci.</source><year>2020</year><volume>7</volume><elocation-id>173</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci7040173</pub-id><pub-id pub-id-type="pmid">33182667</pub-id>
</element-citation></ref><ref id="B14-vetsci-12-00157"><label>14.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Sousa</surname><given-names>T.</given-names></name>
<name><surname>H&#x000e9;braud</surname><given-names>M.</given-names></name>
<name><surname>Enes Dapkevicius</surname><given-names>M.L.N.</given-names></name>
<name><surname>Maltez</surname><given-names>L.</given-names></name>
<name><surname>Pereira</surname><given-names>J.E.</given-names></name>
<name><surname>Capita</surname><given-names>R.</given-names></name>
<name><surname>Alonso-Calleja</surname><given-names>C.</given-names></name>
<name><surname>Igrejas</surname><given-names>G.</given-names></name>
<name><surname>Poeta</surname><given-names>P.</given-names></name>
</person-group><article-title>Genomic and Metabolic Characteristics of the Pathogenicity in <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>Int. J. Mol. Sci.</source><year>2021</year><volume>22</volume><elocation-id>12892</elocation-id><pub-id pub-id-type="doi">10.3390/ijms222312892</pub-id><pub-id pub-id-type="pmid">34884697</pub-id>
</element-citation></ref><ref id="B15-vetsci-12-00157"><label>15.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Verdial</surname><given-names>C.</given-names></name>
<name><surname>Serrano</surname><given-names>I.</given-names></name>
<name><surname>Tavares</surname><given-names>L.</given-names></name>
<name><surname>Gil</surname><given-names>S.</given-names></name>
<name><surname>Oliveira</surname><given-names>M.</given-names></name>
</person-group><article-title>Mechanisms of Antibiotic and Biocide Resistance That Contribute to <italic toggle="yes">Pseudomonas aeruginosa</italic> Persistence in the Hospital Environment</article-title><source>Biomedicines</source><year>2023</year><volume>11</volume><elocation-id>1221</elocation-id><pub-id pub-id-type="doi">10.3390/biomedicines11041221</pub-id><pub-id pub-id-type="pmid">37189839</pub-id>
</element-citation></ref><ref id="B16-vetsci-12-00157"><label>16.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>WHO</collab>
</person-group><source>WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance</source><publisher-name>WHO</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2024</year><volume>Volume 72</volume></element-citation></ref><ref id="B17-vetsci-12-00157"><label>17.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barbu</surname><given-names>I.C.</given-names></name>
<name><surname>Gheorghe-Barbu</surname><given-names>I.</given-names></name>
<name><surname>Grigore</surname><given-names>G.A.</given-names></name>
<name><surname>Vrancianu</surname><given-names>C.O.</given-names></name>
<name><surname>Chifiriuc</surname><given-names>M.C.</given-names></name>
</person-group><article-title>Antimicrobial Resistance in Romania: Updates on Gram-Negative ESCAPE Pathogens in the Clinical, Veterinary, and Aquatic Sectors</article-title><source>Int. J. Mol. Sci.</source><year>2023</year><volume>24</volume><elocation-id>7892</elocation-id><pub-id pub-id-type="doi">10.3390/ijms24097892</pub-id><pub-id pub-id-type="pmid">37175597</pub-id>
</element-citation></ref><ref id="B18-vetsci-12-00157"><label>18.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Elfadadny</surname><given-names>A.</given-names></name>
<name><surname>Ragab</surname><given-names>R.F.</given-names></name>
<name><surname>AlHarbi</surname><given-names>M.</given-names></name>
<name><surname>Badshah</surname><given-names>F.</given-names></name>
<name><surname>Ib&#x000e1;&#x000f1;ez-Arancibia</surname><given-names>E.</given-names></name>
<name><surname>Farag</surname><given-names>A.</given-names></name>
<name><surname>Hendawy</surname><given-names>A.O.</given-names></name>
<name><surname>De los R&#x000ed;os-Escalante</surname><given-names>P.R.</given-names></name>
<name><surname>Aboubakr</surname><given-names>M.</given-names></name>
<name><surname>Zakai</surname><given-names>S.A.</given-names></name>
<etal/>
</person-group><article-title>Antimicrobial Resistance of <italic toggle="yes">Pseudomonas aeruginosa</italic>: Navigating Clinical Impacts, Current Resistance Trends, and Innovations in Breaking Therapies</article-title><source>Front. Microbiol.</source><year>2024</year><volume>15</volume><elocation-id>1374466</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2024.1374466</pub-id><pub-id pub-id-type="pmid">38646632</pub-id>
</element-citation></ref><ref id="B19-vetsci-12-00157"><label>19.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hattab</surname><given-names>J.</given-names></name>
<name><surname>Mosca</surname><given-names>F.</given-names></name>
<name><surname>Di Francesco</surname><given-names>C.E.</given-names></name>
<name><surname>Aste</surname><given-names>G.</given-names></name>
<name><surname>Marruchella</surname><given-names>G.</given-names></name>
<name><surname>Guardiani</surname><given-names>P.</given-names></name>
<name><surname>Giorgio Tiscar</surname><given-names>P.</given-names></name>
</person-group><article-title>Occurrence, Antimicrobial Susceptibility, and Pathogenic Factors of <italic toggle="yes">Pseudomonas aeruginosa</italic> in Canine Clinical Samples</article-title><source>Vet. World</source><year>2021</year><volume>14</volume><fpage>978</fpage><pub-id pub-id-type="doi">10.14202/vetworld.2021.978-985</pub-id><pub-id pub-id-type="pmid">34083949</pub-id>
</element-citation></ref><ref id="B20-vetsci-12-00157"><label>20.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>D&#x000e9;gi</surname><given-names>J.</given-names></name>
<name><surname>Mo&#x0021b;co</surname><given-names>O.A.</given-names></name>
<name><surname>D&#x000e9;gi</surname><given-names>D.M.</given-names></name>
<name><surname>Suici</surname><given-names>T.</given-names></name>
<name><surname>Mare&#x00219;</surname><given-names>M.</given-names></name>
<name><surname>Imre</surname><given-names>K.</given-names></name>
<name><surname>Cristina</surname><given-names>R.T.</given-names></name>
</person-group><article-title>Antibiotic Susceptibility Profile of <italic toggle="yes">Pseudomonas aeruginosa</italic> Canine Isolates from a Multicentric Study in Romania</article-title><source>Antibiotics</source><year>2021</year><volume>10</volume><elocation-id>846</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics10070846</pub-id><pub-id pub-id-type="pmid">34356767</pub-id>
</element-citation></ref><ref id="B21-vetsci-12-00157"><label>21.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mohan</surname><given-names>K.</given-names></name>
<name><surname>Fothergill</surname><given-names>J.L.</given-names></name>
<name><surname>Storrar</surname><given-names>J.</given-names></name>
<name><surname>Ledson</surname><given-names>M.J.</given-names></name>
<name><surname>Winstanley</surname><given-names>C.</given-names></name>
<name><surname>Walshaw</surname><given-names>M.J.</given-names></name>
</person-group><article-title>Transmission of <italic toggle="yes">Pseudomonas aeruginosa</italic> Epidemic Strain from a Patient with Cystic Fibrosis to a Pet Cat</article-title><source>Thorax</source><year>2008</year><volume>63</volume><fpage>839</fpage><lpage>840</lpage><pub-id pub-id-type="doi">10.1136/thx.2007.092486</pub-id><pub-id pub-id-type="pmid">18728207</pub-id>
</element-citation></ref><ref id="B22-vetsci-12-00157"><label>22.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sharma</surname><given-names>D.</given-names></name>
<name><surname>Pakravan</surname><given-names>N.</given-names></name>
<name><surname>Pritchard</surname><given-names>J.C.</given-names></name>
<name><surname>Hartmann</surname><given-names>F.A.</given-names></name>
<name><surname>Young</surname><given-names>K.M.</given-names></name>
</person-group><article-title>Mucoid <italic toggle="yes">Pseudomonas aeruginosa</italic> Infection in a Cat with Severe Chronic Rhinosinusitis</article-title><source>Vet. Clin. Pathol.</source><year>2019</year><volume>48</volume><fpage>300</fpage><lpage>304</lpage><pub-id pub-id-type="doi">10.1111/vcp.12749</pub-id><pub-id pub-id-type="pmid">31210366</pub-id>
</element-citation></ref><ref id="B23-vetsci-12-00157"><label>23.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Alhazmi</surname><given-names>A.</given-names></name>
</person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic>&#x02014;Pathogenesis and Pathogenic Mechanisms</article-title><source>Int. J. Biol.</source><year>2015</year><volume>7</volume><elocation-id>44</elocation-id><pub-id pub-id-type="doi">10.5539/ijb.v7n2p44</pub-id></element-citation></ref><ref id="B24-vetsci-12-00157"><label>24.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Penaranda</surname><given-names>C.</given-names></name>
<name><surname>Chumbler</surname><given-names>N.M.</given-names></name>
<name><surname>Hung</surname><given-names>D.T.</given-names></name>
</person-group><article-title>Dual Transcriptional Analysis Reveals Adaptation of Host and Pathogen to Intracellular Survival of <italic toggle="yes">Pseudomonas aeruginosa</italic> Associated with Urinary Tract Infection</article-title><source>PLoS Pathog.</source><year>2021</year><volume>17</volume><elocation-id>e1009534</elocation-id><pub-id pub-id-type="doi">10.1371/journal.ppat.1009534</pub-id><pub-id pub-id-type="pmid">33901267</pub-id>
</element-citation></ref><ref id="B25-vetsci-12-00157"><label>25.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Sousa</surname><given-names>T.</given-names></name>
<name><surname>Garc&#x000ea;s</surname><given-names>A.</given-names></name>
<name><surname>Silva</surname><given-names>A.</given-names></name>
<name><surname>Lopes</surname><given-names>R.</given-names></name>
<name><surname>Alegria</surname><given-names>N.</given-names></name>
<name><surname>H&#x000e9;braud</surname><given-names>M.</given-names></name>
<name><surname>Igrejas</surname><given-names>G.</given-names></name>
<name><surname>Poeta</surname><given-names>P.</given-names></name>
</person-group><article-title>The Impact of the Virulence of <italic toggle="yes">Pseudomonas aeruginosa</italic> Isolated from Dogs</article-title><source>Vet. Sci.</source><year>2023</year><volume>10</volume><elocation-id>343</elocation-id><pub-id pub-id-type="doi">10.3390/vetsci10050343</pub-id><pub-id pub-id-type="pmid">37235426</pub-id>
</element-citation></ref><ref id="B26-vetsci-12-00157"><label>26.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sana</surname><given-names>T.G.</given-names></name>
<name><surname>Baumann</surname><given-names>C.</given-names></name>
<name><surname>Merdes</surname><given-names>A.</given-names></name>
<name><surname>Soscia</surname><given-names>C.</given-names></name>
<name><surname>Rattei</surname><given-names>T.</given-names></name>
<name><surname>Hachani</surname><given-names>A.</given-names></name>
<name><surname>Jones</surname><given-names>C.</given-names></name>
<name><surname>Bennett</surname><given-names>K.L.</given-names></name>
<name><surname>Filloux</surname><given-names>A.</given-names></name>
<name><surname>Superti-Furga</surname><given-names>G.</given-names></name>
<etal/>
</person-group><article-title>Internalization of <italic toggle="yes">Pseudomonas aeruginosa</italic> Strain PAO1 into Epithelial Cells Is Promoted by Interaction of a T6SS Effector with the Microtubule Network</article-title><source>Am. Soc. Microbiol.</source><year>2015</year><volume>6</volume><fpage>e00712-15</fpage><pub-id pub-id-type="doi">10.1128/mBio.00712-15</pub-id></element-citation></ref><ref id="B27-vetsci-12-00157"><label>27.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Bentzmann</surname><given-names>S.</given-names></name>
<name><surname>Plotkowski</surname><given-names>C.</given-names></name>
<name><surname>Puchelle</surname><given-names>E.</given-names></name>
</person-group><article-title>Receptors in the <italic toggle="yes">Pseudomonas aeruginosa</italic> Adherence to Injured and Repairing Airway Epithelium</article-title><source>Am. J. Respir. Crit. Care Med.</source><year>2012</year><volume>154</volume><fpage>S155</fpage><lpage>S162</lpage><pub-id pub-id-type="doi">10.1164/ajrccm/154.4_Pt_2.S155</pub-id></element-citation></ref><ref id="B28-vetsci-12-00157"><label>28.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zahm</surname><given-names>J.M.</given-names></name>
<name><surname>Chevillard</surname><given-names>M.</given-names></name>
<name><surname>Puchelle</surname><given-names>E.</given-names></name>
</person-group><article-title>Wound Repair of Human Surface Respiratory Epithelium</article-title><source>Am. J. Respir. Cell Mol. Biol.</source><year>2012</year><volume>5</volume><fpage>242</fpage><lpage>248</lpage><pub-id pub-id-type="doi">10.1165/ajrcmb/5.3.242</pub-id></element-citation></ref><ref id="B29-vetsci-12-00157"><label>29.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yamaguchi</surname><given-names>T.</given-names></name>
<name><surname>Yamada</surname><given-names>H.</given-names></name>
</person-group><article-title>Role of Mechanical Injury on Airway Surface in the Pathogenesis of <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>Am. Rev. Respir. Dis.</source><year>2012</year><volume>144</volume><fpage>1147</fpage><lpage>1152</lpage><pub-id pub-id-type="doi">10.1164/ajrccm/144.5.1147</pub-id></element-citation></ref><ref id="B30-vetsci-12-00157"><label>30.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Newman</surname><given-names>J.N.</given-names></name>
<name><surname>Floyd</surname><given-names>R.V.</given-names></name>
<name><surname>Fothergill</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Invasion and Diversity in <italic toggle="yes">Pseudomonas aeruginosa</italic> Urinary Tract Infections</article-title><source>J. Med. Microbiol.</source><year>2022</year><volume>71</volume><elocation-id>1458</elocation-id><pub-id pub-id-type="doi">10.1099/jmm.0.001458</pub-id></element-citation></ref><ref id="B31-vetsci-12-00157"><label>31.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gomila</surname><given-names>A.</given-names></name>
<name><surname>Carratal&#x000e0;</surname><given-names>J.</given-names></name>
<name><surname>Eliakim-Raz</surname><given-names>N.</given-names></name>
<name><surname>Shaw</surname><given-names>E.</given-names></name>
<name><surname>Wiegand</surname><given-names>I.</given-names></name>
<name><surname>Vallejo-Torres</surname><given-names>L.</given-names></name>
<name><surname>Gorostiza</surname><given-names>A.</given-names></name>
<name><surname>Vigo</surname><given-names>J.M.</given-names></name>
<name><surname>Morris</surname><given-names>S.</given-names></name>
<name><surname>Stoddart</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Risk Factors and Prognosis of Complicated Urinary Tract Infections Caused by <italic toggle="yes">Pseudomonas aeruginosa</italic> in Hospitalized Patients: A Retrospective Multicenter Cohort Study</article-title><source>Infect. Drug Resist.</source><year>2018</year><volume>11</volume><fpage>2571</fpage><lpage>2581</lpage><pub-id pub-id-type="doi">10.2147/IDR.S185753</pub-id><pub-id pub-id-type="pmid">30588040</pub-id>
</element-citation></ref><ref id="B32-vetsci-12-00157"><label>32.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Park</surname><given-names>W.S.</given-names></name>
<name><surname>Lee</surname><given-names>J.</given-names></name>
<name><surname>Na</surname><given-names>G.</given-names></name>
<name><surname>Park</surname><given-names>S.</given-names></name>
<name><surname>Seo</surname><given-names>S.K.</given-names></name>
<name><surname>Choi</surname><given-names>J.S.</given-names></name>
<name><surname>Jung</surname><given-names>W.K.</given-names></name>
<name><surname>Choi</surname><given-names>I.W.</given-names></name>
</person-group><article-title>Benzyl Isothiocyanate Attenuates Inflammasome Activation in <italic toggle="yes">Pseudomonas aeruginosa</italic> LPS-Stimulated THP-1 Cells and Exerts Regulation through the MAPKs/NF-&#x0039a;B Pathway</article-title><source>Int. J. Mol. Sci.</source><year>2022</year><volume>23</volume><elocation-id>1228</elocation-id><pub-id pub-id-type="doi">10.3390/ijms23031228</pub-id><pub-id pub-id-type="pmid">35163151</pub-id>
</element-citation></ref><ref id="B33-vetsci-12-00157"><label>33.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Chambers</surname><given-names>J.R.</given-names></name>
<name><surname>Cherny</surname><given-names>K.E.</given-names></name>
<name><surname>Sauer</surname><given-names>K.</given-names></name>
</person-group><article-title>Susceptibility of <italic toggle="yes">Pseudomonas aeruginosa</italic> Dispersed Cells to Antimicrobial Agents Is Dependent on the Dispersion Cue and Class of the Antimicrobial Agent Used</article-title><source>Antimicrob. Agents Chemother.</source><year>2017</year><volume>61</volume><fpage>e00846-17</fpage><pub-id pub-id-type="doi">10.1128/AAC.00846-17</pub-id><pub-id pub-id-type="pmid">28971863</pub-id>
</element-citation></ref><ref id="B34-vetsci-12-00157"><label>34.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sabnis</surname><given-names>A.</given-names></name>
<name><surname>Hagart</surname><given-names>K.L.H.</given-names></name>
<name><surname>Kl&#x000f6;ckner</surname><given-names>A.</given-names></name>
<name><surname>Becce</surname><given-names>M.</given-names></name>
<name><surname>Evans</surname><given-names>L.E.</given-names></name>
<name><surname>Furniss</surname><given-names>R.C.D.</given-names></name>
<name><surname>Mavridou</surname><given-names>D.A.I.</given-names></name>
<name><surname>Murphy</surname><given-names>R.</given-names></name>
<name><surname>Stevens</surname><given-names>M.M.</given-names></name>
<name><surname>Davies</surname><given-names>J.C.</given-names></name>
<etal/>
</person-group><article-title>Colistin Kills Bacteria by Targeting Lipopolysaccharide in the Cytoplasmic Membrane</article-title><source>Elife</source><year>2021</year><volume>10</volume><fpage>65836</fpage><pub-id pub-id-type="doi">10.7554/eLife.65836</pub-id><pub-id pub-id-type="pmid">33821795</pub-id>
</element-citation></ref><ref id="B35-vetsci-12-00157"><label>35.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Qin</surname><given-names>S.</given-names></name>
<name><surname>Xiao</surname><given-names>W.</given-names></name>
<name><surname>Zhou</surname><given-names>C.</given-names></name>
<name><surname>Pu</surname><given-names>Q.</given-names></name>
<name><surname>Deng</surname><given-names>X.</given-names></name>
<name><surname>Lan</surname><given-names>L.</given-names></name>
<name><surname>Liang</surname><given-names>H.</given-names></name>
<name><surname>Song</surname><given-names>X.</given-names></name>
<name><surname>Wu</surname><given-names>M.</given-names></name>
</person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic>: Pathogenesis, Virulence Factors, Antibiotic Resistance, Interaction with Host, Technology Advances and Emerging Therapeutics</article-title><source>Signal Transduct. Target. Ther.</source><year>2022</year><volume>7</volume><fpage>1</fpage><lpage>27</lpage><pub-id pub-id-type="doi">10.1038/s41392-022-01056-1</pub-id><pub-id pub-id-type="pmid">34980881</pub-id>
</element-citation></ref><ref id="B36-vetsci-12-00157"><label>36.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mittal</surname><given-names>R.</given-names></name>
<name><surname>Khandwaha</surname><given-names>R.K.</given-names></name>
<name><surname>Gupta</surname><given-names>V.</given-names></name>
<name><surname>Mittal</surname><given-names>P.K.</given-names></name>
<name><surname>Harjai</surname><given-names>K.</given-names></name>
</person-group><article-title>Phenotypic Characters of Urinary Isolates of <italic toggle="yes">Pseudomonas aeruginosa</italic> &#x00026; Their Association with Mouse Renal Colonization</article-title><source>Indian. J. Med. Res.</source><year>2006</year><volume>123</volume><fpage>67</fpage><lpage>72</lpage><pub-id pub-id-type="pmid">16567871</pub-id>
</element-citation></ref><ref id="B37-vetsci-12-00157"><label>37.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>El Zowalaty</surname><given-names>M.E.</given-names></name>
<name><surname>Al Thani</surname><given-names>A.A.</given-names></name>
<name><surname>Webster</surname><given-names>T.J.</given-names></name>
<name><surname>El Zowalaty</surname><given-names>A.E.</given-names></name>
<name><surname>Schweizer</surname><given-names>H.P.</given-names></name>
<name><surname>Nasrallah</surname><given-names>G.K.</given-names></name>
<name><surname>Marei</surname><given-names>H.E.</given-names></name>
<name><surname>Ashour</surname><given-names>H.M.</given-names></name>
</person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic>: Arsenal of Resistance Mechanisms, Decades of Changing Resistance Profiles, and Future Antimicrobial Therapies</article-title><source>Future Microbiol.</source><year>2015</year><volume>10</volume><fpage>1683</fpage><lpage>1706</lpage><pub-id pub-id-type="doi">10.2217/fmb.15.48</pub-id><pub-id pub-id-type="pmid">26439366</pub-id>
</element-citation></ref><ref id="B38-vetsci-12-00157"><label>38.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Shaji</surname><given-names>J.C.</given-names></name>
<name><surname>Kumar</surname><given-names>R.</given-names></name>
</person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic> as a Cause for Urinary Tract Infection in Children with No Predisposing Factors</article-title><source>Pediatr. Infect. Dis.</source><year>2022</year><volume>3</volume><fpage>119</fpage><lpage>120</lpage><pub-id pub-id-type="doi">10.5005/jp-journals-10081-1292</pub-id></element-citation></ref><ref id="B39-vetsci-12-00157"><label>39.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guardabassi</surname><given-names>L.</given-names></name>
<name><surname>Schwarz</surname><given-names>S.</given-names></name>
<name><surname>Lloyd</surname><given-names>D.H.</given-names></name>
</person-group><article-title>Pet Animals as Reservoirs of Antimicrobial-Resistant Bacteria: Review</article-title><source>J. Antimicrob. Chemother.</source><year>2004</year><volume>54</volume><fpage>321</fpage><lpage>332</lpage><pub-id pub-id-type="doi">10.1093/jac/dkh332</pub-id><pub-id pub-id-type="pmid">15254022</pub-id>
</element-citation></ref><ref id="B40-vetsci-12-00157"><label>40.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jangsangthong</surname><given-names>A.</given-names></name>
<name><surname>Lugsomya</surname><given-names>K.</given-names></name>
<name><surname>Apiratwarrasakul</surname><given-names>S.</given-names></name>
<name><surname>Phumthanakorn</surname><given-names>N.</given-names></name>
</person-group><article-title>Distribution of Sequence Types and Antimicrobial Resistance of Clinical <italic toggle="yes">Pseudomonas aeruginosa</italic> Isolates from Dogs and Cats Visiting a Veterinary Teaching Hospital in Thailand</article-title><source>BMC Vet. Res.</source><year>2024</year><volume>20</volume><fpage>1</fpage><lpage>6</lpage><pub-id pub-id-type="doi">10.1186/s12917-024-04098-5</pub-id><pub-id pub-id-type="pmid">38172872</pub-id>
</element-citation></ref><ref id="B41-vetsci-12-00157"><label>41.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x00142;&#x000f3;karz</surname><given-names>D.</given-names></name>
<name><surname>Czopowicz</surname><given-names>M.</given-names></name>
<name><surname>Bierowiec</surname><given-names>K.</given-names></name>
<name><surname>Rypu&#x00142;a</surname><given-names>K.</given-names></name>
</person-group><article-title>Virulence Genes as Markers for <italic toggle="yes">Pseudomonas aeruginosa</italic> Biofilm Formation in Dogs and Cats</article-title><source>Animals</source><year>2022</year><volume>12</volume><elocation-id>422</elocation-id><pub-id pub-id-type="doi">10.3390/ani12040422</pub-id><pub-id pub-id-type="pmid">35203130</pub-id>
</element-citation></ref><ref id="B42-vetsci-12-00157"><label>42.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cole</surname><given-names>S.J.</given-names></name>
<name><surname>Records</surname><given-names>A.R.</given-names></name>
<name><surname>Orr</surname><given-names>M.W.</given-names></name>
<name><surname>Linden</surname><given-names>S.B.</given-names></name>
<name><surname>Lee</surname><given-names>V.T.</given-names></name>
</person-group><article-title>Catheter-Associated Urinary Tract Infection by <italic toggle="yes">Pseudomonas aeruginosa</italic> Is Mediated by Exopolysaccharide-Independent Biofilms</article-title><source>Infect. Immun.</source><year>2014</year><volume>82</volume><fpage>2048</fpage><lpage>2058</lpage><pub-id pub-id-type="doi">10.1128/IAI.01652-14</pub-id><pub-id pub-id-type="pmid">24595142</pub-id>
</element-citation></ref><ref id="B43-vetsci-12-00157"><label>43.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Damborg</surname><given-names>P.</given-names></name>
<name><surname>Broens</surname><given-names>E.M.</given-names></name>
<name><surname>Chomel</surname><given-names>B.B.</given-names></name>
<name><surname>Guenther</surname><given-names>S.</given-names></name>
<name><surname>Pasmans</surname><given-names>F.</given-names></name>
<name><surname>Wagenaar</surname><given-names>J.A.</given-names></name>
<name><surname>Weese</surname><given-names>J.S.</given-names></name>
<name><surname>Wieler</surname><given-names>L.H.</given-names></name>
<name><surname>Windahl</surname><given-names>U.</given-names></name>
<name><surname>Vanrompay</surname><given-names>D.</given-names></name>
<etal/>
</person-group><article-title>Bacterial Zoonoses Transmitted by Household Pets: State-of-the-Art and Future Perspectives for Targeted Research and Policy Actions</article-title><source>J. Comp. Pathol.</source><year>2016</year><volume>155</volume><fpage>S27</fpage><lpage>S40</lpage><pub-id pub-id-type="doi">10.1016/j.jcpa.2015.03.004</pub-id><pub-id pub-id-type="pmid">25958184</pub-id>
</element-citation></ref><ref id="B44-vetsci-12-00157"><label>44.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pina-S&#x000e1;nchez</surname><given-names>M.</given-names></name>
<name><surname>Rua</surname><given-names>M.</given-names></name>
<name><surname>Pozo</surname><given-names>J.L.</given-names></name>
</person-group><article-title>Del Present and Future of Resistance in <italic toggle="yes">Pseudomonas aeruginosa</italic>: Implications for Treatment</article-title><source>Rev. Esp. Quim.</source><year>2023</year><volume>36</volume><issue>(Suppl. 1)</issue><fpage>54</fpage><lpage>58</lpage><pub-id pub-id-type="doi">10.37201/req/s01.13.2023</pub-id><pub-id pub-id-type="pmid">37997873</pub-id>
</element-citation></ref><ref id="B45-vetsci-12-00157"><label>45.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Norris</surname><given-names>C.R.</given-names></name>
<name><surname>Williams</surname><given-names>B.J.</given-names></name>
<name><surname>Ling</surname><given-names>G.V.</given-names></name>
<name><surname>Franti</surname><given-names>C.E.</given-names></name>
<name><surname>Johnson</surname><given-names>D.L.</given-names></name>
<name><surname>Ruby</surname><given-names>A.L.</given-names></name>
</person-group><article-title>Recurrent and Persistent Urinary Tract Infections in Dogs: 383 Cases (1969&#x02013;1995)</article-title><source>J. Am. Anim. Hosp. Assoc.</source><year>2000</year><volume>36</volume><fpage>484</fpage><lpage>492</lpage><pub-id pub-id-type="doi">10.5326/15473317-36-6-484</pub-id><pub-id pub-id-type="pmid">11105884</pub-id>
</element-citation></ref><ref id="B46-vetsci-12-00157"><label>46.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ataya</surname><given-names>H.A.S.</given-names></name>
<name><surname>Soliman</surname><given-names>S.M.</given-names></name>
<name><surname>Kayaf</surname><given-names>K.A.H.</given-names></name>
<name><surname>Marouf</surname><given-names>S.</given-names></name>
<name><surname>Al-Amry</surname><given-names>K.</given-names></name>
</person-group><article-title>Incidence, Bacterial Causes and Antibiotic Resistance Patterns of Urinary Tract Infection in Pet Animals</article-title><source>J. Appl. Vet. Sci.</source><year>2023</year><volume>8</volume><fpage>35</fpage><lpage>43</lpage><pub-id pub-id-type="doi">10.21608/javs.2023.179690.1199</pub-id></element-citation></ref><ref id="B47-vetsci-12-00157"><label>47.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zendri</surname><given-names>F.</given-names></name>
<name><surname>Isgren</surname><given-names>C.M.</given-names></name>
<name><surname>Devaney</surname><given-names>J.</given-names></name>
<name><surname>Schmidt</surname><given-names>V.</given-names></name>
<name><surname>Rankin</surname><given-names>R.</given-names></name>
<name><surname>Timofte</surname><given-names>D.</given-names></name>
</person-group><article-title>Resistome-Based Surveillance Identifies ESKAPE Pathogens as the Predominant Gram-Negative Organisms Circulating in Veterinary Hospitals</article-title><source>Front. Microbiol.</source><year>2023</year><volume>14</volume><elocation-id>1252216</elocation-id><pub-id pub-id-type="doi">10.3389/fmicb.2023.1252216</pub-id><pub-id pub-id-type="pmid">37744932</pub-id>
</element-citation></ref><ref id="B48-vetsci-12-00157"><label>48.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Xu</surname><given-names>Z.G.</given-names></name>
<name><surname>Gao</surname><given-names>Y.</given-names></name>
<name><surname>He</surname><given-names>J.G.</given-names></name>
<name><surname>Xu</surname><given-names>W.F.</given-names></name>
<name><surname>Jiang</surname><given-names>M.</given-names></name>
<name><surname>Jin</surname><given-names>H.S.</given-names></name>
</person-group><article-title>Effects of Azithromycin on <italic toggle="yes">Pseudomonas aeruginosa</italic> Isolates from Catheter-Associated Urinary Tract Infection</article-title><source>Exp. Ther. Med.</source><year>2014</year><volume>9</volume><fpage>569</fpage><pub-id pub-id-type="doi">10.3892/etm.2014.2120</pub-id><pub-id pub-id-type="pmid">25574236</pub-id>
</element-citation></ref><ref id="B49-vetsci-12-00157"><label>49.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Curran</surname><given-names>K.</given-names></name>
<name><surname>Leeper</surname><given-names>H.</given-names></name>
<name><surname>O&#x02032;Reilly</surname><given-names>K.</given-names></name>
<name><surname>Jacob</surname><given-names>J.</given-names></name>
<name><surname>Bermudez</surname><given-names>L.E.</given-names></name>
</person-group><article-title>An Analysis of the Infections and Determination of Empiric Antibiotic Therapy in Cats and Dogs with Cancer-Associated Infections</article-title><source>Antibiotics</source><year>2021</year><volume>10</volume><elocation-id>700</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics10060700</pub-id><pub-id pub-id-type="pmid">34208146</pub-id>
</element-citation></ref><ref id="B50-vetsci-12-00157"><label>50.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Flores-Mireles</surname><given-names>A.</given-names></name>
<name><surname>Hreha</surname><given-names>T.N.</given-names></name>
<name><surname>Hunstad</surname><given-names>D.A.</given-names></name>
</person-group><article-title>Pathophysiology, Treatment, and Prevention of Catheter-Associated Urinary Tract Infection</article-title><source>Top. Spinal. Cord. Inj. Rehabil.</source><year>2019</year><volume>25</volume><fpage>228</fpage><lpage>240</lpage><pub-id pub-id-type="doi">10.1310/sci2503-228</pub-id><pub-id pub-id-type="pmid">31548790</pub-id>
</element-citation></ref><ref id="B51-vetsci-12-00157"><label>51.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Farzin</surname><given-names>A.</given-names></name>
<name><surname>Mizanur Rahman</surname><given-names>M.</given-names></name>
<name><surname>Ara Mollika</surname><given-names>F.</given-names></name>
</person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic>: The Alarming Pathogen of Hospital Acquired Infection</article-title><source>Pseudomonas aeruginosa&#x02014;New Perspectives and Applications</source><publisher-name>InTech</publisher-name><publisher-loc>Rijeka, Croatia</publisher-loc><year>2024</year></element-citation></ref><ref id="B52-vetsci-12-00157"><label>52.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fernandes</surname><given-names>M.R.</given-names></name>
<name><surname>Sellera</surname><given-names>F.P.</given-names></name>
<name><surname>Moura</surname><given-names>Q.</given-names></name>
<name><surname>Carvalho</surname><given-names>M.P.N.</given-names></name>
<name><surname>Rosato</surname><given-names>P.N.</given-names></name>
<name><surname>Cerdeira</surname><given-names>L.</given-names></name>
<name><surname>Lincopan</surname><given-names>N.</given-names></name>
</person-group><article-title>Zooanthroponotic Transmission of Drug-Resistant <italic toggle="yes">Pseudomonas aeruginosa</italic>, Brazil</article-title><source>Emerg. Infect. Dis. J.</source><year>2018</year><volume>24</volume><fpage>1160</fpage><lpage>1162</lpage><pub-id pub-id-type="doi">10.3201/eid2406.180335</pub-id></element-citation></ref><ref id="B53-vetsci-12-00157"><label>53.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mekonnen</surname><given-names>S.A.</given-names></name>
<name><surname>El Husseini</surname><given-names>N.</given-names></name>
<name><surname>Turdiev</surname><given-names>A.</given-names></name>
<name><surname>Carter</surname><given-names>J.A.</given-names></name>
<name><surname>Belew</surname><given-names>A.T.</given-names></name>
<name><surname>El-Sayed</surname><given-names>N.M.</given-names></name>
<name><surname>Lee</surname><given-names>V.T.</given-names></name>
</person-group><article-title>Catheter-Associated Urinary Tract Infection by <italic toggle="yes">Pseudomonas aeruginosa</italic> Progresses through Acute and Chronic Phases of Infection</article-title><source>Proc. Natl. Acad. Sci. USA</source><year>2022</year><volume>119</volume><fpage>e2209383119</fpage><pub-id pub-id-type="doi">10.1073/pnas.2209383119</pub-id><pub-id pub-id-type="pmid">36469780</pub-id>
</element-citation></ref><ref id="B54-vetsci-12-00157"><label>54.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>De Sousa</surname><given-names>T.</given-names></name>
<name><surname>H&#x000e9;braud</surname><given-names>M.</given-names></name>
<name><surname>Alves</surname><given-names>O.</given-names></name>
<name><surname>Costa</surname><given-names>E.</given-names></name>
<name><surname>Maltez</surname><given-names>L.</given-names></name>
<name><surname>Pereira</surname><given-names>J.E.</given-names></name>
<name><surname>Martins</surname><given-names>&#x000c2;.</given-names></name>
<name><surname>Igrejas</surname><given-names>G.</given-names></name>
<name><surname>Poeta</surname><given-names>P.</given-names></name>
</person-group><article-title>Study of Antimicrobial Resistance, Biofilm Formation, and Motility of <italic toggle="yes">Pseudomonas aeruginosa</italic> Derived from Urine Samples</article-title><source>Microorganisms</source><year>2023</year><volume>11</volume><elocation-id>1345</elocation-id><pub-id pub-id-type="doi">10.3390/microorganisms11051345</pub-id><pub-id pub-id-type="pmid">37317319</pub-id>
</element-citation></ref><ref id="B55-vetsci-12-00157"><label>55.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hugonnard</surname><given-names>M.</given-names></name>
<name><surname>Chalvet-Monfray</surname><given-names>K.</given-names></name>
<name><surname>Dernis</surname><given-names>J.</given-names></name>
<name><surname>Pouzot-Nevoret</surname><given-names>C.</given-names></name>
<name><surname>Barth&#x000e9;l&#x000e9;my</surname><given-names>A.</given-names></name>
<name><surname>Vialard</surname><given-names>J.</given-names></name>
<name><surname>Goy-Thollot</surname><given-names>I.</given-names></name>
</person-group><article-title>Occurrence of Bacteriuria in 18 Catheterised Cats with Obstructive Lower Urinary Tract Disease: A Pilot Study</article-title><source>J. Feline Med. Surg.</source><year>2013</year><volume>15</volume><fpage>843</fpage><lpage>848</lpage><pub-id pub-id-type="doi">10.1177/1098612X13477414</pub-id><pub-id pub-id-type="pmid">23400682</pub-id>
</element-citation></ref><ref id="B56-vetsci-12-00157"><label>56.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ruple-Czerniak</surname><given-names>A.</given-names></name>
<name><surname>Aceto</surname><given-names>H.W.</given-names></name>
<name><surname>Bender</surname><given-names>J.B.</given-names></name>
<name><surname>Paradis</surname><given-names>M.R.</given-names></name>
<name><surname>Shaw</surname><given-names>S.P.</given-names></name>
<name><surname>Van Metre</surname><given-names>D.C.</given-names></name>
<name><surname>Weese</surname><given-names>J.S.</given-names></name>
<name><surname>Wilson</surname><given-names>D.A.</given-names></name>
<name><surname>Wilson</surname><given-names>J.H.</given-names></name>
<name><surname>Morley</surname><given-names>P.S.</given-names></name>
</person-group><article-title>Using Syndromic Surveillance to Estimate Baseline Rates for Healthcare-Associated Infections in Critical Care Units of Small Animal Referral Hospitals</article-title><source>J. Vet. Intern. Med.</source><year>2013</year><volume>27</volume><fpage>1392</fpage><lpage>1399</lpage><pub-id pub-id-type="doi">10.1111/jvim.12190</pub-id><pub-id pub-id-type="pmid">24134779</pub-id>
</element-citation></ref><ref id="B57-vetsci-12-00157"><label>57.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sawa</surname><given-names>T.</given-names></name>
<name><surname>Shimizu</surname><given-names>M.</given-names></name>
<name><surname>Moriyama</surname><given-names>K.</given-names></name>
<name><surname>Wiener-Kronish</surname><given-names>J.P.</given-names></name>
</person-group><article-title>Association between <italic toggle="yes">Pseudomonas aeruginosa</italic> Type III Secretion, Antibiotic Resistance, and Clinical Outcome: A Review</article-title><source>Crit. Care</source><year>2014</year><volume>18</volume><fpage>668</fpage><pub-id pub-id-type="doi">10.1186/s13054-014-0668-9</pub-id><pub-id pub-id-type="pmid">25672496</pub-id>
</element-citation></ref><ref id="B58-vetsci-12-00157"><label>58.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ozer</surname><given-names>E.</given-names></name>
<name><surname>Yaniv</surname><given-names>K.</given-names></name>
<name><surname>Chetrit</surname><given-names>E.</given-names></name>
<name><surname>Boyarski</surname><given-names>A.</given-names></name>
<name><surname>Meijler</surname><given-names>M.M.</given-names></name>
<name><surname>Berkovich</surname><given-names>R.</given-names></name>
<name><surname>Kushmaro</surname><given-names>A.</given-names></name>
<name><surname>Alfonta</surname><given-names>L.</given-names></name>
</person-group><article-title>An inside Look at a Biofilm: <italic toggle="yes">Pseudomonas aeruginosa</italic> Flagella Biotracking</article-title><source>Sci. Adv.</source><year>2021</year><volume>7</volume><fpage>eabg8581</fpage><pub-id pub-id-type="doi">10.1126/sciadv.abg8581</pub-id><pub-id pub-id-type="pmid">34117070</pub-id>
</element-citation></ref><ref id="B59-vetsci-12-00157"><label>59.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Argud&#x000ed;n</surname><given-names>M.A.</given-names></name>
<name><surname>Deplano</surname><given-names>A.</given-names></name>
<name><surname>Meghraoui</surname><given-names>A.</given-names></name>
<name><surname>Dod&#x000e9;mont</surname><given-names>M.</given-names></name>
<name><surname>Heinrichs</surname><given-names>A.</given-names></name>
<name><surname>Denis</surname><given-names>O.</given-names></name>
<name><surname>Nonhoff</surname><given-names>C.</given-names></name>
<name><surname>Roisin</surname><given-names>S.</given-names></name>
</person-group><article-title>Bacteria from Animals as a Pool of Antimicrobial Resistance Genes</article-title><source>Antibiotics</source><year>2017</year><volume>6</volume><elocation-id>12</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics6020012</pub-id><pub-id pub-id-type="pmid">28587316</pub-id>
</element-citation></ref><ref id="B60-vetsci-12-00157"><label>60.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lin</surname><given-names>D.M.</given-names></name>
<name><surname>Koskella</surname><given-names>B.</given-names></name>
<name><surname>Lin</surname><given-names>H.C.</given-names></name>
</person-group><article-title>Phage Therapy: An Alternative to Antibiotics in the Age of Multi-Drug Resistance</article-title><source>World J. Gastrointest. Pharmacol. Ther.</source><year>2017</year><volume>8</volume><fpage>162</fpage><pub-id pub-id-type="doi">10.4292/wjgpt.v8.i3.162</pub-id><pub-id pub-id-type="pmid">28828194</pub-id>
</element-citation></ref><ref id="B61-vetsci-12-00157"><label>61.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vingopoulou</surname><given-names>E.I.</given-names></name>
<name><surname>Delis</surname><given-names>G.A.</given-names></name>
<name><surname>Batzias</surname><given-names>G.C.</given-names></name>
<name><surname>Kaltsogianni</surname><given-names>F.</given-names></name>
<name><surname>Koutinas</surname><given-names>A.</given-names></name>
<name><surname>Kristo</surname><given-names>I.</given-names></name>
<name><surname>Pournaras</surname><given-names>S.</given-names></name>
<name><surname>Saridomichelakis</surname><given-names>M.N.</given-names></name>
<name><surname>Siarkou</surname><given-names>V.I.</given-names></name>
</person-group><article-title>Prevalence and Mechanisms of Resistance to Fluoroquinolones in <italic toggle="yes">Pseudomonas aeruginosa</italic> and <italic toggle="yes">Escherichia coli</italic> Isolates Recovered from Dogs Suffering from Otitis in Greece</article-title><source>Vet. Microbiol.</source><year>2018</year><volume>213</volume><fpage>102</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2017.11.024</pub-id><pub-id pub-id-type="pmid">29291992</pub-id>
</element-citation></ref><ref id="B62-vetsci-12-00157"><label>62.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pelegrin</surname><given-names>A.C.</given-names></name>
<name><surname>Palmieri</surname><given-names>M.</given-names></name>
<name><surname>Mirande</surname><given-names>C.</given-names></name>
<name><surname>Oliver</surname><given-names>A.</given-names></name>
<name><surname>Moons</surname><given-names>P.</given-names></name>
<name><surname>Goossens</surname><given-names>H.</given-names></name>
<name><surname>Van Belkum</surname><given-names>A.</given-names></name>
</person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic>: A Clinical and Genomics Update</article-title><source>FEMS Microbiol. Rev.</source><year>2021</year><volume>45</volume><elocation-id>fuab026</elocation-id><pub-id pub-id-type="doi">10.1093/femsre/fuab026</pub-id><pub-id pub-id-type="pmid">33970247</pub-id>
</element-citation></ref><ref id="B63-vetsci-12-00157"><label>63.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lister</surname><given-names>P.D.</given-names></name>
<name><surname>Wolter</surname><given-names>D.J.</given-names></name>
<name><surname>Hanson</surname><given-names>N.D.</given-names></name>
</person-group><article-title>Antibacterial-Resistant <italic toggle="yes">Pseudomonas aeruginosa</italic>: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance Mechanisms</article-title><source>Clin. Microbiol. Rev.</source><year>2009</year><volume>22</volume><fpage>582</fpage><lpage>610</lpage><pub-id pub-id-type="doi">10.1128/CMR.00040-09</pub-id><pub-id pub-id-type="pmid">19822890</pub-id>
</element-citation></ref><ref id="B64-vetsci-12-00157"><label>64.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Moradali</surname><given-names>M.F.</given-names></name>
<name><surname>Ghods</surname><given-names>S.</given-names></name>
<name><surname>Rehm</surname><given-names>B.H.A.</given-names></name>
</person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic> Lifestyle: A Paradigm for Adaptation, Survival, and Persistence</article-title><source>Front. Cell Infect. Microbiol.</source><year>2017</year><volume>7</volume><elocation-id>249785</elocation-id><pub-id pub-id-type="doi">10.3389/fcimb.2017.00039</pub-id><pub-id pub-id-type="pmid">28261568</pub-id>
</element-citation></ref><ref id="B65-vetsci-12-00157"><label>65.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lupo</surname><given-names>A.</given-names></name>
<name><surname>Haenni</surname><given-names>M.</given-names></name>
<name><surname>Madec</surname><given-names>J.-Y.</given-names></name>
</person-group><article-title>Antimicrobial Resistance in <italic toggle="yes">Acinetobacter</italic> spp. and <italic toggle="yes">Pseudomonas</italic> spp.</article-title><source>Microbiol. Spectr.</source><year>2018</year><volume>6</volume><fpage>377</fpage><lpage>393</lpage><pub-id pub-id-type="doi">10.1128/microbiolspec.ARBA-0007-2017</pub-id><pub-id pub-id-type="pmid">30101740</pub-id>
</element-citation></ref><ref id="B66-vetsci-12-00157"><label>66.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Saini</surname><given-names>H.</given-names></name>
<name><surname>Chhibber</surname><given-names>S.</given-names></name>
<name><surname>Harjai</surname><given-names>K.</given-names></name>
</person-group><article-title>Azithromycin and Ciprofloxacin: A Possible Synergistic Combination against <italic toggle="yes">Pseudomonas aeruginosa</italic> Biofilm-Associated Urinary Tract Infections</article-title><source>Int. J. Antimicrob. Agents</source><year>2015</year><volume>45</volume><fpage>359</fpage><lpage>367</lpage><pub-id pub-id-type="doi">10.1016/j.ijantimicag.2014.11.008</pub-id><pub-id pub-id-type="pmid">25604277</pub-id>
</element-citation></ref><ref id="B67-vetsci-12-00157"><label>67.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ocak</surname><given-names>F.</given-names></name>
<name><surname>Turkyilmaz</surname><given-names>S.</given-names></name>
</person-group><article-title>Investigation of Antimicrobial Resistance, Biofilm Production, Biofilm Associated Virulence Genes and Integron Genes of <italic toggle="yes">Pseudomonas Aeroginosa</italic> Isolates Obtained from Animal Clinical Samples</article-title><source>Isr. J. Vet. Med.</source><year>2022</year><volume>77</volume><fpage>15</fpage><lpage>26</lpage></element-citation></ref><ref id="B68-vetsci-12-00157"><label>68.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Patel</surname><given-names>H.</given-names></name>
<name><surname>Buchad</surname><given-names>H.</given-names></name>
<name><surname>Gajjar</surname><given-names>D.</given-names></name>
</person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic> Persister Cell Formation upon Antibiotic Exposure in Planktonic and Biofilm State</article-title><source>Sci. Rep.</source><year>2022</year><volume>12</volume><fpage>1</fpage><lpage>12</lpage><pub-id pub-id-type="doi">10.1038/s41598-022-20323-3</pub-id><pub-id pub-id-type="pmid">34992227</pub-id>
</element-citation></ref><ref id="B69-vetsci-12-00157"><label>69.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Jin</surname><given-names>M.</given-names></name>
<name><surname>Osman</surname><given-names>M.</given-names></name>
<name><surname>Green</surname><given-names>B.A.</given-names></name>
<name><surname>Yang</surname><given-names>Y.</given-names></name>
<name><surname>Ahuja</surname><given-names>A.</given-names></name>
<name><surname>Lu</surname><given-names>Z.</given-names></name>
<name><surname>Cazer</surname><given-names>C.L.</given-names></name>
</person-group><article-title>Evidence for the Transmission of Antimicrobial Resistant Bacteria between Humans and Companion Animals: A Scoping Review</article-title><source>One Health</source><year>2023</year><volume>17</volume><fpage>100593</fpage><pub-id pub-id-type="doi">10.1016/j.onehlt.2023.100593</pub-id><pub-id pub-id-type="pmid">37448771</pub-id>
</element-citation></ref><ref id="B70-vetsci-12-00157"><label>70.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McEwen</surname><given-names>S.A.</given-names></name>
<name><surname>Fedorka-Cray</surname><given-names>P.J.</given-names></name>
</person-group><article-title>Antimicrobial Use and Resistance in Animals</article-title><source>Clin. Infect. Dis.</source><year>2002</year><volume>34</volume><fpage>S93</fpage><lpage>S106</lpage><pub-id pub-id-type="doi">10.1086/340246</pub-id><pub-id pub-id-type="pmid">11988879</pub-id>
</element-citation></ref><ref id="B71-vetsci-12-00157"><label>71.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Thanner</surname><given-names>S.</given-names></name>
<name><surname>Drissner</surname><given-names>D.</given-names></name>
<name><surname>Walsh</surname><given-names>F.</given-names></name>
</person-group><article-title>Antimicrobial Resistance in Agriculture</article-title><source>mBio</source><year>2016</year><volume>7</volume><fpage>e02227-15</fpage><pub-id pub-id-type="doi">10.1128/mBio.02227-15</pub-id><pub-id pub-id-type="pmid">27094336</pub-id>
</element-citation></ref><ref id="B72-vetsci-12-00157"><label>72.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Panagea</surname><given-names>S.</given-names></name>
<name><surname>Winstanley</surname><given-names>C.</given-names></name>
<name><surname>Walshaw</surname><given-names>M.J.</given-names></name>
<name><surname>Ledson</surname><given-names>M.J.</given-names></name>
<name><surname>Hart</surname><given-names>C.A.</given-names></name>
</person-group><article-title>Environmental Contamination with an Epidemic Strain of <italic toggle="yes">Pseudomonas aeruginosa</italic> in a Liverpool Cystic Fibrosis Centre, and Study of Its Survival on Dry Surfaces</article-title><source>J. Hosp. Infect.</source><year>2005</year><volume>59</volume><fpage>102</fpage><lpage>107</lpage><pub-id pub-id-type="doi">10.1016/j.jhin.2004.09.018</pub-id><pub-id pub-id-type="pmid">15620443</pub-id>
</element-citation></ref><ref id="B73-vetsci-12-00157"><label>73.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Walther</surname><given-names>B.</given-names></name>
<name><surname>Hermes</surname><given-names>J.</given-names></name>
<name><surname>Cuny</surname><given-names>C.</given-names></name>
<name><surname>Wieler</surname><given-names>L.H.</given-names></name>
<name><surname>Vincze</surname><given-names>S.</given-names></name>
<name><surname>Elnaga</surname><given-names>Y.A.</given-names></name>
<name><surname>Stamm</surname><given-names>I.</given-names></name>
<name><surname>Kopp</surname><given-names>P.A.</given-names></name>
<name><surname>Kohn</surname><given-names>B.</given-names></name>
<name><surname>Witte</surname><given-names>W.</given-names></name>
<etal/>
</person-group><article-title>Sharing More than Friendship&#x02014;Nasal Colonization with Coagulase-Positive <italic toggle="yes">Staphylococci</italic> (CPS) and Co-Habitation Aspects of Dogs and Their Owners</article-title><source>PLoS ONE</source><year>2012</year><volume>7</volume><elocation-id>e35197</elocation-id><pub-id pub-id-type="doi">10.1371/journal.pone.0035197</pub-id><pub-id pub-id-type="pmid">22529990</pub-id>
</element-citation></ref><ref id="B74-vetsci-12-00157"><label>74.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Varriale</surname><given-names>L.</given-names></name>
<name><surname>Dipineto</surname><given-names>L.</given-names></name>
<name><surname>Russo</surname><given-names>T.P.</given-names></name>
<name><surname>Borrelli</surname><given-names>L.</given-names></name>
<name><surname>Romano</surname><given-names>V.</given-names></name>
<name><surname>D&#x02019;orazio</surname><given-names>S.</given-names></name>
<name><surname>Pace</surname><given-names>A.</given-names></name>
<name><surname>Menna</surname><given-names>L.F.</given-names></name>
<name><surname>Fioretti</surname><given-names>A.</given-names></name>
<name><surname>Santaniello</surname><given-names>A.</given-names></name>
</person-group><article-title>Antimicrobial Resistance of <italic toggle="yes">Escherichia coli</italic> and <italic toggle="yes">Pseudomonas aeruginosa</italic> from Companion Birds</article-title><source>Antibiotics</source><year>2020</year><volume>9</volume><elocation-id>780</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics9110780</pub-id><pub-id pub-id-type="pmid">33171927</pub-id>
</element-citation></ref><ref id="B75-vetsci-12-00157"><label>75.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wright</surname><given-names>E.A.</given-names></name>
<name><surname>Di Lorenzo</surname><given-names>V.</given-names></name>
<name><surname>Trappetti</surname><given-names>C.</given-names></name>
<name><surname>Liciardi</surname><given-names>M.</given-names></name>
<name><surname>Orru</surname><given-names>G.</given-names></name>
<name><surname>Viti</surname><given-names>C.</given-names></name>
<name><surname>Bronowski</surname><given-names>C.</given-names></name>
<name><surname>Hall</surname><given-names>A.J.</given-names></name>
<name><surname>Darby</surname><given-names>A.C.</given-names></name>
<name><surname>Oggioni</surname><given-names>M.R.</given-names></name>
<etal/>
</person-group><article-title>Divergence of a Strain of <italic toggle="yes">Pseudomonas aeruginosa</italic> during an Outbreak of Ovine Mastitis</article-title><source>Vet. Microbiol.</source><year>2015</year><volume>175</volume><fpage>105</fpage><lpage>113</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2014.11.011</pub-id><pub-id pub-id-type="pmid">25475851</pub-id>
</element-citation></ref><ref id="B76-vetsci-12-00157"><label>76.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Goldstein</surname><given-names>E.J.C.</given-names></name>
<name><surname>Agyare</surname><given-names>E.O.</given-names></name>
<name><surname>Vagvolgyi</surname><given-names>A.E.</given-names></name>
<name><surname>Halpern</surname><given-names>M.</given-names></name>
</person-group><article-title>Aerobic Bacterial Oral Flora of Garter Snakes: Development of Normal Flora and Pathogenic Potential for Snakes and Humans</article-title><source>J. Clin. Microbiol.</source><year>1981</year><volume>13</volume><fpage>954</fpage><lpage>956</lpage><pub-id pub-id-type="doi">10.1128/jcm.13.5.954-956.1981</pub-id><pub-id pub-id-type="pmid">7240404</pub-id>
</element-citation></ref><ref id="B77-vetsci-12-00157"><label>77.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Von Degerfeld</surname><given-names>M.M.</given-names></name>
<name><surname>Banchi</surname><given-names>P.</given-names></name>
<name><surname>Quaranta</surname><given-names>G.</given-names></name>
</person-group><article-title>Successful Treatment of Pyometra Caused by <italic toggle="yes">Pseudomonas aeruginosa</italic> Infection in a Rabbit</article-title><source>Top. Companion Anim. Med.</source><year>2020</year><volume>41</volume><fpage>100473</fpage><pub-id pub-id-type="doi">10.1016/j.tcam.2020.100473</pub-id><pub-id pub-id-type="pmid">32919061</pub-id>
</element-citation></ref><ref id="B78-vetsci-12-00157"><label>78.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Martins</surname><given-names>W.M.B.S.</given-names></name>
<name><surname>Narciso</surname><given-names>A.C.</given-names></name>
<name><surname>Cay&#x000f4;</surname><given-names>R.</given-names></name>
<name><surname>Santos</surname><given-names>S.V.</given-names></name>
<name><surname>Fehlberg</surname><given-names>L.C.C.</given-names></name>
<name><surname>Ramos</surname><given-names>P.L.</given-names></name>
<name><surname>da Cruz</surname><given-names>J.B.</given-names></name>
<name><surname>Gales</surname><given-names>A.C.</given-names></name>
</person-group><article-title>SPM-1-Producing <italic toggle="yes">Pseudomonas aeruginosa</italic> ST277 Clone Recovered from Microbiota of Migratory Birds</article-title><source>Diagn. Microbiol. Infect. Dis.</source><year>2018</year><volume>90</volume><fpage>221</fpage><lpage>227</lpage><pub-id pub-id-type="doi">10.1016/j.diagmicrobio.2017.11.003</pub-id><pub-id pub-id-type="pmid">29224710</pub-id>
</element-citation></ref><ref id="B79-vetsci-12-00157"><label>79.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhang</surname><given-names>R.</given-names></name>
<name><surname>Liu</surname><given-names>Z.</given-names></name>
<name><surname>Li</surname><given-names>J.</given-names></name>
<name><surname>Lei</surname><given-names>L.</given-names></name>
<name><surname>Yin</surname><given-names>W.</given-names></name>
<name><surname>Li</surname><given-names>M.</given-names></name>
<name><surname>Wu</surname><given-names>C.</given-names></name>
<name><surname>Walsh</surname><given-names>T.R.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Wang</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Presence of VIM-Positive <italic toggle="yes">Pseudomonas</italic> Species in Chickens and Their Surrounding Environment</article-title><source>Antimicrob. Agents Chemother.</source><year>2017</year><volume>61</volume><pub-id pub-id-type="doi">10.1128/AAC.00167-17</pub-id></element-citation></ref><ref id="B80-vetsci-12-00157"><label>80.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Oliveira</surname><given-names>M.</given-names></name>
<name><surname>Serrano</surname><given-names>I.</given-names></name>
<name><surname>Santos</surname><given-names>J.P.</given-names></name>
<name><surname>Bilocq</surname><given-names>F.</given-names></name>
<name><surname>Pereira</surname><given-names>N.</given-names></name>
<name><surname>de Santos Loureiro</surname><given-names>N.</given-names></name>
<name><surname>Tavares</surname><given-names>L.</given-names></name>
<name><surname>Pirnay</surname><given-names>J.P.</given-names></name>
<name><surname>De Vos</surname><given-names>D.</given-names></name>
</person-group><article-title><italic toggle="yes">Pseudomonads</italic> from Wild Free-Living Sea Turtles in Pr&#x000ed;ncipe Island, Gulf of Guinea</article-title><source>Ecol. Indic.</source><year>2017</year><volume>81</volume><fpage>260</fpage><lpage>264</lpage><pub-id pub-id-type="doi">10.1016/j.ecolind.2017.06.005</pub-id></element-citation></ref><ref id="B81-vetsci-12-00157"><label>81.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ruiz-Rold&#x000e1;n</surname><given-names>L.</given-names></name>
<name><surname>Rojo-Bezares</surname><given-names>B.</given-names></name>
<name><surname>de Toro</surname><given-names>M.</given-names></name>
<name><surname>L&#x000f3;pez</surname><given-names>M.</given-names></name>
<name><surname>Toledano</surname><given-names>P.</given-names></name>
<name><surname>Lozano</surname><given-names>C.</given-names></name>
<name><surname>Chich&#x000f3;n</surname><given-names>G.</given-names></name>
<name><surname>Alvarez-Erviti</surname><given-names>L.</given-names></name>
<name><surname>Torres</surname><given-names>C.</given-names></name>
<name><surname>S&#x000e1;enz</surname><given-names>Y.</given-names></name>
</person-group><article-title>Antimicrobial Resistance and Virulence of <italic toggle="yes">Pseudomonas</italic> Spp. among Healthy Animals: Concern about Exolysin ExlA Detection</article-title><source>Sci. Rep.</source><year>2020</year><volume>10</volume><fpage>1</fpage><lpage>11</lpage><pub-id pub-id-type="doi">10.1038/s41598-020-68575-1</pub-id><pub-id pub-id-type="pmid">31913322</pub-id>
</element-citation></ref><ref id="B82-vetsci-12-00157"><label>82.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Colinon</surname><given-names>C.</given-names></name>
<name><surname>Jocktane</surname><given-names>D.</given-names></name>
<name><surname>Brothier</surname><given-names>E.</given-names></name>
<name><surname>Rossolini</surname><given-names>G.M.</given-names></name>
<name><surname>Cournoyer</surname><given-names>B.</given-names></name>
<name><surname>Nazaret</surname><given-names>S.</given-names></name>
</person-group><article-title>Genetic Analyses of <italic toggle="yes">Pseudomonas aeruginosa</italic> Isolated from Healthy Captive Snakes: Evidence of High Inter- and Intrasite Dissemination and Occurrence of Antibiotic Resistance Genes</article-title><source>Environ. Microbiol.</source><year>2010</year><volume>12</volume><fpage>716</fpage><lpage>729</lpage><pub-id pub-id-type="doi">10.1111/j.1462-2920.2009.02115.x</pub-id><pub-id pub-id-type="pmid">20002132</pub-id>
</element-citation></ref><ref id="B83-vetsci-12-00157"><label>83.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>P&#x00142;&#x000f3;karz</surname><given-names>D.</given-names></name>
<name><surname>Rypu&#x00142;a</surname><given-names>K.</given-names></name>
</person-group><article-title>A One Health Perspective on the Human-Pets <italic toggle="yes">Pseudomonas aeruginosa</italic> Transmission</article-title><source>Appl. Microbiol.</source><year>2022</year><volume>8</volume><fpage>1</fpage><lpage>3</lpage></element-citation></ref><ref id="B84-vetsci-12-00157"><label>84.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Scott</surname><given-names>A.</given-names></name>
<name><surname>Pottenger</surname><given-names>S.</given-names></name>
<name><surname>Timofte</surname><given-names>D.</given-names></name>
<name><surname>Moore</surname><given-names>M.</given-names></name>
<name><surname>Wright</surname><given-names>L.</given-names></name>
<name><surname>Kukavica-Ibrulj</surname><given-names>I.</given-names></name>
<name><surname>Jeukens</surname><given-names>J.</given-names></name>
<name><surname>Levesque</surname><given-names>R.C.</given-names></name>
<name><surname>Freschi</surname><given-names>L.</given-names></name>
<name><surname>Pinchbeck</surname><given-names>G.L.</given-names></name>
<etal/>
</person-group><article-title>Reservoirs of Resistance: Polymyxin Resistance in Veterinary-Associated Companion Animal Isolates of <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>Vet. Rec.</source><year>2019</year><volume>185</volume><fpage>206</fpage><pub-id pub-id-type="doi">10.1136/vr.105075</pub-id><pub-id pub-id-type="pmid">31239295</pub-id>
</element-citation></ref><ref id="B85-vetsci-12-00157"><label>85.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fothergill</surname><given-names>J.L.</given-names></name>
<name><surname>Walshaw</surname><given-names>M.J.</given-names></name>
<name><surname>Winstanley</surname><given-names>C.</given-names></name>
</person-group><article-title>Transmissible Strains of <italic toggle="yes">Pseudomonas aeruginosa</italic> in Cystic Fibrosis Lung Infections</article-title><source>Eur. Respir. J.</source><year>2012</year><volume>40</volume><fpage>227</fpage><lpage>238</lpage><pub-id pub-id-type="doi">10.1183/09031936.00204411</pub-id><pub-id pub-id-type="pmid">22323572</pub-id>
</element-citation></ref><ref id="B86-vetsci-12-00157"><label>86.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pomba</surname><given-names>C.</given-names></name>
<name><surname>Rantala</surname><given-names>M.</given-names></name>
<name><surname>Greko</surname><given-names>C.</given-names></name>
<name><surname>Baptiste</surname><given-names>K.E.</given-names></name>
<name><surname>Catry</surname><given-names>B.</given-names></name>
<name><surname>van Duijkeren</surname><given-names>E.</given-names></name>
<name><surname>Mateus</surname><given-names>A.</given-names></name>
<name><surname>Moreno</surname><given-names>M.A.</given-names></name>
<name><surname>Py&#x000f6;r&#x000e4;l&#x000e4;</surname><given-names>S.</given-names></name>
<name><surname>Ru&#x0017e;auskas</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Public Health Risk of Antimicrobial Resistance Transfer from Companion Animals</article-title><source>J. Antimicrob. Chemother.</source><year>2017</year><volume>72</volume><fpage>957</fpage><lpage>968</lpage><pub-id pub-id-type="doi">10.1093/jac/dkw481</pub-id><pub-id pub-id-type="pmid">27999066</pub-id>
</element-citation></ref><ref id="B87-vetsci-12-00157"><label>87.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Michl</surname><given-names>R.K.</given-names></name>
<name><surname>Beck</surname><given-names>J.F.</given-names></name>
<name><surname>Mainz</surname><given-names>J.G.</given-names></name>
</person-group><article-title>Cystic Fibrosis Patient&#x02019;s Best Friend? Potential Transmission of <italic toggle="yes">Pseudomonas aeruginosa</italic> from a Dog</article-title><source>Klin. Padiatr.</source><year>2017</year><volume>229</volume><fpage>245</fpage><lpage>246</lpage><pub-id pub-id-type="doi">10.1055/s-0043-110766</pub-id><pub-id pub-id-type="pmid">28558414</pub-id>
</element-citation></ref><ref id="B88-vetsci-12-00157"><label>88.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Morris</surname><given-names>D.O.</given-names></name>
<name><surname>Davis</surname><given-names>M.F.</given-names></name>
<name><surname>Palmeiro</surname><given-names>B.S.</given-names></name>
<name><surname>O&#x02019;Shea</surname><given-names>K.</given-names></name>
<name><surname>Rankin</surname><given-names>S.C.</given-names></name>
</person-group><article-title>Molecular and Epidemiological Characterization of Canine <italic toggle="yes">Pseudomonas</italic> Otitis Using a Prospective Case-Control Study Design</article-title><source>Vet. Dermatol.</source><year>2017</year><volume>28</volume><fpage>118-e25</fpage><pub-id pub-id-type="doi">10.1111/vde.12347</pub-id><pub-id pub-id-type="pmid">27426073</pub-id>
</element-citation></ref><ref id="B89-vetsci-12-00157"><label>89.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pham</surname><given-names>T.M.</given-names></name>
<name><surname>B&#x000fc;chler</surname><given-names>A.C.</given-names></name>
<name><surname>Voor in &#x02018;t holt</surname><given-names>A.F.</given-names></name>
<name><surname>Severin</surname><given-names>J.A.</given-names></name>
<name><surname>Bootsma</surname><given-names>M.C.J.</given-names></name>
<name><surname>Gommers</surname><given-names>D.</given-names></name>
<name><surname>Kretzschmar</surname><given-names>M.E.</given-names></name>
<name><surname>Vos</surname><given-names>M.C.</given-names></name>
</person-group><article-title>Routes of Transmission of VIM-Positive <italic toggle="yes">Pseudomonas aeruginosa</italic> in the Adult Intensive Care Unit-Analysis of 9 Years of Surveillance at a University Hospital Using a Mathematical Model</article-title><source>Antimicrob. Resist. Infect. Control</source><year>2022</year><volume>11</volume><fpage>1</fpage><lpage>9</lpage><pub-id pub-id-type="doi">10.1186/s13756-022-01095-x</pub-id><pub-id pub-id-type="pmid">34991724</pub-id>
</element-citation></ref><ref id="B90-vetsci-12-00157"><label>90.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Da Costa</surname><given-names>P.M.</given-names></name>
<name><surname>Loureiro</surname><given-names>L.</given-names></name>
<name><surname>Matos</surname><given-names>A.J.F.</given-names></name>
</person-group><article-title>Transfer of Multidrug-Resistant Bacteria Between Intermingled Ecological Niches: The Interface Between Humans, Animals and the Environment</article-title><source>Int. J. Environ. Res. Public Health</source><year>2013</year><volume>10</volume><fpage>278</fpage><lpage>294</lpage><pub-id pub-id-type="doi">10.3390/ijerph10010278</pub-id><pub-id pub-id-type="pmid">23343983</pub-id>
</element-citation></ref><ref id="B91-vetsci-12-00157"><label>91.</label><element-citation publication-type="webpage"><article-title>ResistanceMap</article-title><comment>Available online: <ext-link xlink:href="https://resistancemap.onehealthtrust.org/CountryPage.php?countryId=29&#x00026;country=Portugal" ext-link-type="uri">https://resistancemap.onehealthtrust.org/CountryPage.php?countryId=29&#x00026;country=Portugal</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-02-10">(accessed on 10 February 2025)</date-in-citation></element-citation></ref><ref id="B92-vetsci-12-00157"><label>92.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sebola</surname><given-names>D.C.</given-names></name>
<name><surname>Oguttu</surname><given-names>J.W.</given-names></name>
<name><surname>Malahlela</surname><given-names>M.N.</given-names></name>
<name><surname>Kock</surname><given-names>M.M.</given-names></name>
<name><surname>Qekwana</surname><given-names>D.N.</given-names></name>
</person-group><article-title>Occurrence and Characterization of ESKAPE Organisms on the Hands of Veterinary Students before Patient Contact at a Veterinary Academic Hospital, South Africa</article-title><source>BMC Vet. Res.</source><year>2024</year><volume>20</volume><elocation-id>475</elocation-id><pub-id pub-id-type="doi">10.1186/s12917-024-04322-2</pub-id><pub-id pub-id-type="pmid">39420336</pub-id>
</element-citation></ref><ref id="B93-vetsci-12-00157"><label>93.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Schmidt</surname><given-names>J.S.</given-names></name>
<name><surname>Kuster</surname><given-names>S.P.</given-names></name>
<name><surname>Nigg</surname><given-names>A.</given-names></name>
<name><surname>Dazio</surname><given-names>V.</given-names></name>
<name><surname>Brilhante</surname><given-names>M.</given-names></name>
<name><surname>Rohrbach</surname><given-names>H.</given-names></name>
<name><surname>Bernasconi</surname><given-names>O.J.</given-names></name>
<name><surname>B&#x000fc;del</surname><given-names>T.</given-names></name>
<name><surname>Campos-Madueno</surname><given-names>E.I.</given-names></name>
<name><surname>Gobeli Brawand</surname><given-names>S.</given-names></name>
<etal/>
</person-group><article-title>Poor Infection Prevention and Control Standards Are Associated with Environmental Contamination with Carbapenemase-Producing Enterobacterales and Other Multidrug-Resistant Bacteria in Swiss Companion Animal Clinics</article-title><source>Antimicrob. Resist. Infect. Control</source><year>2020</year><volume>9</volume><fpage>1</fpage><lpage>13</lpage><pub-id pub-id-type="doi">10.1186/s13756-020-00742-5</pub-id><pub-id pub-id-type="pmid">31908772</pub-id>
</element-citation></ref><ref id="B94-vetsci-12-00157"><label>94.</label><element-citation publication-type="book"><person-group person-group-type="author">
<collab>WHO</collab>
</person-group><source>Guidelines for the Prevention and Control of Carbapenem-Resistant Enterobacteriaceae, Acinetobacter Baumannii and <italic toggle="yes">Pseudomonas aeruginosa</italic> in Health Care Facilities</source><publisher-name>WHO</publisher-name><publisher-loc>Geneva, Switzerland</publisher-loc><year>2017</year></element-citation></ref><ref id="B95-vetsci-12-00157"><label>95.</label><element-citation publication-type="webpage"><article-title>European Antimicrobial Resistance Surveillance Network (EARS-Net)</article-title><comment>Available online: <ext-link xlink:href="https://www.ecdc.europa.eu/en/about-us/networks/disease-networks-and-laboratory-networks/ears-net-data" ext-link-type="uri">https://www.ecdc.europa.eu/en/about-us/networks/disease-networks-and-laboratory-networks/ears-net-data</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-30">(accessed on 30 January 2025)</date-in-citation></element-citation></ref><ref id="B96-vetsci-12-00157"><label>96.</label><element-citation publication-type="webpage"><article-title>Search|European Centre for Disease Prevention and Control</article-title><comment>Available online: <ext-link xlink:href="https://www.ecdc.europa.eu/en/search?s=pseudomonas+aeruginosa" ext-link-type="uri">https://www.ecdc.europa.eu/en/search?s=pseudomonas+aeruginosa</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-30">(accessed on 30 January 2025)</date-in-citation></element-citation></ref><ref id="B97-vetsci-12-00157"><label>97.</label><element-citation publication-type="webpage"><article-title>Antimicrobial Consumption Dashboard (ESAC-Net)</article-title><comment>Available online: <ext-link xlink:href="https://www.ecdc.europa.eu/en/antimicrobial-consumption/surveillance-and-disease-data/database" ext-link-type="uri">https://www.ecdc.europa.eu/en/antimicrobial-consumption/surveillance-and-disease-data/database</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-30">(accessed on 30 January 2025)</date-in-citation></element-citation></ref><ref id="B98-vetsci-12-00157"><label>98.</label><element-citation publication-type="webpage"><article-title>Antimicrobial Resistance in Veterinary Medicine|European Medicines Agency (EMA)</article-title><comment>Available online: <ext-link xlink:href="https://www.ema.europa.eu/en/veterinary-regulatory-overview/antimicrobial-resistance-veterinary-medicine" ext-link-type="uri">https://www.ema.europa.eu/en/veterinary-regulatory-overview/antimicrobial-resistance-veterinary-medicine</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-30">(accessed on 30 January 2025)</date-in-citation></element-citation></ref><ref id="B99-vetsci-12-00157"><label>99.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>McGovern</surname><given-names>D.A.</given-names></name>
<name><surname>Gaschen</surname><given-names>F.</given-names></name>
<name><surname>Roy</surname><given-names>A.</given-names></name>
</person-group><article-title>Antimicrobial Susceptibility Patterns and Clinical Parameters in 208 Dogs with Positive Urine Cultures (2012-2014)</article-title><source>J. Am. Anim. Hosp. Assoc.</source><year>2019</year><volume>55</volume><fpage>306</fpage><lpage>313</lpage><pub-id pub-id-type="doi">10.5326/JAAHA-MS-6796</pub-id><pub-id pub-id-type="pmid">31525091</pub-id>
</element-citation></ref><ref id="B100-vetsci-12-00157"><label>100.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Yudhanto</surname><given-names>S.</given-names></name>
<name><surname>Hung</surname><given-names>C.C.</given-names></name>
<name><surname>Maddox</surname><given-names>C.W.</given-names></name>
<name><surname>Varga</surname><given-names>C.</given-names></name>
</person-group><article-title>Antimicrobial Resistance in Bacteria Isolated from Canine Urine Samples Submitted to a Veterinary Diagnostic Laboratory, Illinois, United States</article-title><source>Front. Vet. Sci.</source><year>2022</year><volume>9</volume><elocation-id>867784</elocation-id><pub-id pub-id-type="doi">10.3389/fvets.2022.867784</pub-id><pub-id pub-id-type="pmid">35601398</pub-id>
</element-citation></ref><ref id="B101-vetsci-12-00157"><label>101.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Rampacci</surname><given-names>E.</given-names></name>
<name><surname>Bottinelli</surname><given-names>M.</given-names></name>
<name><surname>Stefanetti</surname><given-names>V.</given-names></name>
<name><surname>Hyatt</surname><given-names>D.R.</given-names></name>
<name><surname>Sgariglia</surname><given-names>E.</given-names></name>
<name><surname>Coletti</surname><given-names>M.</given-names></name>
<name><surname>Passamonti</surname><given-names>F.</given-names></name>
</person-group><article-title>Antimicrobial Susceptibility Survey on Bacterial Agents of Canine and Feline Urinary Tract Infections: Weight of the Empirical Treatment</article-title><source>J. Glob. Antimicrob. Resist.</source><year>2018</year><volume>13</volume><fpage>192</fpage><lpage>196</lpage><pub-id pub-id-type="doi">10.1016/j.jgar.2018.01.011</pub-id><pub-id pub-id-type="pmid">29408407</pub-id>
</element-citation></ref><ref id="B102-vetsci-12-00157"><label>102.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Salas</surname><given-names>C.S.</given-names></name>
</person-group><source>Caracteriza&#x000e7;&#x000e3;o da Infe&#x000e7;&#x000e3;o do Trato Urin&#x000e1;rio em c&#x000e3;es e gatos e Utiliza&#x000e7;&#x000e3;o de &#x0201c;Formula for Rational Antimicrobial Therapy&#x0201d; na Avalia&#x000e7;&#x000e3;o da Antibioterapia Emp&#x000ed;rica em Portugal</source><publisher-name>Universidade de Lisboa</publisher-name><publisher-loc>Lisboa, Portugal</publisher-loc><year>2021</year></element-citation></ref><ref id="B103-vetsci-12-00157"><label>103.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Temmerman</surname><given-names>R.</given-names></name>
<name><surname>Berlamont</surname><given-names>H.</given-names></name>
<name><surname>El Garch</surname><given-names>F.</given-names></name>
<name><surname>Rose</surname><given-names>M.</given-names></name>
<name><surname>Simjee</surname><given-names>S.</given-names></name>
<name><surname>Meschi</surname><given-names>S.</given-names></name>
<name><surname>de Jong</surname><given-names>A.</given-names></name>
</person-group><article-title>Antimicrobial Susceptibility of Canine and Feline Urinary Tract. Infection Pathogens Isolated from Animals with Clinical Signs in European Veterinary Practices during the Period 2013&#x02013;2018</article-title><source>Antibiotics</source><year>2024</year><volume>13</volume><elocation-id>500</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics13060500</pub-id><pub-id pub-id-type="pmid">38927167</pub-id>
</element-citation></ref><ref id="B104-vetsci-12-00157"><label>104.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Medeiros de Rezende</surname><given-names>G.</given-names></name>
<name><surname>Eduarda Monteiro Silva</surname><given-names>M.</given-names></name>
<name><surname>Bistritschan Israel</surname><given-names>C.</given-names></name>
<name><surname>Ferreira Bernardo</surname><given-names>V.</given-names></name>
<name><surname>Junio Moreira Fernandes</surname><given-names>A.</given-names></name>
<name><surname>Ferreira Bastos</surname><given-names>B.</given-names></name>
</person-group><article-title>Infec&#x000e7;&#x000f5;es Do Trato Urin&#x000e1;rio De C&#x000e3;es E Gatos: Avalia&#x000e7;&#x000e3;o &#x0201c;In Vitro&#x0201d; Da Sensibilidade Bacteriana A Antibi&#x000f3;ticos</article-title><source>Rev. De Med. Vet. Do UNIFESO</source><year>2023</year><volume>3</volume><fpage>61</fpage><lpage>67</lpage></element-citation></ref><ref id="B105-vetsci-12-00157"><label>105.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Farag</surname><given-names>H.S.</given-names></name>
<name><surname>Ali</surname><given-names>M.E.</given-names></name>
<name><surname>Abdel Masseih</surname><given-names>E.S.</given-names></name>
<name><surname>Bakry</surname><given-names>N.M.</given-names></name>
</person-group><article-title>Diagnostic Ultrasonography and Antimicrobial Resistance of Different Pathogens Associated with Canine and Feline Lower Urinary Tract Disorders</article-title><source>Comp. Immunol. Microbiol. Infect. Dis.</source><year>2024</year><volume>112</volume><elocation-id>102216</elocation-id><pub-id pub-id-type="doi">10.1016/j.cimid.2024.102216</pub-id><pub-id pub-id-type="pmid">39033672</pub-id>
</element-citation></ref><ref id="B106-vetsci-12-00157"><label>106.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Elfadadny</surname><given-names>A.</given-names></name>
<name><surname>Uchiyama</surname><given-names>J.</given-names></name>
<name><surname>Goto</surname><given-names>K.</given-names></name>
<name><surname>Imanishi</surname><given-names>I.</given-names></name>
<name><surname>Ragab</surname><given-names>R.F.</given-names></name>
<name><surname>Nageeb</surname><given-names>W.M.</given-names></name>
<name><surname>Iyori</surname><given-names>K.</given-names></name>
<name><surname>Toyoda</surname><given-names>Y.</given-names></name>
<name><surname>Tsukui</surname><given-names>T.</given-names></name>
<name><surname>Ide</surname><given-names>K.</given-names></name>
<etal/>
</person-group><article-title>Antimicrobial Resistance and Genotyping of <italic toggle="yes">Pseudomonas aeruginosa</italic> Isolated from the Ear Canals of Dogs in Japan</article-title><source>Front. Vet. Sci.</source><year>2023</year><volume>10</volume><elocation-id>1074127</elocation-id><pub-id pub-id-type="doi">10.3389/fvets.2023.1074127</pub-id><pub-id pub-id-type="pmid">37546340</pub-id>
</element-citation></ref><ref id="B107-vetsci-12-00157"><label>107.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Litster</surname><given-names>A.</given-names></name>
<name><surname>Moss</surname><given-names>S.M.</given-names></name>
<name><surname>Honnery</surname><given-names>M.</given-names></name>
<name><surname>Rees</surname><given-names>B.</given-names></name>
<name><surname>Trott</surname><given-names>D.J.</given-names></name>
</person-group><article-title>Prevalence of Bacterial Species in Cats with Clinical Signs of Lower Urinary Tract Disease: Recognition of <italic toggle="yes">Staphylococcus felis</italic> as a Possible Feline Urinary Tract Pathogen</article-title><source>Vet. Microbiol.</source><year>2007</year><volume>121</volume><fpage>182</fpage><lpage>188</lpage><pub-id pub-id-type="doi">10.1016/j.vetmic.2006.11.025</pub-id><pub-id pub-id-type="pmid">17169507</pub-id>
</element-citation></ref><ref id="B108-vetsci-12-00157"><label>108.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Garc&#x000ea;s</surname><given-names>A.</given-names></name>
<name><surname>Lopes</surname><given-names>R.</given-names></name>
<name><surname>Silva</surname><given-names>A.</given-names></name>
<name><surname>Sampaio</surname><given-names>F.</given-names></name>
<name><surname>Duque</surname><given-names>D.</given-names></name>
<name><surname>Brilhante-Sim&#x000f5;es</surname><given-names>P.</given-names></name>
</person-group><article-title>Bacterial Isolates from Urinary Tract Infection in Dogs and Cats in Portugal, and Their Antibiotic Susceptibility Pattern: A Retrospective Study of 5 Years (2017&#x02013;2021)</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>1520</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11111520</pub-id><pub-id pub-id-type="pmid">36358175</pub-id>
</element-citation></ref><ref id="B109-vetsci-12-00157"><label>109.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Smoglica</surname><given-names>C.</given-names></name>
<name><surname>Evangelisti</surname><given-names>G.</given-names></name>
<name><surname>Fani</surname><given-names>C.</given-names></name>
<name><surname>Marsilio</surname><given-names>F.</given-names></name>
<name><surname>Trotta</surname><given-names>M.</given-names></name>
<name><surname>Messina</surname><given-names>F.</given-names></name>
<name><surname>Di Francesco</surname><given-names>C.E.</given-names></name>
</person-group><article-title>Antimicrobial Resistance Profile of Bacterial Isolates from Urinary Tract Infections in Companion Animals in Central Italy</article-title><source>Antibiotics</source><year>2022</year><volume>11</volume><elocation-id>1363</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics11101363</pub-id><pub-id pub-id-type="pmid">36290021</pub-id>
</element-citation></ref><ref id="B110-vetsci-12-00157"><label>110.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Aurori</surname><given-names>M.</given-names></name>
<name><surname>Novac</surname><given-names>C.&#x00218;.</given-names></name>
<name><surname>Nad&#x00103;&#x00219;</surname><given-names>G.C.</given-names></name>
<name><surname>Cr&#x00103;ciun</surname><given-names>S.</given-names></name>
<name><surname>Fi&#x00163;</surname><given-names>N.</given-names></name>
<name><surname>Andrei</surname><given-names>S.</given-names></name>
</person-group><article-title>The Antimicrobial Effect of <italic toggle="yes">Cornus mas</italic> L. and <italic toggle="yes">Sorbus aucuparia</italic> L. Fruit Extracts against Resistant Uropathogens in Correlation with the Prevalence of Urinary Tract Infections in Companion Animals</article-title><source>Pharmaceuticals</source><year>2024</year><volume>17</volume><elocation-id>814</elocation-id><pub-id pub-id-type="doi">10.3390/ph17060814</pub-id><pub-id pub-id-type="pmid">38931481</pub-id>
</element-citation></ref><ref id="B111-vetsci-12-00157"><label>111.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Foster</surname><given-names>J.D.</given-names></name>
</person-group><article-title>Today&#x02019;s Veterinary Practice. Use of Antibiotics for Treating UTIs in Dogs and Cats</article-title><source>Focus. Pharmacol.</source><year>2017</year><volume>7</volume><fpage>119</fpage><lpage>127</lpage></element-citation></ref><ref id="B112-vetsci-12-00157"><label>112.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pinthanon</surname><given-names>A.</given-names></name>
<name><surname>Nithitarnwat</surname><given-names>C.</given-names></name>
<name><surname>Pintapin</surname><given-names>C.</given-names></name>
<name><surname>Siripanee</surname><given-names>C.</given-names></name>
<name><surname>Yindee</surname><given-names>J.</given-names></name>
<name><surname>Am-in</surname><given-names>N.</given-names></name>
<name><surname>Kesdangsakonwut</surname><given-names>S.</given-names></name>
<name><surname>Surachetpong</surname><given-names>S.</given-names></name>
<name><surname>Prapasarakul</surname><given-names>N.</given-names></name>
</person-group><article-title>Rapid Identification of Canine Uropathogens by Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry and the Clinical Factors That Correlated Bacterial Species and Antimicrobial Resistance</article-title><source>Vet. Res. Commun.</source><year>2023</year><volume>47</volume><fpage>1457</fpage><lpage>1469</lpage><pub-id pub-id-type="doi">10.1007/s11259-023-10096-z</pub-id><pub-id pub-id-type="pmid">37036600</pub-id>
</element-citation></ref><ref id="B113-vetsci-12-00157"><label>113.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Maeda</surname><given-names>H.</given-names></name>
<name><surname>Hayashi</surname><given-names>K.</given-names></name>
<name><surname>Ishige</surname><given-names>T.</given-names></name>
<name><surname>Sunagawa</surname><given-names>T.</given-names></name>
<name><surname>Tanigawa</surname><given-names>S.</given-names></name>
<name><surname>Mishina</surname><given-names>M.</given-names></name>
<name><surname>Watanabe</surname><given-names>T.</given-names></name>
<name><surname>Sogawa</surname><given-names>K.</given-names></name>
</person-group><article-title>Use of the Maldi Biotyper System and Rapid Bacpro with Maldi-Tof MS for Rapid Identification of Microorganisms Causing Bacterial Urinary Tract Infection in Feline Urine Samples</article-title><source>J. Vet. Med. Sci.</source><year>2018</year><volume>80</volume><fpage>1490</fpage><lpage>1494</lpage><pub-id pub-id-type="doi">10.1292/jvms.18-0145</pub-id><pub-id pub-id-type="pmid">30089741</pub-id>
</element-citation></ref><ref id="B114-vetsci-12-00157"><label>114.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Fe&#x000df;ler</surname><given-names>A.T.</given-names></name>
<name><surname>Wang</surname><given-names>Y.</given-names></name>
<name><surname>Burbick</surname><given-names>C.R.</given-names></name>
<name><surname>Diaz-Campos</surname><given-names>D.</given-names></name>
<name><surname>Fajt</surname><given-names>V.R.</given-names></name>
<name><surname>Lawhon</surname><given-names>S.D.</given-names></name>
<name><surname>Li</surname><given-names>X.-Z.</given-names></name>
<name><surname>Lubbers</surname><given-names>B.V.</given-names></name>
<name><surname>Maddock</surname><given-names>K.</given-names></name>
<name><surname>Miller</surname><given-names>R.A.</given-names></name>
<etal/>
</person-group><article-title>Antimicrobial Susceptibility Testing in Veterinary Medicine: Performance, Interpretation of Results, Best Practices and Pitfalls</article-title><source>One Health Adv.</source><year>2023</year><volume>1</volume><fpage>1</fpage><lpage>16</lpage><pub-id pub-id-type="doi">10.1186/s44280-023-00024-w</pub-id><pub-id pub-id-type="pmid">37521534</pub-id>
</element-citation></ref><ref id="B115-vetsci-12-00157"><label>115.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hall-Stoodley</surname><given-names>L.</given-names></name>
<name><surname>Stoodley</surname><given-names>P.</given-names></name>
<name><surname>Kathju</surname><given-names>S.</given-names></name>
<name><surname>H&#x000f8;iby</surname><given-names>N.</given-names></name>
<name><surname>Moser</surname><given-names>C.</given-names></name>
<name><surname>William Costerton</surname><given-names>J.</given-names></name>
<name><surname>Moter</surname><given-names>A.</given-names></name>
<name><surname>Bjarnsholt</surname><given-names>T.</given-names></name>
</person-group><article-title>Towards Diagnostic Guidelines for Biofilm-Associated Infections</article-title><source>FEMS Immunol. Med. Microbiol.</source><year>2012</year><volume>65</volume><fpage>127</fpage><lpage>145</lpage><pub-id pub-id-type="doi">10.1111/j.1574-695X.2012.00968.x</pub-id><pub-id pub-id-type="pmid">22469292</pub-id>
</element-citation></ref><ref id="B116-vetsci-12-00157"><label>116.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Abdullahi</surname><given-names>U.F.</given-names></name>
<name><surname>Igwenagu</surname><given-names>E.</given-names></name>
<name><surname>Mu&#x02019;azu</surname><given-names>A.</given-names></name>
<name><surname>Aliyu</surname><given-names>S.</given-names></name>
<name><surname>Umar</surname><given-names>M.I.</given-names></name>
</person-group><article-title>Intrigues of Biofilm: A Perspective in Veterinary Medicine</article-title><source>Vet. World</source><year>2016</year><volume>9</volume><fpage>12</fpage><lpage>18</lpage><pub-id pub-id-type="doi">10.14202/vetworld.2016.12-18</pub-id><pub-id pub-id-type="pmid">27051178</pub-id>
</element-citation></ref><ref id="B117-vetsci-12-00157"><label>117.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Wu</surname><given-names>H.</given-names></name>
<name><surname>Moser</surname><given-names>C.</given-names></name>
<name><surname>Wang</surname><given-names>H.Z.</given-names></name>
<name><surname>H&#x000f8;iby</surname><given-names>N.</given-names></name>
<name><surname>Song</surname><given-names>Z.J.</given-names></name>
</person-group><article-title>Strategies for Combating Bacterial Biofilm Infections</article-title><source>Int. J. Oral. Sci.</source><year>2015</year><volume>7</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="doi">10.1038/ijos.2014.65</pub-id><pub-id pub-id-type="pmid">25504208</pub-id>
</element-citation></ref><ref id="B118-vetsci-12-00157"><label>118.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Gatoria</surname><given-names>I.S.</given-names></name>
<name><surname>Saini</surname><given-names>N.S.</given-names></name>
<name><surname>Rai</surname><given-names>T.S.</given-names></name>
<name><surname>Dwivedi</surname><given-names>P.N.</given-names></name>
</person-group><article-title>Comparison of Three Techniques for the Diagnosis of Urinary Tract Infections in Dogs with Urolithiasis</article-title><source>J. Small Anim. Pract.</source><year>2006</year><volume>47</volume><fpage>727</fpage><lpage>732</lpage><pub-id pub-id-type="doi">10.1111/j.1748-5827.2006.00169.x</pub-id><pub-id pub-id-type="pmid">17201824</pub-id>
</element-citation></ref><ref id="B119-vetsci-12-00157"><label>119.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Evans</surname><given-names>S.R.</given-names></name>
<name><surname>Tran</surname><given-names>T.T.T.</given-names></name>
<name><surname>Hujer</surname><given-names>A.M.</given-names></name>
<name><surname>Hill</surname><given-names>C.B.</given-names></name>
<name><surname>Hujer</surname><given-names>K.M.</given-names></name>
<name><surname>Mediavilla</surname><given-names>J.R.</given-names></name>
<name><surname>Manca</surname><given-names>C.</given-names></name>
<name><surname>Domitrovic</surname><given-names>T.N.</given-names></name>
<name><surname>Perez</surname><given-names>F.</given-names></name>
<name><surname>Farmer</surname><given-names>M.</given-names></name>
<etal/>
</person-group><article-title>Rapid Molecular Diagnostics to Inform Empiric Use of Ceftazidime/Avibactam and Ceftolozane/Tazobactam Against <italic toggle="yes">Pseudomonas aeruginosa</italic>: PRIMERS IV</article-title><source>Clin. Infect. Dis.</source><year>2019</year><volume>68</volume><fpage>1823</fpage><lpage>1830</lpage><pub-id pub-id-type="doi">10.1093/cid/ciy801</pub-id><pub-id pub-id-type="pmid">30239599</pub-id>
</element-citation></ref><ref id="B120-vetsci-12-00157"><label>120.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Voulgari</surname><given-names>E.</given-names></name>
<name><surname>Miliotis</surname><given-names>G.</given-names></name>
<name><surname>Siatravani</surname><given-names>E.</given-names></name>
<name><surname>Tzouvelekis</surname><given-names>L.S.</given-names></name>
<name><surname>Tzelepi</surname><given-names>E.</given-names></name>
<name><surname>Miriagou</surname><given-names>V.</given-names></name>
</person-group><article-title>Evaluation of the Performance of Acuitas<sup>&#x000ae;</sup> Resistome Test and the Acuitas Lighthouse<sup>&#x000ae;</sup> Software for the Detection of &#x003b2;-Lactamase-Producing Microorganisms</article-title><source>J. Glob. Antimicrob. Resist.</source><year>2020</year><volume>22</volume><fpage>184</fpage><lpage>189</lpage><pub-id pub-id-type="doi">10.1016/j.jgar.2020.01.017</pub-id><pub-id pub-id-type="pmid">32061878</pub-id>
</element-citation></ref><ref id="B121-vetsci-12-00157"><label>121.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hu</surname><given-names>Y.Y.</given-names></name>
<name><surname>Cao</surname><given-names>J.M.</given-names></name>
<name><surname>Yang</surname><given-names>Q.</given-names></name>
<name><surname>Chen</surname><given-names>S.</given-names></name>
<name><surname>Lv</surname><given-names>H.Y.</given-names></name>
<name><surname>Zhou</surname><given-names>H.W.</given-names></name>
<name><surname>Wu</surname><given-names>Z.</given-names></name>
<name><surname>Zhang</surname><given-names>R.</given-names></name>
</person-group><article-title>Risk Factors for Carbapenem-Resistant <italic toggle="yes">Pseudomonas aeruginosa</italic>, Zhejiang Province, China</article-title><source>Emerg. Infect. Dis.</source><year>2019</year><volume>25</volume><fpage>1861</fpage><pub-id pub-id-type="doi">10.3201/eid2510.181699</pub-id><pub-id pub-id-type="pmid">31538558</pub-id>
</element-citation></ref><ref id="B122-vetsci-12-00157"><label>122.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Gigu&#x000e8;re</surname><given-names>S.</given-names></name>
<name><surname>Prescott</surname><given-names>J.F.</given-names></name>
<name><surname>Dowling</surname><given-names>P.M.</given-names></name>
</person-group><source>Antimicrobial Therapy in Veterinary Medicine</source><edition>5th ed.</edition><person-group person-group-type="editor">
<name><surname>Gigu&#x000e8;re</surname><given-names>S.</given-names></name>
<name><surname>Prescott</surname><given-names>J.F.</given-names></name>
<name><surname>Dowling</surname><given-names>P.M.</given-names></name>
</person-group><publisher-name>Wiley-Blackwell</publisher-name><publisher-loc>Hoboken, NJ, USA</publisher-loc><year>2013</year></element-citation></ref><ref id="B123-vetsci-12-00157"><label>123.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pang</surname><given-names>Z.</given-names></name>
<name><surname>Raudonis</surname><given-names>R.</given-names></name>
<name><surname>Glick</surname><given-names>B.R.</given-names></name>
<name><surname>Lin</surname><given-names>T.J.</given-names></name>
<name><surname>Cheng</surname><given-names>Z.</given-names></name>
</person-group><article-title>Antibiotic Resistance in <italic toggle="yes">Pseudomonas aeruginosa</italic>: Mechanisms and Alternative Therapeutic Strategies</article-title><source>Biotechnol. Adv.</source><year>2019</year><volume>37</volume><fpage>177</fpage><lpage>192</lpage><pub-id pub-id-type="doi">10.1016/j.biotechadv.2018.11.013</pub-id><pub-id pub-id-type="pmid">30500353</pub-id>
</element-citation></ref><ref id="B124-vetsci-12-00157"><label>124.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Barnard</surname><given-names>N.</given-names></name>
<name><surname>Foster</surname><given-names>A.</given-names></name>
</person-group><article-title>How to Treat <italic toggle="yes">Pseudomonas</italic> Otitis in Dogs</article-title><source>Vet. Rec.</source><year>2018</year><volume>182</volume><fpage>109</fpage><lpage>110</lpage><pub-id pub-id-type="doi">10.1136/vr.k413</pub-id><pub-id pub-id-type="pmid">29374119</pub-id>
</element-citation></ref><ref id="B125-vetsci-12-00157"><label>125.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Cabassi</surname><given-names>C.S.</given-names></name>
<name><surname>Sala</surname><given-names>A.</given-names></name>
<name><surname>Santospirito</surname><given-names>D.</given-names></name>
<name><surname>Alborali</surname><given-names>G.L.</given-names></name>
<name><surname>Carretto</surname><given-names>E.</given-names></name>
<name><surname>Ghibaudo</surname><given-names>G.</given-names></name>
<name><surname>Taddei</surname><given-names>S.</given-names></name>
</person-group><article-title>Activity of AMP2041 against Human and Animal Multidrug Resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> Clinical Isolates</article-title><source>Ann. Clin. Microbiol. Antimicrob.</source><year>2017</year><volume>16</volume><elocation-id>17</elocation-id><pub-id pub-id-type="doi">10.1186/s12941-017-0193-1</pub-id><pub-id pub-id-type="pmid">28335779</pub-id>
</element-citation></ref><ref id="B126-vetsci-12-00157"><label>126.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ghasemian</surname><given-names>E.</given-names></name>
<name><surname>Naghoni</surname><given-names>A.</given-names></name>
<name><surname>Rahvar</surname><given-names>H.</given-names></name>
<name><surname>Kialha</surname><given-names>M.</given-names></name>
<name><surname>Tabaraie</surname><given-names>B.</given-names></name>
</person-group><article-title>Evaluating the Effect of Copper Nanoparticles in Inhibiting <italic toggle="yes">Pseudomonas aeruginosa</italic> and <italic toggle="yes">Listeria monocytogenes</italic> Biofilm Formation</article-title><source>Jundishapur J. Microbiol.</source><year>2015</year><volume>8</volume><elocation-id>e17430</elocation-id><pub-id pub-id-type="doi">10.5812/jjm.17430</pub-id><pub-id pub-id-type="pmid">26290685</pub-id>
</element-citation></ref><ref id="B127-vetsci-12-00157"><label>127.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Zhou</surname><given-names>S.</given-names></name>
<name><surname>Zhang</surname><given-names>A.</given-names></name>
<name><surname>Chu</surname><given-names>W.</given-names></name>
</person-group><article-title>Phillyrin Is an Effective Inhibitor of Quorum Sensing with Potential as an Anti-<italic toggle="yes">Pseudomonas aeruginosa</italic> Infection Therapy</article-title><source>J. Vet. Med. Sci.</source><year>2019</year><volume>81</volume><fpage>473</fpage><pub-id pub-id-type="doi">10.1292/jvms.18-0523</pub-id><pub-id pub-id-type="pmid">30686799</pub-id>
</element-citation></ref><ref id="B128-vetsci-12-00157"><label>128.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Furusawa</surname><given-names>T.</given-names></name>
<name><surname>Iwano</surname><given-names>H.</given-names></name>
<name><surname>Higuchi</surname><given-names>H.</given-names></name>
<name><surname>Yokota</surname><given-names>H.</given-names></name>
<name><surname>Usui</surname><given-names>M.</given-names></name>
<name><surname>Iwasaki</surname><given-names>T.</given-names></name>
<name><surname>Tamura</surname><given-names>Y.</given-names></name>
</person-group><article-title>Bacteriophage Can Lyse Antibiotic-Resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> Isolated from Canine Diseases</article-title><source>J. Vet. Med. Sci.</source><year>2016</year><volume>78</volume><fpage>1035</fpage><lpage>1038</lpage><pub-id pub-id-type="doi">10.1292/jvms.15-0310</pub-id><pub-id pub-id-type="pmid">26876365</pub-id>
</element-citation></ref><ref id="B129-vetsci-12-00157"><label>129.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>D&#x000f6;ring</surname><given-names>G.</given-names></name>
<name><surname>Pier</surname><given-names>G.B.</given-names></name>
</person-group><article-title>Vaccines and Immunotherapy against <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>Vaccine</source><year>2008</year><volume>26</volume><fpage>1011</fpage><lpage>1024</lpage><pub-id pub-id-type="doi">10.1016/j.vaccine.2007.12.007</pub-id><pub-id pub-id-type="pmid">18242792</pub-id>
</element-citation></ref><ref id="B130-vetsci-12-00157"><label>130.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Guo</surname><given-names>Z.</given-names></name>
<name><surname>Zhu</surname><given-names>Y.</given-names></name>
<name><surname>Du</surname><given-names>G.</given-names></name>
<name><surname>Qin</surname><given-names>M.</given-names></name>
<name><surname>He</surname><given-names>C.</given-names></name>
<name><surname>He</surname><given-names>P.</given-names></name>
<name><surname>Song</surname><given-names>Y.</given-names></name>
<name><surname>Chen</surname><given-names>W.</given-names></name>
<name><surname>Bai</surname><given-names>S.</given-names></name>
<name><surname>Wu</surname><given-names>F.</given-names></name>
<etal/>
</person-group><article-title>Rapid Development of a Subunit Nano-Vaccine against Drug-Resistant <italic toggle="yes">Pseudomonas aeruginosa</italic> with Effective Cross-Protection</article-title><source>Nano Today</source><year>2022</year><volume>43</volume><fpage>101398</fpage><pub-id pub-id-type="doi">10.1016/j.nantod.2022.101398</pub-id></element-citation></ref><ref id="B131-vetsci-12-00157"><label>131.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Sultana</surname><given-names>S.T.</given-names></name>
<name><surname>Atci</surname><given-names>E.</given-names></name>
<name><surname>Babauta</surname><given-names>J.T.</given-names></name>
<name><surname>Mohamed Falghoush</surname><given-names>A.</given-names></name>
<name><surname>Snekvik</surname><given-names>K.R.</given-names></name>
<name><surname>Call</surname><given-names>D.R.</given-names></name>
<name><surname>Beyenal</surname><given-names>H.</given-names></name>
</person-group><article-title>Electrochemical Scaffold Generates Localized, Low Concentration of Hydrogen Peroxide That Inhibits Bacterial Pathogens and Biofilms</article-title><source>Sci. Rep.</source><year>2015</year><volume>5</volume><elocation-id>14908</elocation-id><pub-id pub-id-type="doi">10.1038/srep14908</pub-id><pub-id pub-id-type="pmid">26464174</pub-id>
</element-citation></ref><ref id="B132-vetsci-12-00157"><label>132.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>DiBartola</surname><given-names>S.P.</given-names></name>
<name><surname>Westropp</surname><given-names>J.D.</given-names></name>
</person-group><source>Small Animall Internal Medicine</source><edition>6th ed.</edition><person-group person-group-type="editor">
<name><surname>Couto</surname><given-names>G.</given-names></name>
<name><surname>Richard</surname><given-names>N.</given-names></name>
</person-group><publisher-name>Elsevier</publisher-name><publisher-loc>St Louis, MI, USA</publisher-loc><year>2023</year></element-citation></ref><ref id="B133-vetsci-12-00157"><label>133.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kovarikova</surname><given-names>S.</given-names></name>
</person-group><article-title>Urinary Biomarkers of Renal Function in Dogs and Cats: A Review</article-title><source>Vet. Med.</source><year>2015</year><volume>60</volume><fpage>589</fpage><lpage>602</lpage><pub-id pub-id-type="doi">10.17221/8527-VETMED</pub-id></element-citation></ref><ref id="B134-vetsci-12-00157"><label>134.</label><element-citation publication-type="webpage"><article-title>Diagnosing and Managing Feline Lower Urinary Tract Disease</article-title><comment>Available online: <ext-link xlink:href="https://todaysveterinarypractice.com/urology-renal-medicine/diagnosing-and-managing-feline-lower-urinary-tract-disease/" ext-link-type="uri">https://todaysveterinarypractice.com/urology-renal-medicine/diagnosing-and-managing-feline-lower-urinary-tract-disease/</ext-link></comment><date-in-citation content-type="access-date" iso-8601-date="2025-01-07">(accessed on 7 January 2025)</date-in-citation></element-citation></ref><ref id="B135-vetsci-12-00157"><label>135.</label><element-citation publication-type="book"><person-group person-group-type="author">
<name><surname>Rodriguez</surname><given-names>M.D.</given-names></name>
</person-group><source>Enfermedades Del Tracto Urinario</source><person-group person-group-type="editor">
<collab>Manual Cl&#x000ed;nico de Medicina Interna En Peque&#x000f1;os Animales</collab>
</person-group><publisher-name>5M Publishing Ltd., Benchmark House</publisher-name><publisher-loc>London, UK</publisher-loc><year>2016</year><volume>Volume II</volume></element-citation></ref><ref id="B136-vetsci-12-00157"><label>136.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Pereira</surname><given-names>A.</given-names></name>
<name><surname>Jota Baptista</surname><given-names>C.</given-names></name>
<name><surname>Oliveira</surname><given-names>P.A.</given-names></name>
<name><surname>Coelho</surname><given-names>A.C.</given-names></name>
</person-group><article-title>Urinary Tract Bacterial Infections in Small Animal Practice: Clinical and Epidemiological Aspects</article-title><source>Vet. Stanica</source><year>2024</year><volume>55</volume><fpage>703</fpage><lpage>720</lpage><pub-id pub-id-type="doi">10.46419/vs.55.6.8</pub-id></element-citation></ref><ref id="B137-vetsci-12-00157"><label>137.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Marques</surname><given-names>C.</given-names></name>
<name><surname>Belas</surname><given-names>A.</given-names></name>
<name><surname>Franco</surname><given-names>A.</given-names></name>
<name><surname>Aboim</surname><given-names>C.</given-names></name>
<name><surname>Gama</surname><given-names>L.T.</given-names></name>
<name><surname>Pomba</surname><given-names>C.</given-names></name>
</person-group><article-title>Increase in Antimicrobial Resistance and Emergence of Major International High-Risk Clonal Lineages in Dogs and Cats with Urinary Tract Infection: 16 Year Retrospective Study</article-title><source>J. Antimicrob. Chemother.</source><year>2018</year><volume>73</volume><fpage>377</fpage><lpage>384</lpage><pub-id pub-id-type="doi">10.1093/jac/dkx401</pub-id><pub-id pub-id-type="pmid">29136156</pub-id>
</element-citation></ref><ref id="B138-vetsci-12-00157"><label>138.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Escher</surname><given-names>M.</given-names></name>
<name><surname>Vanni</surname><given-names>M.</given-names></name>
<name><surname>Intorre</surname><given-names>L.</given-names></name>
<name><surname>Caprioli</surname><given-names>A.</given-names></name>
<name><surname>Tognetti</surname><given-names>R.</given-names></name>
<name><surname>Scavia</surname><given-names>G.</given-names></name>
</person-group><article-title>Use of Antimicrobials in Companion Animal Practice: A Retrospective Study in a Veterinary Teaching Hospital in Italy</article-title><source>J. Antimicrob. Chemother.</source><year>2011</year><volume>66</volume><fpage>920</fpage><lpage>927</lpage><pub-id pub-id-type="doi">10.1093/jac/dkq543</pub-id><pub-id pub-id-type="pmid">21393194</pub-id>
</element-citation></ref><ref id="B139-vetsci-12-00157"><label>139.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Caneschi</surname><given-names>A.</given-names></name>
<name><surname>Bardhi</surname><given-names>A.</given-names></name>
<name><surname>Barbarossa</surname><given-names>A.</given-names></name>
<name><surname>Zaghini</surname><given-names>A.</given-names></name>
</person-group><article-title>The Use of Antibiotics and Antimicrobial Resistance in Veterinary Medicine, a Complex Phenomenon: A Narrative Review</article-title><source>Antibiotics</source><year>2023</year><volume>12</volume><elocation-id>487</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics12030487</pub-id><pub-id pub-id-type="pmid">36978354</pub-id>
</element-citation></ref><ref id="B140-vetsci-12-00157"><label>140.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mesaros</surname><given-names>N.</given-names></name>
<name><surname>Nordmann</surname><given-names>P.</given-names></name>
<name><surname>Pl&#x000e9;siat</surname><given-names>P.</given-names></name>
<name><surname>Roussel-Delvallez</surname><given-names>M.</given-names></name>
<name><surname>Van Eldere</surname><given-names>J.</given-names></name>
<name><surname>Glupczynski</surname><given-names>Y.</given-names></name>
<name><surname>Van Laethem</surname><given-names>Y.</given-names></name>
<name><surname>Jacobs</surname><given-names>F.</given-names></name>
<name><surname>Lebecque</surname><given-names>P.</given-names></name>
<name><surname>Malfroot</surname><given-names>A.</given-names></name>
<etal/>
</person-group><article-title><italic toggle="yes">Pseudomonas aeruginosa</italic>: Resistance and Therapeutic Options at the Turn of the New Millennium</article-title><source>Clin. Microbiol. Infect.</source><year>2007</year><volume>13</volume><fpage>S27</fpage><lpage>S40</lpage><pub-id pub-id-type="doi">10.1111/j.1469-0691.2007.01681.x</pub-id></element-citation></ref><ref id="B141-vetsci-12-00157"><label>141.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Robbins</surname><given-names>S.N.</given-names></name>
<name><surname>Goggs</surname><given-names>R.</given-names></name>
<name><surname>Lhermie</surname><given-names>G.</given-names></name>
<name><surname>Lalonde-Paul</surname><given-names>D.F.</given-names></name>
<name><surname>Menard</surname><given-names>J.</given-names></name>
</person-group><article-title>Antimicrobial Prescribing Practices in Small Animal Emergency and Critical Care</article-title><source>Front. Vet. Sci.</source><year>2020</year><volume>7</volume><elocation-id>110</elocation-id><pub-id pub-id-type="doi">10.3389/fvets.2020.00110</pub-id><pub-id pub-id-type="pmid">32258067</pub-id>
</element-citation></ref><ref id="B142-vetsci-12-00157"><label>142.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Mouiche</surname><given-names>M.M.M.</given-names></name>
<name><surname>Mpouam</surname><given-names>S.E.</given-names></name>
<name><surname>Moffo</surname><given-names>F.</given-names></name>
<name><surname>Nkassa</surname><given-names>C.M.N.</given-names></name>
<name><surname>Mbah</surname><given-names>C.K.</given-names></name>
<name><surname>Mapiefou</surname><given-names>N.P.</given-names></name>
<name><surname>Awah-Ndukum</surname><given-names>J.</given-names></name>
</person-group><article-title>Prescription Pattern of Antimicrobial Use in Small Animal Veterinary Practice in Cameroon</article-title><source>Top. Companion Anim. Med.</source><year>2021</year><volume>44</volume><fpage>100540</fpage><pub-id pub-id-type="doi">10.1016/j.tcam.2021.100540</pub-id><pub-id pub-id-type="pmid">33984558</pub-id>
</element-citation></ref><ref id="B143-vetsci-12-00157"><label>143.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Foglia Manzillo</surname><given-names>V.</given-names></name>
<name><surname>Peruzy</surname><given-names>M.F.</given-names></name>
<name><surname>Gizzarelli</surname><given-names>M.</given-names></name>
<name><surname>Izzo</surname><given-names>B.</given-names></name>
<name><surname>Sarnelli</surname><given-names>P.</given-names></name>
<name><surname>Carrella</surname><given-names>A.</given-names></name>
<name><surname>Vinciguerra</surname><given-names>G.</given-names></name>
<name><surname>Chirollo</surname><given-names>C.</given-names></name>
<name><surname>Ben Fayala</surname><given-names>N.E.H.</given-names></name>
<name><surname>Balestrino</surname><given-names>I.</given-names></name>
<etal/>
</person-group><article-title>Examining the Veterinary Electronic Antimicrobial Prescriptions for Dogs and Cats in the Campania Region, Italy: Corrective Strategies Are Imperative</article-title><source>Animals</source><year>2023</year><volume>13</volume><elocation-id>2869</elocation-id><pub-id pub-id-type="doi">10.3390/ani13182869</pub-id><pub-id pub-id-type="pmid">37760269</pub-id>
</element-citation></ref><ref id="B144-vetsci-12-00157"><label>144.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Kothari</surname><given-names>A.</given-names></name>
<name><surname>Kherdekar</surname><given-names>R.</given-names></name>
<name><surname>Mago</surname><given-names>V.</given-names></name>
<name><surname>Uniyal</surname><given-names>M.</given-names></name>
<name><surname>Mamgain</surname><given-names>G.</given-names></name>
<name><surname>Kalia</surname><given-names>R.B.</given-names></name>
<name><surname>Kumar</surname><given-names>S.</given-names></name>
<name><surname>Jain</surname><given-names>N.</given-names></name>
<name><surname>Pandey</surname><given-names>A.</given-names></name>
<name><surname>Omar</surname><given-names>B.J.</given-names></name>
</person-group><article-title>Age of Antibiotic Resistance in MDR/XDR Clinical Pathogen of <italic toggle="yes">Pseudomonas aeruginosa</italic></article-title><source>Pharmaceuticals</source><year>2023</year><volume>16</volume><elocation-id>1230</elocation-id><pub-id pub-id-type="doi">10.3390/ph16091230</pub-id><pub-id pub-id-type="pmid">37765038</pub-id>
</element-citation></ref><ref id="B145-vetsci-12-00157"><label>145.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Vercelli</surname><given-names>C.</given-names></name>
<name><surname>Della Ricca</surname><given-names>M.</given-names></name>
<name><surname>Re</surname><given-names>M.</given-names></name>
<name><surname>Gambino</surname><given-names>G.</given-names></name>
<name><surname>Re</surname><given-names>G.</given-names></name>
</person-group><article-title>Antibiotic Stewardship for Canine and Feline Acute Urinary Tract Infection: An Observational Study in a Small Animal Hospital in Northwest Italy</article-title><source>Antibiotics</source><year>2021</year><volume>10</volume><elocation-id>562</elocation-id><pub-id pub-id-type="doi">10.3390/antibiotics10050562</pub-id><pub-id pub-id-type="pmid">34064943</pub-id>
</element-citation></ref><ref id="B146-vetsci-12-00157"><label>146.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Hubbuch</surname><given-names>A.</given-names></name>
<name><surname>Schmitt</surname><given-names>K.</given-names></name>
<name><surname>Lehner</surname><given-names>C.</given-names></name>
<name><surname>Hartnack</surname><given-names>S.</given-names></name>
<name><surname>Schuller</surname><given-names>S.</given-names></name>
<name><surname>Sch&#x000fc;pbach-Regula</surname><given-names>G.</given-names></name>
<name><surname>Mevissen</surname><given-names>M.</given-names></name>
<name><surname>Peter</surname><given-names>R.</given-names></name>
<name><surname>M&#x000fc;ntener</surname><given-names>C.</given-names></name>
<name><surname>Naegeli</surname><given-names>H.</given-names></name>
<etal/>
</person-group><article-title>Antimicrobial Prescriptions in Cats in Switzerland before and after the Introduction of an Online Antimicrobial Stewardship Tool</article-title><source>BMC Vet. Res.</source><year>2020</year><volume>16</volume><fpage>229</fpage><pub-id pub-id-type="doi">10.1186/s12917-020-02447-8</pub-id><pub-id pub-id-type="pmid">32620170</pub-id>
</element-citation></ref><ref id="B147-vetsci-12-00157"><label>147.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Lehner</surname><given-names>C.</given-names></name>
<name><surname>Hubbuch</surname><given-names>A.</given-names></name>
<name><surname>Schmitt</surname><given-names>K.</given-names></name>
<name><surname>Schuepbach-Regula</surname><given-names>G.</given-names></name>
<name><surname>Willi</surname><given-names>B.</given-names></name>
<name><surname>Mevissen</surname><given-names>M.</given-names></name>
<name><surname>Peter</surname><given-names>R.</given-names></name>
<name><surname>Muentener</surname><given-names>C.R.</given-names></name>
<name><surname>Naegeli</surname><given-names>H.</given-names></name>
<name><surname>Schuller</surname><given-names>S.</given-names></name>
</person-group><article-title>Effect of Antimicrobial Stewardship on Antimicrobial Prescriptions for Selected Diseases of Dogs in Switzerland</article-title><source>J. Vet. Intern. Med.</source><year>2020</year><volume>34</volume><fpage>2418</fpage><lpage>2431</lpage><pub-id pub-id-type="doi">10.1111/jvim.15906</pub-id><pub-id pub-id-type="pmid">33112451</pub-id>
</element-citation></ref><ref id="B148-vetsci-12-00157"><label>148.</label><element-citation publication-type="journal"><person-group person-group-type="author">
<name><surname>Ghadaksaz</surname><given-names>A.</given-names></name>
<name><surname>Imani Fooladi</surname><given-names>A.A.</given-names></name>
<name><surname>Hosseini</surname><given-names>H.M.</given-names></name>
<name><surname>Amin</surname><given-names>M.</given-names></name>
</person-group><article-title>The Prevalence of Some <italic toggle="yes">Pseudomonas</italic> Virulence Genes Related to Biofilm Formation and Alginate Production among Clinical Isolates</article-title><source>J. Appl. Biomed.</source><year>2015</year><volume>13</volume><fpage>61</fpage><lpage>68</lpage><pub-id pub-id-type="doi">10.1016/j.jab.2014.05.002</pub-id></element-citation></ref></ref-list></back><floats-group><fig position="float" id="vetsci-12-00157-f002"><label>Figure 2</label><caption><p>The distribution of MRD PA across various countries in the European Union. <uri xlink:href="https://atlas.ecdc.europa.eu/public/index.aspx">https://atlas.ecdc.europa.eu/public/index.aspx</uri> accessed on 30 January 2025.</p></caption><graphic xlink:href="vetsci-12-00157-g002" position="float"/></fig><fig position="float" id="vetsci-12-00157-f003"><label>Figure 3</label><caption><p>Antibiotic resistance of Pseudomonas in Portugal. OneHealthTrust. ResistanceMap: antibiotic resistance of <italic toggle="yes">Pseudomonas aeruginosa</italic> in Portugal. 2025. OneHealthTrust. Date accessed: 28 January 2025.</p></caption><graphic xlink:href="vetsci-12-00157-g003" position="float"/></fig><table-wrap position="float" id="vetsci-12-00157-t004"><object-id pub-id-type="pii">vetsci-12-00157-t004_Table 4</object-id><label>Table 4</label><caption><p>Published research on alternative strategies for antimicrobial treatment.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Alternative Strategy</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">Description</th><th align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1" colspan="1">References</th></tr></thead><tbody><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Peptide Amp 2041</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Positive results in human and animal research.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B125-vetsci-12-00157" ref-type="bibr">125</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Fruit extracts <break/> (<italic toggle="yes">Cornus mas</italic> L. and <italic toggle="yes">Sorbus aucuparia</italic>)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Might be used as substitutes or adjuvants for antibiotics in UTI isolates of companion animals.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B110-vetsci-12-00157" ref-type="bibr">110</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Nanoparticles</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Promising in reducing PA growth as well as in the formation of its biofilm.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B126-vetsci-12-00157" ref-type="bibr">126</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phillyrin</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">It is an effective inhibitor of quorum sensing with potential for PA infection therapy.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B127-vetsci-12-00157" ref-type="bibr">127</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Phages</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">In a study on dogs with PA skin infection, the application of phages was greatly effective in the control of this pathogen.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B60-vetsci-12-00157" ref-type="bibr">60</xref>,<xref rid="B128-vetsci-12-00157" ref-type="bibr">128</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">PEM (protein epitope mimetic)</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">It has emerged as a novel class of antibiotics against PA. They inhibit the transport of LPS to the outer membrane.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B123-vetsci-12-00157" ref-type="bibr">123</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Vaccines</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">There is not a PA vaccine currently available on the market, although several different vaccines and several monoclonal antibodies have been developed in recent decades.</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B129-vetsci-12-00157" ref-type="bibr">129</xref>,<xref rid="B130-vetsci-12-00157" ref-type="bibr">130</xref>]</td></tr><tr><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Electrochemical <break/> scaffold</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">Disruption of bacterial biofilms and increase in antibiotic penetration</td><td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">[<xref rid="B131-vetsci-12-00157" ref-type="bibr">131</xref>]</td></tr></tbody></table></table-wrap></floats-group></article>